Procedure Code |
Procedure Description |
Pricing Indicator |
Rate Type |
Mod1 |
Mod2 |
Mod3 |
Mod4 |
Max Fee |
Max Fee Eff. Date |
Max Fee End Date |
PA |
0001A |
ADM SARSCOV2 30MCG/0.3ML 1ST |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
0001A |
ADM SARSCOV2 30MCG/0.3ML 1ST |
MAXFEE |
DEF |
|
|
|
|
37.66 |
1/1/2022 |
12/31/2299 |
N |
0002A |
ADM SARSCOV2 30MCG/0.3ML 2ND |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
0002A |
ADM SARSCOV2 30MCG/0.3ML 2ND |
MAXFEE |
DEF |
|
|
|
|
37.66 |
1/1/2022 |
12/31/2299 |
N |
0003A |
ADM SARSCOV2 30MCG/0.3ML 3RD |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
0003A |
ADM SARSCOV2 30MCG/0.3ML 3RD |
MAXFEE |
DEF |
|
|
|
|
37.66 |
1/1/2022 |
12/31/2299 |
N |
0004A |
ADM SARSCOV2 30MCG/0.3ML BST |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
0004A |
ADM SARSCOV2 30MCG/0.3ML BST |
MAXFEE |
DEF |
|
|
|
|
37.66 |
1/1/2022 |
12/31/2299 |
N |
0011A |
ADM SARSCOV2 100MCG/0.5ML1ST |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
0011A |
ADM SARSCOV2 100MCG/0.5ML1ST |
MAXFEE |
DEF |
|
|
|
|
37.66 |
1/1/2022 |
12/31/2299 |
N |
0012A |
ADM SARSCOV2 100MCG/0.5ML2ND |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
0012A |
ADM SARSCOV2 100MCG/0.5ML2ND |
MAXFEE |
DEF |
|
|
|
|
37.66 |
1/1/2022 |
12/31/2299 |
N |
0013A |
ADM SARSCOV2 100MCG/0.5ML3RD |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
0013A |
ADM SARSCOV2 100MCG/0.5ML3RD |
MAXFEE |
DEF |
|
|
|
|
37.66 |
1/1/2022 |
12/31/2299 |
N |
0041A |
ADM SARSCOV2 5MCG/0.5ML 1ST |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
0041A |
ADM SARSCOV2 5MCG/0.5ML 1ST |
MAXFEE |
DEF |
|
|
|
|
39.94 |
7/1/2023 |
12/31/2299 |
N |
0042A |
ADM SARSCOV2 5MCG/0.5ML 2ND |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
0042A |
ADM SARSCOV2 5MCG/0.5ML 2ND |
MAXFEE |
DEF |
|
|
|
|
39.94 |
7/1/2023 |
12/31/2299 |
N |
0044A |
ADM SARSCOV2 5MCG/0.5ML BST |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
0044A |
ADM SARSCOV2 5MCG/0.5ML BST |
MAXFEE |
DEF |
|
|
|
|
39.94 |
7/1/2023 |
12/31/2299 |
N |
0051A |
ADM SARSCV2 30MCG TRS-SUCR 1 |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
0051A |
ADM SARSCV2 30MCG TRS-SUCR 1 |
MAXFEE |
DEF |
|
|
|
|
37.66 |
1/3/2022 |
12/31/2299 |
N |
0052A |
ADM SARSCV2 30MCG TRS-SUCR 2 |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
0052A |
ADM SARSCV2 30MCG TRS-SUCR 2 |
MAXFEE |
DEF |
|
|
|
|
37.66 |
1/3/2022 |
12/31/2299 |
N |
0053A |
ADM SARSCV2 30MCG TRS-SUCR 3 |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
0053A |
ADM SARSCV2 30MCG TRS-SUCR 3 |
MAXFEE |
DEF |
|
|
|
|
37.66 |
1/3/2022 |
12/31/2299 |
N |
0054A |
ADM SARSCV2 30MCG TRS-SUCR B |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
0054A |
ADM SARSCV2 30MCG TRS-SUCR B |
MAXFEE |
DEF |
|
|
|
|
37.66 |
1/3/2022 |
12/31/2299 |
N |
0064A |
ADM SARSCOV2 50MCG/0.25MLBST |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
0064A |
ADM SARSCOV2 50MCG/0.25MLBST |
MAXFEE |
DEF |
|
|
|
|
37.66 |
1/1/2022 |
12/31/2299 |
N |
0071A |
ADM SARSCV2 10MCG TRS-SUCR 1 |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
0071A |
ADM SARSCV2 10MCG TRS-SUCR 1 |
MAXFEE |
DEF |
|
|
|
|
37.66 |
1/1/2022 |
12/31/2299 |
N |
0072A |
ADM SARSCV2 10MCG TRS-SUCR 2 |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
0072A |
ADM SARSCV2 10MCG TRS-SUCR 2 |
MAXFEE |
DEF |
|
|
|
|
37.66 |
1/1/2022 |
12/31/2299 |
N |
0073A |
ADM SARSCV2 10MCG TRS-SUCR 3 |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
0073A |
ADM SARSCV2 10MCG TRS-SUCR 3 |
MAXFEE |
DEF |
|
|
|
|
37.66 |
1/3/2022 |
12/31/2299 |
N |
0074A |
ADM SARSCV2 10MCG TRS-SUCR B |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
0074A |
ADM SARSCV2 10MCG TRS-SUCR B |
MAXFEE |
DEF |
|
|
|
|
37.66 |
5/17/2022 |
12/31/2299 |
N |
0081A |
ADM SARSCV2 3MCG TRS-SUCR 1 |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
0081A |
ADM SARSCV2 3MCG TRS-SUCR 1 |
MAXFEE |
DEF |
|
|
|
|
37.66 |
6/17/2022 |
12/31/2299 |
N |
0082A |
ADM SARSCV2 3MCG TRS-SUCR 2 |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
0082A |
ADM SARSCV2 3MCG TRS-SUCR 2 |
MAXFEE |
DEF |
|
|
|
|
37.66 |
6/17/2022 |
12/31/2299 |
N |
0083A |
ADM SARSCV2 3MCG TRS-SUCR 3 |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
0083A |
ADM SARSCV2 3MCG TRS-SUCR 3 |
MAXFEE |
DEF |
|
|
|
|
37.66 |
6/17/2022 |
12/31/2299 |
N |
0091A |
ADM SARSCOV2 50 MCG/.5 ML1ST |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
0091A |
ADM SARSCOV2 50 MCG/.5 ML1ST |
MAXFEE |
DEF |
|
|
|
|
37.66 |
6/17/2022 |
12/31/2299 |
N |
0092A |
ADM SARSCOV2 50 MCG/.5 ML2ND |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
0092A |
ADM SARSCOV2 50 MCG/.5 ML2ND |
MAXFEE |
DEF |
|
|
|
|
37.66 |
6/17/2022 |
12/31/2299 |
N |
0093A |
ADM SARSCOV2 50 MCG/.5 ML3RD |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
0093A |
ADM SARSCOV2 50 MCG/.5 ML3RD |
MAXFEE |
DEF |
|
|
|
|
37.66 |
6/17/2022 |
12/31/2299 |
N |
0094A |
ADM SARSCOV2 50 MCG/.5 MLBST |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
0094A |
ADM SARSCOV2 50 MCG/.5 MLBST |
MAXFEE |
DEF |
|
|
|
|
37.66 |
3/29/2022 |
12/31/2299 |
N |
0111A |
ADM SARSCOV2 25MCG/0.25ML1ST |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
0111A |
ADM SARSCOV2 25MCG/0.25ML1ST |
MAXFEE |
DEF |
|
|
|
|
37.66 |
6/17/2022 |
12/31/2299 |
N |
0112A |
ADM SARSCOV2 25MCG/0.25ML2ND |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
0112A |
ADM SARSCOV2 25MCG/0.25ML2ND |
MAXFEE |
DEF |
|
|
|
|
37.66 |
6/17/2022 |
12/31/2299 |
N |
0113A |
ADM SARSCOV2 25MCG/0.25ML3RD |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
0113A |
ADM SARSCOV2 25MCG/0.25ML3RD |
MAXFEE |
DEF |
|
|
|
|
37.66 |
8/31/2022 |
12/31/2299 |
N |
0121A |
ADM SARSCV2 BVL 30MCG/.3ML 1 |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
0121A |
ADM SARSCV2 BVL 30MCG/.3ML 1 |
MAXFEE |
DEF |
|
|
|
|
39.94 |
4/18/2023 |
12/31/2299 |
N |
0124A |
ADM SARSCV2 BVL 30MCG/.3ML A |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
0124A |
ADM SARSCV2 BVL 30MCG/.3ML A |
MAXFEE |
DEF |
|
|
|
|
39.94 |
7/1/2023 |
12/31/2299 |
N |
0134A |
ADM SARSCV2 BVL 50MCG/.5ML A |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
0134A |
ADM SARSCV2 BVL 50MCG/.5ML A |
MAXFEE |
DEF |
|
|
|
|
39.94 |
7/1/2023 |
12/31/2299 |
N |
0141A |
ADM SRSCV2 BVL 25MCG/.25ML 1 |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
0141A |
ADM SRSCV2 BVL 25MCG/.25ML 1 |
MAXFEE |
DEF |
|
|
|
|
39.94 |
4/18/2023 |
12/31/2299 |
N |
0142A |
ADM SRSCV2 BVL 25MCG/.25ML 2 |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
0142A |
ADM SRSCV2 BVL 25MCG/.25ML 2 |
MAXFEE |
DEF |
|
|
|
|
39.94 |
4/18/2023 |
12/31/2299 |
N |
0144A |
ADM SRSCV2 BVL 25MCG/.25ML A |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
0144A |
ADM SRSCV2 BVL 25MCG/.25ML A |
MAXFEE |
DEF |
|
|
|
|
39.94 |
7/1/2023 |
12/31/2299 |
N |
0151A |
ADM SARSCV2 BVL 10MCG/.2ML 1 |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
0151A |
ADM SARSCV2 BVL 10MCG/.2ML 1 |
MAXFEE |
DEF |
|
|
|
|
39.94 |
4/18/2023 |
12/31/2299 |
N |
0154A |
ADM SARSCV2 BVL 10MCG/.2ML A |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
0154A |
ADM SARSCV2 BVL 10MCG/.2ML A |
MAXFEE |
DEF |
|
|
|
|
39.94 |
7/1/2023 |
12/31/2299 |
N |
0164A |
ADM SRSCV2 BVL 10MCG/0.2ML A |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
0164A |
ADM SRSCV2 BVL 10MCG/0.2ML A |
MAXFEE |
DEF |
|
|
|
|
39.94 |
7/1/2023 |
12/31/2299 |
N |
0171A |
ADM SARSCV2 BVL 3MCG/0.2ML 1 |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
0171A |
ADM SARSCV2 BVL 3MCG/0.2ML 1 |
MAXFEE |
DEF |
|
|
|
|
39.94 |
4/18/2023 |
12/31/2299 |
N |
0172A |
ADM SARSCV2 BVL 3MCG/0.2ML 2 |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
0172A |
ADM SARSCV2 BVL 3MCG/0.2ML 2 |
MAXFEE |
DEF |
|
|
|
|
39.94 |
4/18/2023 |
12/31/2299 |
N |
0173A |
ADM SARSCV2 BVL 3MCG/0.2ML 3 |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
0173A |
ADM SARSCV2 BVL 3MCG/0.2ML 3 |
MAXFEE |
DEF |
|
|
|
|
39.94 |
7/1/2023 |
12/31/2299 |
N |
0174A |
ADM SARSCV2 BVL 3MCG/0.2ML A |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
0174A |
ADM SARSCV2 BVL 3MCG/0.2ML A |
MAXFEE |
DEF |
|
|
|
|
39.94 |
7/1/2023 |
12/31/2299 |
N |
90281 |
HUMAN IG IM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90281 |
HUMAN IG IM |
MAXFEE |
DEF |
|
|
|
|
26.37 |
9/1/2013 |
12/31/2299 |
N |
90284 |
HUMAN IG SC |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90284 |
HUMAN IG SC |
MAXFEE |
DEF |
|
|
|
|
28.07 |
9/1/2013 |
12/31/2299 |
N |
90287 |
BOTULINUM ANTITOXIN |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90287 |
BOTULINUM ANTITOXIN |
MAXFEE |
DEF |
|
|
|
|
40.99 |
7/1/2003 |
12/31/2299 |
N |
90291 |
CMV IG IV |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90291 |
CMV IG IV |
MAXFEE |
DEF |
|
|
|
|
24.90 |
9/1/2013 |
12/31/2299 |
N |
90296 |
DIPHTHERIA ANTITOXIN |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90296 |
DIPHTHERIA ANTITOXIN |
MANUAL |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90371 |
HEP B IG IM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90371 |
HEP B IG IM |
MAXFEE |
DEF |
|
|
|
|
136.74 |
7/1/2023 |
12/31/2299 |
N |
90375 |
RABIES IG IM/SC |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90375 |
RABIES IG IM/SC |
MAXFEE |
DEF |
|
|
|
|
284.68 |
7/1/2023 |
12/31/2299 |
N |
90376 |
RABIES IG HEAT TREATED |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90376 |
RABIES IG HEAT TREATED |
MAXFEE |
DEF |
|
|
|
|
250.09 |
7/1/2023 |
12/31/2299 |
N |
90377 |
RABIES IG HT&SOL HUMAN IM/SC |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90377 |
RABIES IG HT&SOL HUMAN IM/SC |
MAXFEE |
DEF |
|
|
|
|
234.09 |
7/1/2023 |
12/31/2299 |
N |
90378 |
RSV MAB IM 50MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90378 |
RSV MAB IM 50MG |
MAXFEE |
DEF |
|
|
|
|
1359.81 |
9/1/2013 |
12/31/2299 |
N |
90384 |
RH IG FULL-DOSE IM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90384 |
RH IG FULL-DOSE IM |
MAXFEE |
DEF |
|
|
|
|
112.13 |
9/1/2013 |
12/31/2299 |
N |
90385 |
RH IG MINIDOSE IM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90385 |
RH IG MINIDOSE IM |
MAXFEE |
DEF |
|
|
|
|
34.66 |
8/1/2014 |
12/31/2299 |
N |
90389 |
TETANUS IG IM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90389 |
TETANUS IG IM |
MAXFEE |
DEF |
|
|
|
|
367.31 |
9/1/2013 |
12/31/2299 |
N |
90393 |
VACCINA IG IM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90393 |
VACCINA IG IM |
MANUAL |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90396 |
VARICELLA-ZOSTER IG IM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90396 |
VARICELLA-ZOSTER IG IM |
MAXFEE |
DEF |
|
|
|
|
695.50 |
9/1/2013 |
12/31/2299 |
N |
90460 |
IM ADMIN 1ST/ONLY COMPONENT |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90460 |
IM ADMIN 1ST/ONLY COMPONENT |
MAXFEE |
DEF |
|
|
|
|
15 |
1/1/2016 |
12/31/2299 |
N |
90471 |
IMMUNIZATION ADMIN |
MAXFLT |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90471 |
IMMUNIZATION ADMIN |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90472 |
IMMUNIZATION ADMIN EACH ADD |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90472 |
IMMUNIZATION ADMIN EACH ADD |
MAXFEE |
DEF |
|
|
|
|
9.85 |
1/1/2022 |
12/31/2299 |
N |
90473 |
IMMUNE ADMIN ORAL/NASAL |
MAXFLT |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90473 |
IMMUNE ADMIN ORAL/NASAL |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90474 |
IMMUNE ADMIN ORAL/NASAL ADDL |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90474 |
IMMUNE ADMIN ORAL/NASAL ADDL |
MAXFEE |
DEF |
|
|
|
|
9.85 |
1/1/2022 |
12/31/2299 |
N |
90584 |
DENGUE VACC QUAD 2 DOSE SUBQ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90584 |
DENGUE VACC QUAD 2 DOSE SUBQ |
MAXFEE |
VFC |
|
|
|
|
0 |
7/1/2022 |
12/31/2299 |
N |
90585 |
BCG VACCINE PERCUT |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90585 |
BCG VACCINE PERCUT |
MAXFEE |
VFC |
|
|
|
|
NA |
|
|
N |
90585 |
BCG VACCINE PERCUT |
MAXFEE |
DEF |
|
|
|
|
141.25 |
1/1/2020 |
12/31/2299 |
N |
90586 |
BCG VACCINE INTRAVESICAL |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90586 |
BCG VACCINE INTRAVESICAL |
MAXFEE |
VFC |
|
|
|
|
NA |
|
|
N |
90586 |
BCG VACCINE INTRAVESICAL |
MAXFEE |
DEF |
|
|
|
|
144.71 |
7/1/2023 |
12/31/2299 |
N |
90611 |
SMALLPOX&MONKEYPOX VAC 0.5ML |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90611 |
SMALLPOX&MONKEYPOX VAC 0.5ML |
MAXFEE |
DEF |
|
|
|
|
0.01 |
7/26/2022 |
12/31/2299 |
N |
90619 |
MENACWY-TT VACCINE IM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90619 |
MENACWY-TT VACCINE IM |
MAXFEE |
VFC |
|
|
|
|
0 |
10/1/2021 |
12/31/2299 |
N |
90619 |
MENACWY-TT VACCINE IM |
MAXFEE |
DEF |
|
|
|
|
150.53 |
10/1/2021 |
12/31/2299 |
N |
90620 |
MENB-4C VACC 2 DOSE IM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90620 |
MENB-4C VACC 2 DOSE IM |
MAXFEE |
VFC |
|
|
|
|
0 |
1/1/2016 |
12/31/2299 |
N |
90620 |
MENB-4C VACC 2 DOSE IM |
MAXFEE |
DEF |
|
|
|
|
171.20 |
8/1/2015 |
12/31/2299 |
N |
90621 |
MENB-FHBP VACC 2/3 DOSE IM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90621 |
MENB-FHBP VACC 2/3 DOSE IM |
MAXFEE |
VFC |
|
|
|
|
0 |
1/1/2016 |
12/31/2299 |
N |
90621 |
MENB-FHBP VACC 2/3 DOSE IM |
MAXFEE |
DEF |
|
|
|
|
123.05 |
8/1/2015 |
12/31/2299 |
N |
90622 |
VACCINIA VRS VAC 0.3 ML PERQ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90622 |
VACCINIA VRS VAC 0.3 ML PERQ |
MAXFEE |
DEF |
|
|
|
|
0.01 |
7/26/2022 |
12/31/2299 |
N |
90626 |
TIC-BRN ENCEPH VAC 0.25ML IM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90626 |
TIC-BRN ENCEPH VAC 0.25ML IM |
MANUAL |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90627 |
TIC-BRN ENCEPH VAC 0.5ML IM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90627 |
TIC-BRN ENCEPH VAC 0.5ML IM |
MANUAL |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90630 |
FLU VACC IIV4 NO PRESERV ID |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90630 |
FLU VACC IIV4 NO PRESERV ID |
MAXFEE |
VFC |
|
|
|
|
NA |
|
|
N |
90630 |
FLU VACC IIV4 NO PRESERV ID |
MAXFEE |
DEF |
|
|
|
|
20.34 |
10/1/2016 |
12/31/2299 |
N |
90632 |
HEPA VACCINE ADULT IM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90632 |
HEPA VACCINE ADULT IM |
MAXFEE |
VFC |
|
|
|
|
NA |
|
|
N |
90632 |
HEPA VACCINE ADULT IM |
MAXFEE |
DEF |
|
|
|
|
71.85 |
7/1/2023 |
12/31/2299 |
N |
90633 |
HEPA VACC PED/ADOL 2 DOSE IM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90633 |
HEPA VACC PED/ADOL 2 DOSE IM |
MAXFEE |
VFC |
|
|
|
|
0 |
1/1/2016 |
12/31/2299 |
N |
90633 |
HEPA VACC PED/ADOL 2 DOSE IM |
MAXFEE |
DEF |
|
|
|
|
74.60 |
10/1/2021 |
12/31/2299 |
N |
90634 |
HEPA VACC PED/ADOL 3 DOSE |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90634 |
HEPA VACC PED/ADOL 3 DOSE |
MAXFEE |
VFC |
|
|
|
|
0 |
1/1/2016 |
12/31/2299 |
N |
90634 |
HEPA VACC PED/ADOL 3 DOSE |
MAXFEE |
DEF |
|
|
|
|
61.64 |
9/1/2013 |
12/31/2299 |
N |
90636 |
HEP A/HEP B VACC ADULT IM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90636 |
HEP A/HEP B VACC ADULT IM |
MAXFEE |
VFC |
|
|
|
|
NA |
|
|
N |
90636 |
HEP A/HEP B VACC ADULT IM |
MAXFEE |
DEF |
|
|
|
|
97.37 |
9/1/2013 |
12/31/2299 |
N |
90644 |
HIB-MENCY VACC 6WK-18M0 IM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90644 |
HIB-MENCY VACC 6WK-18M0 IM |
MAXFEE |
VFC |
|
|
|
|
0 |
1/1/2016 |
12/31/2299 |
N |
90644 |
HIB-MENCY VACC 6WK-18M0 IM |
MAXFEE |
DEF |
|
|
|
|
NA |
|
|
N |
90647 |
HIB PRP-OMP VACC 3 DOSE IM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90647 |
HIB PRP-OMP VACC 3 DOSE IM |
MAXFEE |
VFC |
|
|
|
|
0 |
1/1/2016 |
12/31/2299 |
N |
90647 |
HIB PRP-OMP VACC 3 DOSE IM |
MAXFEE |
DEF |
|
|
|
|
30.01 |
10/1/2022 |
12/31/2299 |
N |
90648 |
HIB PRP-T VACCINE 4 DOSE IM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90648 |
HIB PRP-T VACCINE 4 DOSE IM |
MAXFEE |
VFC |
|
|
|
|
0 |
1/1/2016 |
12/31/2299 |
N |
90648 |
HIB PRP-T VACCINE 4 DOSE IM |
MAXFEE |
DEF |
|
|
|
|
28.11 |
2/1/2015 |
12/31/2299 |
N |
90649 |
4VHPV VACCINE 3 DOSE IM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90649 |
4VHPV VACCINE 3 DOSE IM |
MAXFEE |
VFC |
|
|
|
|
0 |
1/1/2016 |
12/31/2299 |
N |
90649 |
4VHPV VACCINE 3 DOSE IM |
MAXFEE |
DEF |
|
|
|
|
144.43 |
9/1/2013 |
12/31/2299 |
N |
90650 |
2VHPV VACCINE 3 DOSE IM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90650 |
2VHPV VACCINE 3 DOSE IM |
MAXFEE |
VFC |
|
|
|
|
0 |
1/1/2016 |
12/31/2299 |
N |
90650 |
2VHPV VACCINE 3 DOSE IM |
MAXFEE |
DEF |
|
|
|
|
136.96 |
9/1/2013 |
12/31/2299 |
N |
90651 |
9VHPV VACCINE 2/3 DOSE IM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90651 |
9VHPV VACCINE 2/3 DOSE IM |
MAXFEE |
VFC |
|
|
|
|
0 |
1/1/2016 |
12/31/2299 |
N |
90651 |
9VHPV VACCINE 2/3 DOSE IM |
MAXFEE |
DEF |
|
|
|
|
286.78 |
10/1/2022 |
12/31/2299 |
N |
90653 |
IIV ADJUVANT VACCINE IM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90653 |
IIV ADJUVANT VACCINE IM |
MAXFEE |
VFC |
|
|
|
|
0 |
10/1/2016 |
12/31/2299 |
N |
90653 |
IIV ADJUVANT VACCINE IM |
MAXFEE |
DEF |
|
|
|
|
59.53 |
11/1/2019 |
12/31/2299 |
N |
90654 |
FLU VACC IIV3 NO PRESERV ID |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90654 |
FLU VACC IIV3 NO PRESERV ID |
MAXFEE |
VFC |
|
|
|
|
NA |
|
|
N |
90654 |
FLU VACC IIV3 NO PRESERV ID |
MAXFEE |
DEF |
|
|
|
|
18.92 |
11/1/2013 |
12/31/2299 |
N |
90655 |
IIV3 VACC NO PRSV 0.25 ML IM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90655 |
IIV3 VACC NO PRSV 0.25 ML IM |
MAXFEE |
VFC |
|
|
|
|
0 |
1/1/2016 |
12/31/2299 |
N |
90655 |
IIV3 VACC NO PRSV 0.25 ML IM |
MAXFEE |
DEF |
|
|
|
|
NA |
|
|
N |
90656 |
IIV3 VACC NO PRSV 0.5 ML IM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90656 |
IIV3 VACC NO PRSV 0.5 ML IM |
MAXFEE |
VFC |
|
|
|
|
0 |
1/1/2016 |
12/31/2299 |
N |
90656 |
IIV3 VACC NO PRSV 0.5 ML IM |
MAXFEE |
DEF |
|
|
|
|
19.77 |
11/1/2018 |
12/31/2299 |
N |
90657 |
IIV3 VACCINE SPLT 0.25 ML IM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90657 |
IIV3 VACCINE SPLT 0.25 ML IM |
MAXFEE |
VFC |
|
|
|
|
0 |
1/1/2016 |
12/31/2299 |
N |
90657 |
IIV3 VACCINE SPLT 0.25 ML IM |
MAXFEE |
DEF |
|
|
|
|
NA |
|
|
N |
90658 |
IIV3 VACCINE SPLT 0.5 ML IM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90658 |
IIV3 VACCINE SPLT 0.5 ML IM |
MAXFEE |
VFC |
|
|
|
|
0 |
1/1/2016 |
12/31/2299 |
N |
90658 |
IIV3 VACCINE SPLT 0.5 ML IM |
MAXFEE |
DEF |
|
|
|
|
10.39 |
9/1/2013 |
12/31/2299 |
N |
90660 |
LAIV3 VACCINE INTRANASAL |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90660 |
LAIV3 VACCINE INTRANASAL |
MAXFEE |
VFC |
|
|
|
|
0 |
1/1/2016 |
12/31/2299 |
N |
90660 |
LAIV3 VACCINE INTRANASAL |
MAXFEE |
DEF |
|
|
|
|
23.46 |
9/1/2013 |
12/31/2299 |
N |
90662 |
IIV NO PRSV INCREASED AG IM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90662 |
IIV NO PRSV INCREASED AG IM |
MAXFEE |
VFC |
|
|
|
|
NA |
|
|
N |
90662 |
IIV NO PRSV INCREASED AG IM |
MAXFEE |
DEF |
|
|
|
|
69.94 |
10/1/2022 |
12/31/2299 |
N |
90668 |
IIV VACCINE PANDEMIC IM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90668 |
IIV VACCINE PANDEMIC IM |
MAXFEE |
VFC |
|
|
|
|
0 |
7/1/2017 |
12/31/2299 |
N |
90668 |
IIV VACCINE PANDEMIC IM |
MAXFEE |
DEF |
|
|
|
|
0 |
1/1/2011 |
12/31/2299 |
N |
90670 |
PCV13 VACCINE IM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90670 |
PCV13 VACCINE IM |
MAXFEE |
VFC |
|
|
|
|
0 |
1/1/2016 |
12/31/2299 |
N |
90670 |
PCV13 VACCINE IM |
MAXFEE |
DEF |
|
|
|
|
257.99 |
4/1/2022 |
12/31/2299 |
N |
90671 |
PCV15 VACCINE IM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90671 |
PCV15 VACCINE IM |
MAXFEE |
DEF |
|
|
|
|
246.20 |
1/1/2022 |
12/31/2299 |
N |
90672 |
LAIV4 VACCINE INTRANASAL |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90672 |
LAIV4 VACCINE INTRANASAL |
MAXFEE |
VFC |
|
|
|
|
0 |
1/1/2016 |
12/31/2299 |
N |
90672 |
LAIV4 VACCINE INTRANASAL |
MAXFEE |
DEF |
|
|
|
|
26.88 |
2/1/2016 |
12/31/2299 |
N |
90673 |
RIV3 VACCINE NO PRESERV IM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90673 |
RIV3 VACCINE NO PRESERV IM |
MAXFEE |
VFC |
|
|
|
|
NA |
|
|
N |
90673 |
RIV3 VACCINE NO PRESERV IM |
MAXFEE |
DEF |
|
|
|
|
40.61 |
10/1/2016 |
12/31/2299 |
N |
90674 |
CCIIV4 VAC NO PRSV 0.5 ML IM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90674 |
CCIIV4 VAC NO PRSV 0.5 ML IM |
MAXFEE |
VFC |
|
|
|
|
0 |
10/1/2016 |
12/31/2299 |
N |
90674 |
CCIIV4 VAC NO PRSV 0.5 ML IM |
MAXFEE |
DEF |
|
|
|
|
32.28 |
10/1/2022 |
12/31/2299 |
N |
90675 |
RABIES VACCINE IM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90675 |
RABIES VACCINE IM |
MAXFEE |
VFC |
|
|
|
|
NA |
|
|
N |
90675 |
RABIES VACCINE IM |
MAXFEE |
DEF |
|
|
|
|
329.99 |
7/1/2023 |
12/31/2299 |
N |
90676 |
RABIES VACCINE ID |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90676 |
RABIES VACCINE ID |
MAXFEE |
VFC |
|
|
|
|
NA |
|
|
N |
90676 |
RABIES VACCINE ID |
MAXFEE |
DEF |
|
|
|
|
259.13 |
9/1/2013 |
12/31/2299 |
N |
90677 |
PCV20 VACCINE IM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90677 |
PCV20 VACCINE IM |
MAXFEE |
DEF |
|
|
|
|
288.66 |
4/1/2023 |
12/31/2299 |
N |
90680 |
RV5 VACC 3 DOSE LIVE ORAL |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90680 |
RV5 VACC 3 DOSE LIVE ORAL |
MAXFEE |
VFC |
|
|
|
|
0 |
1/1/2016 |
12/31/2299 |
N |
90680 |
RV5 VACC 3 DOSE LIVE ORAL |
MAXFEE |
DEF |
|
|
|
|
NA |
|
|
N |
90681 |
RV1 VACC 2 DOSE LIVE ORAL |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90681 |
RV1 VACC 2 DOSE LIVE ORAL |
MAXFEE |
VFC |
|
|
|
|
0 |
1/1/2016 |
12/31/2299 |
N |
90681 |
RV1 VACC 2 DOSE LIVE ORAL |
MAXFEE |
DEF |
|
|
|
|
NA |
|
|
N |
90682 |
RIV4 VACC RECOMBINANT DNA IM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90682 |
RIV4 VACC RECOMBINANT DNA IM |
MAXFEE |
VFC |
|
|
|
|
0 |
11/1/2017 |
12/31/2299 |
N |
90682 |
RIV4 VACC RECOMBINANT DNA IM |
MAXFEE |
DEF |
|
|
|
|
69.94 |
10/1/2022 |
12/31/2299 |
N |
90685 |
IIV4 VACC NO PRSV 0.25 ML IM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90685 |
IIV4 VACC NO PRSV 0.25 ML IM |
MAXFEE |
VFC |
|
|
|
|
0 |
1/1/2016 |
12/31/2299 |
N |
90685 |
IIV4 VACC NO PRSV 0.25 ML IM |
MAXFEE |
DEF |
|
|
|
|
21.64 |
10/1/2021 |
12/31/2299 |
N |
90686 |
IIV4 VACC NO PRSV 0.5 ML IM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90686 |
IIV4 VACC NO PRSV 0.5 ML IM |
MAXFEE |
VFC |
|
|
|
|
0 |
1/1/2016 |
12/31/2299 |
N |
90686 |
IIV4 VACC NO PRSV 0.5 ML IM |
MAXFEE |
DEF |
|
|
|
|
21.52 |
10/1/2022 |
12/31/2299 |
N |
90687 |
IIV4 VACCINE SPLT 0.25 ML IM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90687 |
IIV4 VACCINE SPLT 0.25 ML IM |
MAXFEE |
VFC |
|
|
|
|
0 |
1/1/2016 |
12/31/2299 |
N |
90687 |
IIV4 VACCINE SPLT 0.25 ML IM |
MAXFEE |
DEF |
|
|
|
|
10.24 |
10/1/2022 |
12/31/2299 |
N |
90688 |
IIV4 VACCINE SPLT 0.5 ML IM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90688 |
IIV4 VACCINE SPLT 0.5 ML IM |
MAXFEE |
VFC |
|
|
|
|
0 |
1/1/2016 |
12/31/2299 |
N |
90688 |
IIV4 VACCINE SPLT 0.5 ML IM |
MAXFEE |
DEF |
|
|
|
|
20.48 |
10/1/2022 |
12/31/2299 |
N |
90694 |
VACC AIIV4 NO PRSRV 0.5ML IM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90694 |
VACC AIIV4 NO PRSRV 0.5ML IM |
MAXFEE |
VFC |
|
|
|
|
0 |
1/1/2021 |
12/31/2299 |
N |
90694 |
VACC AIIV4 NO PRSRV 0.5ML IM |
MAXFEE |
DEF |
|
|
|
|
71.68 |
10/1/2022 |
12/31/2299 |
N |
90696 |
DTAP-IPV VACCINE 4-6 YRS IM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90696 |
DTAP-IPV VACCINE 4-6 YRS IM |
MAXFEE |
VFC |
|
|
|
|
0 |
1/1/2016 |
12/31/2299 |
N |
90696 |
DTAP-IPV VACCINE 4-6 YRS IM |
MAXFEE |
DEF |
|
|
|
|
NA |
|
|
N |
90697 |
DTAP-IPV-HIB-HEPB VACCINE IM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90697 |
DTAP-IPV-HIB-HEPB VACCINE IM |
MAXFEE |
VFC |
|
|
|
|
0 |
10/1/2021 |
12/31/2299 |
N |
90698 |
DTAP-IPV/HIB VACCINE IM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90698 |
DTAP-IPV/HIB VACCINE IM |
MAXFEE |
VFC |
|
|
|
|
0 |
1/1/2016 |
12/31/2299 |
N |
90698 |
DTAP-IPV/HIB VACCINE IM |
MAXFEE |
DEF |
|
|
|
|
85.33 |
11/1/2015 |
12/31/2299 |
N |
90700 |
DTAP VACCINE < 7 YRS IM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90700 |
DTAP VACCINE < 7 YRS IM |
MAXFEE |
VFC |
|
|
|
|
0 |
1/1/2016 |
12/31/2299 |
N |
90700 |
DTAP VACCINE < 7 YRS IM |
MAXFEE |
DEF |
|
|
|
|
NA |
|
|
N |
90702 |
DT VACCINE UNDER 7 YRS IM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90702 |
DT VACCINE UNDER 7 YRS IM |
MAXFEE |
VFC |
|
|
|
|
0 |
1/1/2016 |
12/31/2299 |
N |
90702 |
DT VACCINE UNDER 7 YRS IM |
MAXFEE |
DEF |
|
|
|
|
NA |
|
|
N |
90707 |
MMR VACCINE SC |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90707 |
MMR VACCINE SC |
MAXFEE |
VFC |
|
|
|
|
0 |
1/1/2016 |
12/31/2299 |
N |
90707 |
MMR VACCINE SC |
MAXFEE |
DEF |
|
|
|
|
93.75 |
10/1/2022 |
12/31/2299 |
N |
90710 |
MMRV VACCINE SC |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90710 |
MMRV VACCINE SC |
MAXFEE |
VFC |
|
|
|
|
0 |
1/1/2016 |
12/31/2299 |
N |
90710 |
MMRV VACCINE SC |
MAXFEE |
DEF |
|
|
|
|
277.52 |
10/1/2022 |
12/31/2299 |
N |
90713 |
POLIOVIRUS IPV SC/IM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90713 |
POLIOVIRUS IPV SC/IM |
MAXFEE |
VFC |
|
|
|
|
0 |
1/1/2016 |
12/31/2299 |
N |
90713 |
POLIOVIRUS IPV SC/IM |
MAXFEE |
DEF |
|
|
|
|
NA |
|
|
N |
90714 |
TD VACC NO PRESV 7 YRS+ IM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90714 |
TD VACC NO PRESV 7 YRS+ IM |
MAXFEE |
VFC |
|
|
|
|
0 |
1/1/2016 |
12/31/2299 |
N |
90714 |
TD VACC NO PRESV 7 YRS+ IM |
MAXFEE |
DEF |
|
|
|
|
31.05 |
7/1/2023 |
12/31/2299 |
N |
90715 |
TDAP VACCINE 7 YRS/> IM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90715 |
TDAP VACCINE 7 YRS/> IM |
MAXFEE |
VFC |
|
|
|
|
0 |
1/1/2016 |
12/31/2299 |
N |
90715 |
TDAP VACCINE 7 YRS/> IM |
MAXFEE |
DEF |
|
|
|
|
38.75 |
7/1/2023 |
12/31/2299 |
N |
90716 |
VAR VACCINE LIVE SUBQ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90716 |
VAR VACCINE LIVE SUBQ |
MAXFEE |
VFC |
|
|
|
|
0 |
1/1/2016 |
12/31/2299 |
N |
90716 |
VAR VACCINE LIVE SUBQ |
MAXFEE |
DEF |
|
|
|
|
170.39 |
10/1/2022 |
12/31/2299 |
N |
90723 |
DTAP-HEP B-IPV VACCINE IM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90723 |
DTAP-HEP B-IPV VACCINE IM |
MAXFEE |
VFC |
|
|
|
|
0 |
1/1/2016 |
12/31/2299 |
N |
90723 |
DTAP-HEP B-IPV VACCINE IM |
MAXFEE |
DEF |
|
|
|
|
NA |
|
|
N |
90732 |
PPSV23 VACC 2 YRS+ SUBQ/IM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90732 |
PPSV23 VACC 2 YRS+ SUBQ/IM |
MAXFEE |
VFC |
|
|
|
|
0 |
1/1/2016 |
12/31/2299 |
N |
90732 |
PPSV23 VACC 2 YRS+ SUBQ/IM |
MAXFEE |
DEF |
|
|
|
|
133.47 |
1/1/2022 |
12/31/2299 |
N |
90733 |
MPSV4 VACCINE SUBQ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90733 |
MPSV4 VACCINE SUBQ |
MAXFEE |
VFC |
|
|
|
|
0 |
1/1/2016 |
12/31/2299 |
N |
90733 |
MPSV4 VACCINE SUBQ |
MAXFEE |
DEF |
|
|
|
|
126.39 |
2/1/2015 |
12/31/2299 |
N |
90734 |
MENACWYD/MENACWYCRM VACC IM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90734 |
MENACWYD/MENACWYCRM VACC IM |
MAXFEE |
VFC |
|
|
|
|
0 |
1/1/2016 |
12/31/2299 |
N |
90734 |
MENACWYD/MENACWYCRM VACC IM |
MAXFEE |
DEF |
|
|
|
|
115.88 |
2/1/2015 |
12/31/2299 |
N |
90736 |
HZV VACCINE LIVE SUBQ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90736 |
HZV VACCINE LIVE SUBQ |
MAXFEE |
VFC |
|
|
|
|
NA |
|
|
N |
90736 |
HZV VACCINE LIVE SUBQ |
MAXFEE |
DEF |
|
|
|
|
210.93 |
5/1/2015 |
12/31/2299 |
N |
90739 |
HEPB VACC 2/4 DOSE ADULT IM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90739 |
HEPB VACC 2/4 DOSE ADULT IM |
MAXFEE |
VFC |
|
|
|
|
NA |
|
|
N |
90739 |
HEPB VACC 2/4 DOSE ADULT IM |
MAXFEE |
DEF |
|
|
|
|
160.28 |
7/1/2023 |
12/31/2299 |
N |
90740 |
HEPB VACC 3 DOSE IMMUNSUP IM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90740 |
HEPB VACC 3 DOSE IMMUNSUP IM |
MAXFEE |
VFC |
|
|
|
|
NA |
|
|
N |
90740 |
HEPB VACC 3 DOSE IMMUNSUP IM |
MAXFEE |
DEF |
|
|
|
|
152.12 |
4/1/2023 |
12/31/2299 |
N |
90743 |
HEPB VACC 2 DOSE ADOLESC IM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90743 |
HEPB VACC 2 DOSE ADOLESC IM |
MAXFEE |
VFC |
|
|
|
|
0 |
4/1/2022 |
12/31/2299 |
N |
90743 |
HEPB VACC 2 DOSE ADOLESC IM |
MAXFEE |
DEF |
|
|
|
|
0 |
1/1/2001 |
12/31/2299 |
N |
90744 |
HEPB VACC 3 DOSE PED/ADOL IM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90744 |
HEPB VACC 3 DOSE PED/ADOL IM |
MAXFEE |
VFC |
|
|
|
|
0 |
1/1/2016 |
12/31/2299 |
N |
90744 |
HEPB VACC 3 DOSE PED/ADOL IM |
MAXFEE |
DEF |
|
|
|
|
NA |
|
|
N |
90746 |
HEPB VACCINE 3 DOSE ADULT IM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90746 |
HEPB VACCINE 3 DOSE ADULT IM |
MAXFEE |
VFC |
|
|
|
|
NA |
|
|
N |
90746 |
HEPB VACCINE 3 DOSE ADULT IM |
MAXFEE |
DEF |
|
|
|
|
70.38 |
7/1/2022 |
12/31/2299 |
N |
90747 |
HEPB VACC 4 DOSE IMMUNSUP IM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90747 |
HEPB VACC 4 DOSE IMMUNSUP IM |
MAXFEE |
VFC |
|
|
|
|
NA |
|
|
N |
90747 |
HEPB VACC 4 DOSE IMMUNSUP IM |
MAXFEE |
DEF |
|
|
|
|
140.75 |
7/1/2023 |
12/31/2299 |
N |
90749 |
UNLISTED VACCINE/TOXOID |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90749 |
UNLISTED VACCINE/TOXOID |
MAXFEE |
VFC |
|
|
|
|
0 |
1/1/2016 |
12/31/2299 |
N |
90749 |
UNLISTED VACCINE/TOXOID |
MANUAL |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90750 |
HZV VACC RECOMBINANT IM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90750 |
HZV VACC RECOMBINANT IM |
MAXFEE |
VFC |
|
|
|
|
NA |
|
|
N |
90750 |
HZV VACC RECOMBINANT IM |
MAXFEE |
DEF |
|
|
|
|
149.80 |
1/1/2018 |
12/31/2299 |
N |
90756 |
CCIIV4 VACC ABX FREE IM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90756 |
CCIIV4 VACC ABX FREE IM |
MAXFEE |
VFC |
|
|
|
|
NA |
|
|
N |
90756 |
CCIIV4 VACC ABX FREE IM |
MAXFEE |
DEF |
|
|
|
|
30.58 |
10/1/2022 |
12/31/2299 |
N |
90758 |
ZAIRE EBOLAVIRUS VAC LIVE IM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90758 |
ZAIRE EBOLAVIRUS VAC LIVE IM |
MANUAL |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90759 |
HEP B VAC 3AG 10MCG 3 DOS IM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
90759 |
HEP B VAC 3AG 10MCG 3 DOS IM |
MAXFEE |
VFC |
|
|
|
|
0 |
1/1/2022 |
12/31/2299 |
N |
90759 |
HEP B VAC 3AG 10MCG 3 DOS IM |
MAXFEE |
DEF |
|
|
|
|
73.82 |
10/1/2022 |
12/31/2299 |
N |
91300 |
SARSCOV2 VAC 30MCG/0.3ML IM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
91300 |
SARSCOV2 VAC 30MCG/0.3ML IM |
MAXFEE |
DEF |
|
|
|
|
0.01 |
12/11/2020 |
12/31/2299 |
N |
91301 |
SARSCOV2 VAC 100MCG/0.5ML IM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
91301 |
SARSCOV2 VAC 100MCG/0.5ML IM |
MAXFEE |
DEF |
|
|
|
|
0.01 |
12/18/2020 |
12/31/2299 |
N |
91304 |
SARSCOV2 VAC 5MCG/0.5ML IM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
91304 |
SARSCOV2 VAC 5MCG/0.5ML IM |
MAXFEE |
DEF |
|
|
|
|
0.01 |
7/13/2022 |
12/31/2299 |
N |
91305 |
SARSCOV2 VAC 30 MCG TRS-SUCR |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
91305 |
SARSCOV2 VAC 30 MCG TRS-SUCR |
MAXFEE |
DEF |
|
|
|
|
0.01 |
1/3/2022 |
12/31/2299 |
N |
91306 |
SARSCOV2 VAC 50MCG/0.25ML IM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
91306 |
SARSCOV2 VAC 50MCG/0.25ML IM |
MAXFEE |
DEF |
|
|
|
|
0.01 |
10/20/2021 |
12/31/2299 |
N |
91307 |
SARSCOV2 VAC 10 MCG TRS-SUCR |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
91307 |
SARSCOV2 VAC 10 MCG TRS-SUCR |
MAXFEE |
DEF |
|
|
|
|
0.01 |
10/29/2021 |
12/31/2299 |
N |
91308 |
SARSCOV2 VAC 3 MCG TRS-SUCR |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
91308 |
SARSCOV2 VAC 3 MCG TRS-SUCR |
MAXFEE |
DEF |
|
|
|
|
0.01 |
6/17/2022 |
12/31/2299 |
N |
91309 |
SARSCOV2 VAC 50MCG/0.5ML IM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
91309 |
SARSCOV2 VAC 50MCG/0.5ML IM |
MAXFEE |
DEF |
|
|
|
|
0.01 |
3/29/2022 |
12/31/2299 |
N |
91311 |
SARSCOV2 VAC 25MCG/0.25ML IM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
91311 |
SARSCOV2 VAC 25MCG/0.25ML IM |
MAXFEE |
DEF |
|
|
|
|
0.01 |
6/17/2022 |
12/31/2299 |
N |
91312 |
SARSCOV2 VAC BVL 30MCG/0.3ML |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
91312 |
SARSCOV2 VAC BVL 30MCG/0.3ML |
MAXFEE |
DEF |
|
|
|
|
0.01 |
8/31/2022 |
12/31/2299 |
N |
91313 |
SARSCOV2 VAC BVL 50MCG/0.5ML |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
91313 |
SARSCOV2 VAC BVL 50MCG/0.5ML |
MAXFEE |
DEF |
|
|
|
|
0.01 |
8/31/2022 |
12/31/2299 |
N |
91314 |
SARSCOV2 VAC BVL 25MCG/.25ML |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
91314 |
SARSCOV2 VAC BVL 25MCG/.25ML |
MAXFEE |
DEF |
|
|
|
|
0.01 |
10/12/2022 |
12/31/2299 |
N |
91315 |
SARSCOV2 VAC BVL 10MCG/0.2ML |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
91315 |
SARSCOV2 VAC BVL 10MCG/0.2ML |
MAXFEE |
DEF |
|
|
|
|
0.01 |
10/12/2022 |
12/31/2299 |
N |
91316 |
SARSCOV2 VAC BVL 10MCG/0.2ML |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
91316 |
SARSCOV2 VAC BVL 10MCG/0.2ML |
MAXFEE |
DEF |
|
|
|
|
0.01 |
12/8/2022 |
12/31/2299 |
N |
91317 |
SARSCOV2 VAC BVL 3MCG/0.2ML |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
91317 |
SARSCOV2 VAC BVL 3MCG/0.2ML |
MAXFEE |
DEF |
|
|
|
|
0.01 |
12/8/2022 |
12/31/2299 |
N |
96372 |
THER/PROPH/DIAG INJ SC/IM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
96372 |
THER/PROPH/DIAG INJ SC/IM |
MAXFEE |
DEF |
|
|
|
|
14.57 |
1/1/2009 |
12/31/2299 |
N |
99202 |
OFFICE O/P NEW SF 15-29 MIN |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
99202 |
OFFICE O/P NEW SF 15-29 MIN |
MAXFEE |
FAC |
|
|
|
|
20.84 |
1/1/2016 |
12/31/2299 |
N |
99202 |
OFFICE O/P NEW SF 15-29 MIN |
MAXFEE |
NFF |
|
|
|
|
38.93 |
1/1/2016 |
12/31/2299 |
N |
99203 |
OFFICE O/P NEW LOW 30-44 MIN |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
99203 |
OFFICE O/P NEW LOW 30-44 MIN |
MAXFEE |
FAC |
|
|
|
|
32.94 |
1/1/2016 |
12/31/2299 |
N |
99203 |
OFFICE O/P NEW LOW 30-44 MIN |
MAXFEE |
NFF |
|
|
|
|
57.76 |
1/1/2016 |
12/31/2299 |
N |
99211 |
OFF/OP EST MAY X REQ PHY/QHP |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
99211 |
OFF/OP EST MAY X REQ PHY/QHP |
MAXFEE |
FAC |
|
|
|
|
5.55 |
1/1/2016 |
12/31/2299 |
N |
99211 |
OFF/OP EST MAY X REQ PHY/QHP |
MAXFEE |
NFF |
|
|
|
|
14.50 |
1/1/2016 |
12/31/2299 |
N |
99212 |
OFFICE O/P EST SF 10-19 MIN |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
99212 |
OFFICE O/P EST SF 10-19 MIN |
MAXFEE |
FAC |
|
|
|
|
12.81 |
1/1/2016 |
12/31/2299 |
N |
99212 |
OFFICE O/P EST SF 10-19 MIN |
MAXFEE |
NFF |
|
|
|
|
26.73 |
1/1/2016 |
12/31/2299 |
N |
99213 |
OFFICE O/P EST LOW 20-29 MIN |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
99213 |
OFFICE O/P EST LOW 20-29 MIN |
MAXFEE |
FAC |
|
|
|
|
24.85 |
1/1/2016 |
12/31/2299 |
N |
99213 |
OFFICE O/P EST LOW 20-29 MIN |
MAXFEE |
NFF |
|
|
|
|
43.61 |
1/1/2016 |
12/31/2299 |
N |
99401 |
PREVENTIVE COUNSELING INDIV |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
99401 |
PREVENTIVE COUNSELING INDIV |
MAXFEE |
FAC |
|
|
|
|
17.69 |
1/1/2014 |
12/31/2299 |
N |
99401 |
PREVENTIVE COUNSELING INDIV |
MAXFEE |
NFF |
|
|
|
|
26.21 |
1/1/2014 |
12/31/2299 |
N |
99402 |
PREVENTIVE COUNSELING INDIV |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
99402 |
PREVENTIVE COUNSELING INDIV |
MAXFEE |
FAC |
|
|
|
|
28.87 |
1/1/2014 |
12/31/2299 |
N |
99402 |
PREVENTIVE COUNSELING INDIV |
MAXFEE |
NFF |
|
|
|
|
39.90 |
1/1/2014 |
12/31/2299 |
N |
99441 |
PHONE E/M PHYS/QHP 5-10 MIN |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
99441 |
PHONE E/M PHYS/QHP 5-10 MIN |
MAXFEE |
DEF |
|
|
|
|
0 |
1/1/2008 |
12/31/2299 |
N |
99442 |
PHONE E/M PHYS/QHP 11-20 MIN |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
99442 |
PHONE E/M PHYS/QHP 11-20 MIN |
MAXFEE |
DEF |
|
|
|
|
0 |
1/1/2008 |
12/31/2299 |
N |
A9587 |
GALLIUM GA-68 |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
A9587 |
GALLIUM GA-68 |
MAXFEE |
DEF |
|
|
|
|
3210 |
4/1/2022 |
12/31/2299 |
N |
A9591 |
FLUOROESTRADIOL F 18 |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
A9591 |
FLUOROESTRADIOL F 18 |
MAXFEE |
DEF |
|
|
|
|
4100.78 |
4/1/2022 |
12/31/2299 |
N |
G0108 |
DIAB MANAGE TRN PER INDIV |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
G0108 |
DIAB MANAGE TRN PER INDIV |
MAXFEE |
DEF |
|
|
|
|
40.22 |
1/1/2022 |
12/31/2299 |
N |
G0109 |
DIAB MANAGE TRN IND/GROUP |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
G0109 |
DIAB MANAGE TRN IND/GROUP |
MAXFEE |
DEF |
|
|
|
|
11.15 |
1/1/2022 |
12/31/2299 |
N |
G0312 |
IMMUNIZE COUNS < 21YR 5-15 M |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
G0312 |
IMMUNIZE COUNS < 21YR 5-15 M |
MAXFEE |
DEF |
|
|
|
|
26.21 |
6/8/2022 |
12/31/2299 |
N |
G0313 |
IMMUNIZE COUNS < 21YR 6-30 M |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
G0313 |
IMMUNIZE COUNS < 21YR 6-30 M |
MAXFEE |
DEF |
|
|
|
|
39.90 |
6/8/2022 |
12/31/2299 |
N |
G2012 |
BRIEF CHECK IN BY MD/QHP |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
G2012 |
BRIEF CHECK IN BY MD/QHP |
MAXFEE |
FAC |
|
|
|
|
10.41 |
3/9/2020 |
12/31/2299 |
N |
G2012 |
BRIEF CHECK IN BY MD/QHP |
MAXFEE |
NFF |
|
|
|
|
11.46 |
3/9/2020 |
12/31/2299 |
N |
J0121 |
INJ.; OMADACYCLINE; 1 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0121 |
INJ.; OMADACYCLINE; 1 MG |
MAXFEE |
DEF |
|
|
|
|
3.68 |
7/1/2023 |
12/31/2299 |
N |
J0122 |
INJ.; ERAVACYCLINE; 1 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0122 |
INJ.; ERAVACYCLINE; 1 MG |
MAXFEE |
DEF |
|
|
|
|
1.13 |
7/1/2023 |
12/31/2299 |
N |
J0129 |
ABATACEPT INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0129 |
ABATACEPT INJECTION |
MAXFEE |
DEF |
|
|
|
|
43.27 |
7/1/2023 |
12/31/2299 |
N |
J0130 |
ABCIXIMAB INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0130 |
ABCIXIMAB INJECTION |
MAXFEE |
DEF |
|
|
|
|
1429.07 |
2/1/2019 |
12/31/2299 |
N |
J0131 |
INJ; ACETAMINOPHEN (NOS) |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0131 |
INJ; ACETAMINOPHEN (NOS) |
MAXFEE |
DEF |
|
|
|
|
0.09 |
7/1/2023 |
12/31/2299 |
N |
J0132 |
ACETYLCYSTEINE INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0132 |
ACETYLCYSTEINE INJECTION |
MAXFEE |
DEF |
|
|
|
|
0.78 |
7/1/2023 |
12/31/2299 |
N |
J0133 |
ACYCLOVIR INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0133 |
ACYCLOVIR INJECTION |
MAXFEE |
DEF |
|
|
|
|
0.05 |
7/1/2023 |
12/31/2299 |
N |
J0134 |
INJ ACETAMINOPHEN -FRESENIUS |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0134 |
INJ ACETAMINOPHEN -FRESENIUS |
MAXFEE |
DEF |
|
|
|
|
0.07 |
7/1/2023 |
12/31/2299 |
N |
J0135 |
ADALIMUMAB INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0135 |
ADALIMUMAB INJECTION |
MAXFEE |
DEF |
|
|
|
|
909.22 |
1/1/2017 |
12/31/2299 |
N |
J0136 |
INJ; ACETAMINOPHEN (B BRAUN) |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0136 |
INJ; ACETAMINOPHEN (B BRAUN) |
MAXFEE |
DEF |
|
|
|
|
0.05 |
1/1/2023 |
12/31/2299 |
N |
J0137 |
Inj; acetaminophen (hikma) |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0137 |
Inj; acetaminophen (hikma) |
MAXFEE |
DEF |
|
|
|
|
0.08 |
7/1/2023 |
12/31/2299 |
N |
J0153 |
ADENOSINE INJ 1MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0153 |
ADENOSINE INJ 1MG |
MAXFEE |
DEF |
|
|
|
|
0.54 |
7/1/2023 |
12/31/2299 |
N |
J0171 |
ADRENALIN EPINEPHRINE INJECT |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0171 |
ADRENALIN EPINEPHRINE INJECT |
MAXFEE |
DEF |
|
|
|
|
0.73 |
7/1/2023 |
12/31/2299 |
N |
J0172 |
INJ; ADUCANUMAB-AVWA; 2 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0172 |
INJ; ADUCANUMAB-AVWA; 2 MG |
MAXFEE |
DEF |
|
|
|
|
5.98 |
7/1/2022 |
12/31/2299 |
N |
J0173 |
INJ; EPINEPHRINE (BELCHER) |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0173 |
INJ; EPINEPHRINE (BELCHER) |
MANUAL |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0174 |
INJ; LECANEMAB-IRMB; 1 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0174 |
INJ; LECANEMAB-IRMB; 1 MG |
MAXFEE |
DEF |
|
|
|
|
1.36 |
7/6/2023 |
12/31/2299 |
N |
J0178 |
AFLIBERCEPT INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0178 |
AFLIBERCEPT INJECTION |
MAXFEE |
DEF |
|
|
|
|
875.67 |
7/1/2023 |
12/31/2299 |
N |
J0179 |
INJ; BROLUCIZUMAB-DBLL; 1 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0179 |
INJ; BROLUCIZUMAB-DBLL; 1 MG |
MAXFEE |
DEF |
|
|
|
|
319.95 |
7/1/2023 |
12/31/2299 |
N |
J0180 |
AGALSIDASE BETA INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0180 |
AGALSIDASE BETA INJECTION |
MAXFEE |
DEF |
|
|
|
|
215.38 |
7/1/2023 |
12/31/2299 |
N |
J0185 |
INJ.; APREPITANT; 1 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0185 |
INJ.; APREPITANT; 1 MG |
MAXFEE |
DEF |
|
|
|
|
1.73 |
7/1/2023 |
12/31/2299 |
N |
J0202 |
INJECTION; ALEMTUZUMAB |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0202 |
INJECTION; ALEMTUZUMAB |
MAXFEE |
DEF |
|
|
|
|
2283.73 |
7/1/2023 |
12/31/2299 |
N |
J0205 |
ALGLUCERASE INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0205 |
ALGLUCERASE INJECTION |
MAXFEE |
DEF |
|
|
|
|
42 |
7/1/2009 |
12/31/2299 |
N |
J0206 |
Inj allopurinol sodium 1 mg |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0206 |
Inj allopurinol sodium 1 mg |
MAXFEE |
DEF |
|
|
|
|
5.81 |
7/1/2023 |
12/31/2299 |
N |
J0207 |
AMIFOSTINE |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0207 |
AMIFOSTINE |
MAXFEE |
DEF |
|
|
|
|
1135.69 |
7/1/2020 |
12/31/2299 |
N |
J0208 |
INJ SODIUM THIOSULFATE 100MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0208 |
INJ SODIUM THIOSULFATE 100MG |
MANUAL |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0210 |
METHYLDOPATE HCL INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0210 |
METHYLDOPATE HCL INJECTION |
MAXFEE |
DEF |
|
|
|
|
42.40 |
9/1/2013 |
12/31/2299 |
N |
J0215 |
ALEFACEPT |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0215 |
ALEFACEPT |
MAXFEE |
DEF |
|
|
|
|
41.64 |
9/1/2013 |
12/31/2299 |
N |
J0216 |
Inj; alfentanil hcl; 500mcg |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0216 |
Inj; alfentanil hcl; 500mcg |
MAXFEE |
DEF |
|
|
|
|
2.57 |
7/1/2023 |
12/31/2299 |
N |
J0218 |
INJ OLIPUDASE ALFA-RPCP 1MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0218 |
INJ OLIPUDASE ALFA-RPCP 1MG |
MAXFEE |
DEF |
|
|
|
|
377.51 |
7/1/2023 |
12/31/2299 |
N |
J0219 |
INJ AVAL ALFA-NQPT 4MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0219 |
INJ AVAL ALFA-NQPT 4MG |
MAXFEE |
DEF |
|
|
|
|
75.04 |
7/1/2023 |
12/31/2299 |
N |
J0220 |
ALGLUCOSIDASE ALFA INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0220 |
ALGLUCOSIDASE ALFA INJECTION |
MAXFEE |
DEF |
|
|
|
|
206.70 |
2/1/2016 |
12/31/2299 |
N |
J0221 |
LUMIZYME INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0221 |
LUMIZYME INJECTION |
MAXFEE |
DEF |
|
|
|
|
194.92 |
7/1/2023 |
12/31/2299 |
N |
J0222 |
INJ.; PATISIRAN; 0.1 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0222 |
INJ.; PATISIRAN; 0.1 MG |
MAXFEE |
DEF |
|
|
|
|
100.47 |
7/1/2023 |
12/31/2299 |
N |
J0223 |
INJ GIVOSIRAN 0.5 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0223 |
INJ GIVOSIRAN 0.5 MG |
MAXFEE |
DEF |
|
|
|
|
112.49 |
7/1/2023 |
12/31/2299 |
N |
J0224 |
INJ. LUMASIRAN; 0.5 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0224 |
INJ. LUMASIRAN; 0.5 MG |
MAXFEE |
DEF |
|
|
|
|
319 |
7/1/2023 |
12/31/2299 |
N |
J0225 |
INJ; VUTRISIRAN; 1 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0225 |
INJ; VUTRISIRAN; 1 MG |
MAXFEE |
DEF |
|
|
|
|
4940.95 |
7/1/2023 |
12/31/2299 |
N |
J0248 |
INJ; REMDESIVIR; 1 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0248 |
INJ; REMDESIVIR; 1 MG |
MAXFEE |
DEF |
|
|
|
|
6.06 |
7/1/2023 |
12/31/2299 |
N |
J0256 |
ALPHA 1 PROTEINASE INHIBITOR |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0256 |
ALPHA 1 PROTEINASE INHIBITOR |
MAXFEE |
DEF |
|
|
|
|
4.88 |
7/1/2023 |
12/31/2299 |
N |
J0257 |
GLASSIA INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0257 |
GLASSIA INJECTION |
MAXFEE |
DEF |
|
|
|
|
5.31 |
7/1/2023 |
12/31/2299 |
N |
J0270 |
ALPROSTADIL FOR INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0270 |
ALPROSTADIL FOR INJECTION |
MAXFEE |
DEF |
|
|
|
|
0.24 |
9/1/2013 |
12/31/2299 |
N |
J0278 |
AMIKACIN SULFATE INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0278 |
AMIKACIN SULFATE INJECTION |
MAXFEE |
DEF |
|
|
|
|
0.94 |
7/1/2023 |
12/31/2299 |
N |
J0280 |
AMINOPHYLLIN 250 MG INJ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0280 |
AMINOPHYLLIN 250 MG INJ |
MAXFEE |
DEF |
|
|
|
|
4.51 |
7/1/2023 |
12/31/2299 |
N |
J0282 |
AMIODARONE HCL |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0282 |
AMIODARONE HCL |
MAXFEE |
DEF |
|
|
|
|
0.49 |
9/1/2013 |
12/31/2299 |
N |
J0283 |
INJ; AMIODARONE (NEXTERONE) |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0283 |
INJ; AMIODARONE (NEXTERONE) |
MANUAL |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0285 |
AMPHOTERICIN B |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0285 |
AMPHOTERICIN B |
MAXFEE |
DEF |
|
|
|
|
41.67 |
7/1/2023 |
12/31/2299 |
N |
J0287 |
AMPHOTERICIN B LIPID COMPLEX |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0287 |
AMPHOTERICIN B LIPID COMPLEX |
MAXFEE |
DEF |
|
|
|
|
11.13 |
4/1/2023 |
12/31/2299 |
N |
J0288 |
AMPHO B CHOLESTERYL SULFATE |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0288 |
AMPHO B CHOLESTERYL SULFATE |
MAXFEE |
DEF |
|
|
|
|
14 |
9/1/2011 |
12/31/2299 |
N |
J0289 |
AMPHOTERICIN B LIPOSOME INJ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0289 |
AMPHOTERICIN B LIPOSOME INJ |
MAXFEE |
DEF |
|
|
|
|
27.87 |
7/1/2023 |
12/31/2299 |
N |
J0290 |
AMPICILLIN 500 MG INJ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0290 |
AMPICILLIN 500 MG INJ |
MAXFEE |
DEF |
|
|
|
|
0.78 |
7/1/2023 |
12/31/2299 |
N |
J0291 |
INJ.; PLAZOMICIN; 5 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0291 |
INJ.; PLAZOMICIN; 5 MG |
MAXFEE |
DEF |
|
|
|
|
3.36 |
7/1/2023 |
12/31/2299 |
N |
J0295 |
AMPICILLIN SULBACTAM 1.5 GM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0295 |
AMPICILLIN SULBACTAM 1.5 GM |
MAXFEE |
DEF |
|
|
|
|
1.89 |
7/1/2023 |
12/31/2299 |
N |
J0300 |
AMOBARBITAL 125 MG INJ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0300 |
AMOBARBITAL 125 MG INJ |
MAXFEE |
DEF |
|
|
|
|
181.57 |
9/1/2013 |
12/31/2299 |
N |
J0330 |
SUCCINYCHOLINE CHLORIDE INJ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0330 |
SUCCINYCHOLINE CHLORIDE INJ |
MAXFEE |
DEF |
|
|
|
|
0.39 |
9/1/2013 |
12/31/2299 |
N |
J0348 |
ANIDULAFUNGIN INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0348 |
ANIDULAFUNGIN INJECTION |
MAXFEE |
DEF |
|
|
|
|
0.48 |
7/1/2023 |
12/31/2299 |
N |
J0360 |
HYDRALAZINE HCL INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0360 |
HYDRALAZINE HCL INJECTION |
MAXFEE |
DEF |
|
|
|
|
5.71 |
7/1/2023 |
12/31/2299 |
N |
J0364 |
APOMORPHINE HYDROCHLORIDE |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0364 |
APOMORPHINE HYDROCHLORIDE |
MAXFEE |
DEF |
|
|
|
|
32.69 |
4/1/2014 |
12/31/2299 |
N |
J0365 |
APROTONIN; 10;000 KIU |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0365 |
APROTONIN; 10;000 KIU |
MAXFEE |
DEF |
|
|
|
|
2.65 |
9/1/2013 |
12/31/2299 |
N |
J0400 |
ARIPIPRAZOLE INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0400 |
ARIPIPRAZOLE INJECTION |
MAXFEE |
DEF |
|
|
|
|
0.76 |
7/1/2016 |
12/31/2299 |
N |
J0401 |
INJ ARIPIPRAZOLE EXT REL 1MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0401 |
INJ ARIPIPRAZOLE EXT REL 1MG |
MAXFEE |
DEF |
|
|
|
|
6.72 |
7/1/2023 |
12/31/2299 |
N |
J0456 |
AZITHROMYCIN |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0456 |
AZITHROMYCIN |
MAXFEE |
DEF |
|
|
|
|
2.78 |
7/1/2023 |
12/31/2299 |
N |
J0457 |
Injection; aztreonam; 100 mg |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0457 |
Injection; aztreonam; 100 mg |
MAXFEE |
DEF |
|
|
|
|
3.10 |
7/1/2023 |
12/31/2299 |
N |
J0461 |
ATROPINE SULFATE INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0461 |
ATROPINE SULFATE INJECTION |
MAXFEE |
DEF |
|
|
|
|
0.09 |
7/1/2023 |
12/31/2299 |
N |
J0470 |
DIMECAPROL INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0470 |
DIMECAPROL INJECTION |
MAXFEE |
DEF |
|
|
|
|
59.81 |
4/1/2020 |
12/31/2299 |
N |
J0475 |
BACLOFEN 10 MG INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0475 |
BACLOFEN 10 MG INJECTION |
MAXFEE |
DEF |
|
|
|
|
182.49 |
7/1/2023 |
12/31/2299 |
N |
J0476 |
BACLOFEN INTRATHECAL TRIAL |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0476 |
BACLOFEN INTRATHECAL TRIAL |
MAXFEE |
DEF |
|
|
|
|
44.97 |
7/1/2023 |
12/31/2299 |
N |
J0480 |
BASILIXIMAB |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0480 |
BASILIXIMAB |
MAXFEE |
DEF |
|
|
|
|
4389.08 |
7/1/2023 |
12/31/2299 |
N |
J0485 |
BELATACEPT INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0485 |
BELATACEPT INJECTION |
MAXFEE |
DEF |
|
|
|
|
3.78 |
7/1/2023 |
12/31/2299 |
N |
J0490 |
BELIMUMAB INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0490 |
BELIMUMAB INJECTION |
MAXFEE |
DEF |
|
|
|
|
50.93 |
7/1/2023 |
12/31/2299 |
N |
J0500 |
DICYCLOMINE INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0500 |
DICYCLOMINE INJECTION |
MAXFEE |
DEF |
|
|
|
|
25.44 |
7/1/2023 |
12/31/2299 |
N |
J0515 |
INJ BENZTROPINE MESYLATE |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0515 |
INJ BENZTROPINE MESYLATE |
MAXFEE |
DEF |
|
|
|
|
16.21 |
7/1/2023 |
12/31/2299 |
N |
J0517 |
INJ.; BENRALIZUMAB; 1 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0517 |
INJ.; BENRALIZUMAB; 1 MG |
MAXFEE |
DEF |
|
|
|
|
170.93 |
7/1/2023 |
12/31/2299 |
N |
J0558 |
PENG BENZATHINE/PROCAINE INJ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0558 |
PENG BENZATHINE/PROCAINE INJ |
MAXFEE |
DEF |
|
|
|
|
15.67 |
7/1/2023 |
12/31/2299 |
N |
J0561 |
PENICILLIN G BENZATHINE INJ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0561 |
PENICILLIN G BENZATHINE INJ |
MAXFEE |
DEF |
|
|
|
|
20.17 |
7/1/2023 |
12/31/2299 |
N |
J0565 |
INJ; BEZLOTOXUMAB; 10 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0565 |
INJ; BEZLOTOXUMAB; 10 MG |
MAXFEE |
DEF |
|
|
|
|
39.85 |
7/1/2023 |
12/31/2299 |
N |
J0567 |
INJ.; CERLIPONASE ALFA 1 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0567 |
INJ.; CERLIPONASE ALFA 1 MG |
MAXFEE |
DEF |
|
|
|
|
96.30 |
1/1/2019 |
12/31/2299 |
N |
J0570 |
BUPRENORPHINE IMPLANT 74.2MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0570 |
BUPRENORPHINE IMPLANT 74.2MG |
MAXFEE |
DEF |
|
|
|
|
1311.75 |
7/1/2021 |
12/31/2299 |
N |
J0571 |
BUPRENORPHINE ORAL 1MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0571 |
BUPRENORPHINE ORAL 1MG |
MAXFEE |
DEF |
|
|
|
|
2.85 |
1/1/2022 |
12/31/2299 |
N |
J0572 |
BUPREN/NAL UP TO 3MG BUPRENO |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0572 |
BUPREN/NAL UP TO 3MG BUPRENO |
MAXFEE |
DEF |
|
|
|
|
10.10 |
4/1/2022 |
12/31/2299 |
N |
J0573 |
BUPREN/NAL 3.1 TO 6MG BUPREN |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0573 |
BUPREN/NAL 3.1 TO 6MG BUPREN |
MAXFEE |
DEF |
|
|
|
|
9.89 |
1/1/2022 |
12/31/2299 |
N |
J0574 |
BUPREN/NAL 6.1 TO 10MG BUPRE |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0574 |
BUPREN/NAL 6.1 TO 10MG BUPRE |
MAXFEE |
DEF |
|
|
|
|
15.15 |
4/1/2022 |
12/31/2299 |
N |
J0575 |
BUPREN/NAL OVER 10MG BUPRENO |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0575 |
BUPREN/NAL OVER 10MG BUPRENO |
MAXFEE |
DEF |
|
|
|
|
19.77 |
1/1/2022 |
12/31/2299 |
N |
J0583 |
BIVALIRUDIN |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0583 |
BIVALIRUDIN |
MAXFEE |
DEF |
|
|
|
|
0.24 |
7/1/2023 |
12/31/2299 |
N |
J0584 |
INJECTION; BUROSUMAB-TWZA 1M |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0584 |
INJECTION; BUROSUMAB-TWZA 1M |
MAXFEE |
DEF |
|
|
|
|
426.07 |
7/1/2023 |
12/31/2299 |
N |
J0585 |
INJECTION;ONABOTULINUMTOXINA |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0585 |
INJECTION;ONABOTULINUMTOXINA |
MAXFEE |
DEF |
|
|
|
|
6.39 |
7/1/2023 |
12/31/2299 |
N |
J0586 |
ABOBOTULINUMTOXINA |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0586 |
ABOBOTULINUMTOXINA |
MAXFEE |
DEF |
|
|
|
|
8.25 |
7/1/2023 |
12/31/2299 |
N |
J0587 |
INJ; RIMABOTULINUMTOXINB |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0587 |
INJ; RIMABOTULINUMTOXINB |
MAXFEE |
DEF |
|
|
|
|
12.72 |
7/1/2023 |
12/31/2299 |
N |
J0588 |
INCOBOTULINUMTOXIN A |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0588 |
INCOBOTULINUMTOXIN A |
MAXFEE |
DEF |
|
|
|
|
5.20 |
4/1/2023 |
12/31/2299 |
N |
J0592 |
BUPRENORPHINE HYDROCHLORIDE |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0592 |
BUPRENORPHINE HYDROCHLORIDE |
MAXFEE |
DEF |
|
|
|
|
4.06 |
7/1/2023 |
12/31/2299 |
N |
J0593 |
INJ.; LANADELUMAB-FLYO; 1 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0593 |
INJ.; LANADELUMAB-FLYO; 1 MG |
MANUAL |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0594 |
BUSULFAN INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0594 |
BUSULFAN INJECTION |
MAXFEE |
DEF |
|
|
|
|
1.38 |
7/1/2023 |
12/31/2299 |
N |
J0595 |
BUTORPHANOL TARTRATE 1 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0595 |
BUTORPHANOL TARTRATE 1 MG |
MAXFEE |
DEF |
|
|
|
|
5.05 |
7/1/2023 |
12/31/2299 |
N |
J0596 |
INJECTION; RUCONEST |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0596 |
INJECTION; RUCONEST |
MAXFEE |
DEF |
|
|
|
|
33.02 |
7/1/2023 |
12/31/2299 |
N |
J0597 |
C-1 ESTERASE; BERINERT |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0597 |
C-1 ESTERASE; BERINERT |
MAXFEE |
DEF |
|
|
|
|
64.45 |
7/1/2023 |
12/31/2299 |
N |
J0598 |
C-1 ESTERASE; CINRYZE |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0598 |
C-1 ESTERASE; CINRYZE |
MAXFEE |
DEF |
|
|
|
|
60.73 |
7/1/2023 |
12/31/2299 |
N |
J0599 |
INJ.; HAEGARDA 10 UNITS |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0599 |
INJ.; HAEGARDA 10 UNITS |
MAXFEE |
DEF |
|
|
|
|
10.06 |
1/1/2019 |
12/31/2299 |
N |
J0600 |
EDETATE CALCIUM DISODIUM INJ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0600 |
EDETATE CALCIUM DISODIUM INJ |
MAXFEE |
DEF |
|
|
|
|
5708.59 |
7/1/2021 |
12/31/2299 |
N |
J0604 |
CINACALCET; ESRD ON DIALYSIS |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0604 |
CINACALCET; ESRD ON DIALYSIS |
MAXFEE |
DEF |
|
|
|
|
0.09 |
10/1/2020 |
12/31/2299 |
N |
J0606 |
INJ; ETELCALCETIDE; 0.1 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0606 |
INJ; ETELCALCETIDE; 0.1 MG |
MAXFEE |
DEF |
|
|
|
|
2.02 |
10/1/2020 |
12/31/2299 |
N |
J0610 |
CALCIUM GLUCON (FRESENIUS) |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0610 |
CALCIUM GLUCON (FRESENIUS) |
MAXFEE |
DEF |
|
|
|
|
NA |
|
|
N |
J0611 |
CALCIUM GLUCON (WG CRITICAL) |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0611 |
CALCIUM GLUCON (WG CRITICAL) |
MAXFEE |
DEF |
|
|
|
|
NA |
|
|
N |
J0612 |
CALCIUM GLUCON (FRESENIUS) |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0612 |
CALCIUM GLUCON (FRESENIUS) |
MAXFEE |
DEF |
|
|
|
|
0.06 |
7/1/2023 |
12/31/2299 |
N |
J0613 |
CALCIUM GLUCON (WG CRITICAL) |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0613 |
CALCIUM GLUCON (WG CRITICAL) |
MAXFEE |
DEF |
|
|
|
|
0.08 |
4/1/2023 |
12/31/2299 |
N |
J0630 |
CALCITONIN SALMON INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0630 |
CALCITONIN SALMON INJECTION |
MAXFEE |
DEF |
|
|
|
|
1366.44 |
7/1/2023 |
12/31/2299 |
N |
J0636 |
INJ CALCITRIOL PER 0.1 MCG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0636 |
INJ CALCITRIOL PER 0.1 MCG |
MAXFEE |
DEF |
|
|
|
|
0.80 |
7/1/2023 |
12/31/2299 |
N |
J0637 |
CASPOFUNGIN ACETATE |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0637 |
CASPOFUNGIN ACETATE |
MAXFEE |
DEF |
|
|
|
|
8.62 |
7/1/2023 |
12/31/2299 |
N |
J0638 |
CANAKINUMAB INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0638 |
CANAKINUMAB INJECTION |
MAXFEE |
DEF |
|
|
|
|
121.51 |
7/1/2023 |
12/31/2299 |
N |
J0640 |
LEUCOVORIN CALCIUM INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0640 |
LEUCOVORIN CALCIUM INJECTION |
MAXFEE |
DEF |
|
|
|
|
4.70 |
7/1/2023 |
12/31/2299 |
N |
J0641 |
INJ LEVOLEUCOVORIN NOS 0.5MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0641 |
INJ LEVOLEUCOVORIN NOS 0.5MG |
MAXFEE |
DEF |
|
|
|
|
0.27 |
10/1/2022 |
12/31/2299 |
N |
J0642 |
INJECTION; KHAPZORY; 0.5 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0642 |
INJECTION; KHAPZORY; 0.5 MG |
MAXFEE |
DEF |
|
|
|
|
1.48 |
7/1/2023 |
12/31/2299 |
N |
J0665 |
Inj; bupivacaine; nos; 0.5mg |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0665 |
Inj; bupivacaine; nos; 0.5mg |
MAXFEE |
DEF |
|
|
|
|
0.02 |
7/1/2023 |
12/31/2299 |
N |
J0670 |
INJ MEPIVACAINE HCL/10 ML |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0670 |
INJ MEPIVACAINE HCL/10 ML |
MAXFEE |
DEF |
|
|
|
|
3.08 |
7/1/2023 |
12/31/2299 |
N |
J0689 |
INJ CEFAZOLIN SODIUM; BAXTER |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0689 |
INJ CEFAZOLIN SODIUM; BAXTER |
MAXFEE |
DEF |
|
|
|
|
1.22 |
7/1/2023 |
12/31/2299 |
N |
J0690 |
CEFAZOLIN SODIUM INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0690 |
CEFAZOLIN SODIUM INJECTION |
MAXFEE |
DEF |
|
|
|
|
0.87 |
7/1/2023 |
12/31/2299 |
N |
J0691 |
INJ LEFAMULIN 1 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0691 |
INJ LEFAMULIN 1 MG |
MAXFEE |
DEF |
|
|
|
|
0.72 |
7/1/2020 |
12/31/2299 |
N |
J0692 |
CEFEPIME HCL FOR INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0692 |
CEFEPIME HCL FOR INJECTION |
MAXFEE |
DEF |
|
|
|
|
1.23 |
7/1/2023 |
12/31/2299 |
N |
J0693 |
INJ.; CEFIDEROCOL; 5 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0693 |
INJ.; CEFIDEROCOL; 5 MG |
MANUAL |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0694 |
CEFOXITIN SODIUM INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0694 |
CEFOXITIN SODIUM INJECTION |
MAXFEE |
DEF |
|
|
|
|
5 |
7/1/2023 |
12/31/2299 |
N |
J0695 |
INJ CEFTOLOZANE TAZOBACTAM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0695 |
INJ CEFTOLOZANE TAZOBACTAM |
MAXFEE |
DEF |
|
|
|
|
7.54 |
7/1/2023 |
12/31/2299 |
N |
J0696 |
CEFTRIAXONE SODIUM INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0696 |
CEFTRIAXONE SODIUM INJECTION |
MAXFEE |
DEF |
|
|
|
|
0.57 |
7/1/2023 |
12/31/2299 |
N |
J0697 |
STERILE CEFUROXIME INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0697 |
STERILE CEFUROXIME INJECTION |
MAXFEE |
DEF |
|
|
|
|
2.24 |
4/1/2023 |
12/31/2299 |
N |
J0698 |
CEFOTAXIME SODIUM INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0698 |
CEFOTAXIME SODIUM INJECTION |
MAXFEE |
DEF |
|
|
|
|
2.78 |
7/1/2021 |
12/31/2299 |
N |
J0699 |
INJ; CEFIDEROCOL; 10 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0699 |
INJ; CEFIDEROCOL; 10 MG |
MAXFEE |
DEF |
|
|
|
|
2.16 |
7/1/2023 |
12/31/2299 |
N |
J0701 |
INJ. CEFEPIME HCL (BAXTER) |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0701 |
INJ. CEFEPIME HCL (BAXTER) |
MAXFEE |
DEF |
|
|
|
|
5.72 |
7/1/2023 |
12/31/2299 |
N |
J0702 |
BETAMETHASONE ACET&SOD PHOSP |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0702 |
BETAMETHASONE ACET&SOD PHOSP |
MAXFEE |
DEF |
|
|
|
|
6.96 |
7/1/2023 |
12/31/2299 |
N |
J0703 |
INJ; CEFEPIME HCL (B BRAUN) |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0703 |
INJ; CEFEPIME HCL (B BRAUN) |
MAXFEE |
DEF |
|
|
|
|
5.10 |
7/1/2023 |
12/31/2299 |
N |
J0706 |
CAFFEINE CITRATE INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0706 |
CAFFEINE CITRATE INJECTION |
MAXFEE |
DEF |
|
|
|
|
0.55 |
4/1/2014 |
12/31/2299 |
N |
J0712 |
CEFTAROLINE FOSAMIL INJ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0712 |
CEFTAROLINE FOSAMIL INJ |
MAXFEE |
DEF |
|
|
|
|
3.89 |
7/1/2023 |
12/31/2299 |
N |
J0713 |
INJ CEFTAZIDIME PER 500 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0713 |
INJ CEFTAZIDIME PER 500 MG |
MAXFEE |
DEF |
|
|
|
|
1.84 |
7/1/2023 |
12/31/2299 |
N |
J0714 |
CEFTAZIDIME AND AVIBACTAM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0714 |
CEFTAZIDIME AND AVIBACTAM |
MAXFEE |
DEF |
|
|
|
|
92.48 |
7/1/2023 |
12/31/2299 |
N |
J0716 |
CENTRUROIDES IMMUNE F(AB) |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0716 |
CENTRUROIDES IMMUNE F(AB) |
MAXFEE |
DEF |
|
|
|
|
3745 |
9/1/2013 |
12/31/2299 |
N |
J0717 |
CERTOLIZUMAB PEGOL INJ 1MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0717 |
CERTOLIZUMAB PEGOL INJ 1MG |
MAXFEE |
DEF |
|
|
|
|
5.07 |
7/1/2023 |
12/31/2299 |
N |
J0718 |
CERTOLIZUMAB PEGOL INJ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0718 |
CERTOLIZUMAB PEGOL INJ |
MAXFEE |
DEF |
|
|
|
|
NA |
|
|
N |
J0720 |
CHLORAMPHENICOL SODIUM INJEC |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0720 |
CHLORAMPHENICOL SODIUM INJEC |
MAXFEE |
DEF |
|
|
|
|
50.26 |
7/1/2023 |
12/31/2299 |
N |
J0725 |
CHORIONIC GONADOTROPIN/1000U |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0725 |
CHORIONIC GONADOTROPIN/1000U |
MAXFEE |
DEF |
|
|
|
|
23.08 |
7/1/2023 |
12/31/2299 |
N |
J0735 |
CLONIDINE HYDROCHLORIDE |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0735 |
CLONIDINE HYDROCHLORIDE |
MAXFEE |
DEF |
|
|
|
|
21.04 |
7/1/2023 |
12/31/2299 |
N |
J0736 |
Inj; clindamycin phosp 300mg |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0736 |
Inj; clindamycin phosp 300mg |
MAXFEE |
DEF |
|
|
|
|
1.61 |
7/1/2023 |
12/31/2299 |
N |
J0737 |
Inj; clindamycin (baxter) |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0737 |
Inj; clindamycin (baxter) |
MAXFEE |
DEF |
|
|
|
|
1.32 |
7/1/2023 |
12/31/2299 |
N |
J0739 |
INJECTION; CABOTEGRAVIR 1 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0739 |
INJECTION; CABOTEGRAVIR 1 MG |
MANUAL |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0740 |
CIDOFOVIR INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0740 |
CIDOFOVIR INJECTION |
MAXFEE |
DEF |
|
|
|
|
577.03 |
7/1/2023 |
12/31/2299 |
N |
J0741 |
INJ; CABOTE RILPIVIR 2MG 3MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0741 |
INJ; CABOTE RILPIVIR 2MG 3MG |
MAXFEE |
DEF |
|
|
|
|
21.84 |
7/1/2023 |
12/31/2299 |
N |
J0742 |
INJ IMIP 4 CILAS 4 RELEB 2MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0742 |
INJ IMIP 4 CILAS 4 RELEB 2MG |
MAXFEE |
DEF |
|
|
|
|
2.49 |
7/1/2023 |
12/31/2299 |
N |
J0743 |
CILASTATIN SODIUM INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0743 |
CILASTATIN SODIUM INJECTION |
MAXFEE |
DEF |
|
|
|
|
7.15 |
7/1/2023 |
12/31/2299 |
N |
J0744 |
CIPROFLOXACIN IV |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0744 |
CIPROFLOXACIN IV |
MAXFEE |
DEF |
|
|
|
|
1.96 |
7/1/2023 |
12/31/2299 |
N |
J0745 |
INJ CODEINE PHOSPHATE /30 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0745 |
INJ CODEINE PHOSPHATE /30 MG |
MAXFEE |
DEF |
|
|
|
|
1.35 |
9/1/2013 |
12/31/2299 |
N |
J0770 |
COLISTIMETHATE SODIUM INJ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0770 |
COLISTIMETHATE SODIUM INJ |
MAXFEE |
DEF |
|
|
|
|
12.28 |
7/1/2023 |
12/31/2299 |
N |
J0775 |
COLLAGENASE; CLOST HIST INJ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0775 |
COLLAGENASE; CLOST HIST INJ |
MAXFEE |
DEF |
|
|
|
|
65.15 |
7/1/2023 |
12/31/2299 |
N |
J0780 |
PROCHLORPERAZINE INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0780 |
PROCHLORPERAZINE INJECTION |
MAXFEE |
DEF |
|
|
|
|
3.01 |
7/1/2023 |
12/31/2299 |
N |
J0791 |
INJ CRIZANLIZUMAB-TMCA 5MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0791 |
INJ CRIZANLIZUMAB-TMCA 5MG |
MAXFEE |
DEF |
|
|
|
|
126.61 |
7/1/2023 |
12/31/2299 |
N |
J0795 |
CORTICORELIN OVINE TRIFLUTAL |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0795 |
CORTICORELIN OVINE TRIFLUTAL |
MAXFEE |
DEF |
|
|
|
|
9.67 |
4/1/2021 |
12/31/2299 |
N |
J0800 |
CORTICOTROPIN INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0800 |
CORTICOTROPIN INJECTION |
MAXFEE |
DEF |
|
|
|
|
3819.78 |
7/1/2023 |
12/31/2299 |
N |
J0834 |
INJ.; COSYNTROPIN; 0.25 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0834 |
INJ.; COSYNTROPIN; 0.25 MG |
MAXFEE |
DEF |
|
|
|
|
27.88 |
7/1/2023 |
12/31/2299 |
N |
J0840 |
CROTALIDAE POLY IMMUNE FAB |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0840 |
CROTALIDAE POLY IMMUNE FAB |
MAXFEE |
DEF |
|
|
|
|
2056.35 |
7/1/2023 |
12/31/2299 |
N |
J0841 |
INJ CROTALIDAE IM F(AB')2 EQ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0841 |
INJ CROTALIDAE IM F(AB')2 EQ |
MAXFEE |
DEF |
|
|
|
|
1019.46 |
7/1/2023 |
12/31/2299 |
N |
J0850 |
CYTOMEGALOVIRUS IMM IV /VIAL |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0850 |
CYTOMEGALOVIRUS IMM IV /VIAL |
MAXFEE |
DEF |
|
|
|
|
1814.20 |
7/1/2023 |
12/31/2299 |
N |
J0875 |
INJECTION; DALBAVANCIN |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0875 |
INJECTION; DALBAVANCIN |
MAXFEE |
DEF |
|
|
|
|
14.70 |
7/1/2023 |
12/31/2299 |
N |
J0877 |
INJ; DAPTOMYCIN (HOSPIRA) |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0877 |
INJ; DAPTOMYCIN (HOSPIRA) |
MAXFEE |
DEF |
|
|
|
|
0.07 |
7/1/2023 |
12/31/2299 |
N |
J0878 |
DAPTOMYCIN INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0878 |
DAPTOMYCIN INJECTION |
MAXFEE |
DEF |
|
|
|
|
0.08 |
7/1/2023 |
12/31/2299 |
N |
J0879 |
DIFELIKEFALIN; ESRD ON DIALY |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0879 |
DIFELIKEFALIN; ESRD ON DIALY |
MANUAL |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0881 |
DARBEPOETIN ALFA; NON-ESRD |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0881 |
DARBEPOETIN ALFA; NON-ESRD |
MAXFEE |
DEF |
|
|
|
|
2.94 |
7/1/2023 |
12/31/2299 |
N |
J0882 |
DARBEPOETIN ALFA; ESRD USE |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0882 |
DARBEPOETIN ALFA; ESRD USE |
MAXFEE |
DEF |
|
|
|
|
2.94 |
7/1/2023 |
12/31/2299 |
N |
J0883 |
ARGATROBAN NONESRD USE 1MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0883 |
ARGATROBAN NONESRD USE 1MG |
MAXFEE |
DEF |
|
|
|
|
4.31 |
1/1/2017 |
12/31/2299 |
N |
J0884 |
ARGATROBAN ESRD DIALYSIS 1MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0884 |
ARGATROBAN ESRD DIALYSIS 1MG |
MAXFEE |
DEF |
|
|
|
|
4.31 |
1/1/2017 |
12/31/2299 |
N |
J0885 |
EPOETIN ALFA; NON-ESRD |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0885 |
EPOETIN ALFA; NON-ESRD |
MAXFEE |
DEF |
|
|
|
|
6.88 |
7/1/2023 |
12/31/2299 |
N |
J0887 |
EPOETIN BETA ESRD USE |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0887 |
EPOETIN BETA ESRD USE |
MAXFEE |
DEF |
|
|
|
|
1.65 |
7/1/2023 |
12/31/2299 |
N |
J0888 |
EPOETIN BETA NON ESRD |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0888 |
EPOETIN BETA NON ESRD |
MAXFEE |
DEF |
|
|
|
|
1.65 |
7/1/2023 |
12/31/2299 |
N |
J0890 |
PEGINESATIDE INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0890 |
PEGINESATIDE INJECTION |
MAXFEE |
DEF |
|
|
|
|
8.20 |
9/1/2013 |
12/31/2299 |
N |
J0891 |
ARGATROBAN NONESRD (ACCORD) |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0891 |
ARGATROBAN NONESRD (ACCORD) |
MAXFEE |
DEF |
|
|
|
|
0.46 |
7/1/2023 |
12/31/2299 |
N |
J0892 |
ARGATROBAN DIALYSIS (ACCORD) |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0892 |
ARGATROBAN DIALYSIS (ACCORD) |
MAXFEE |
DEF |
|
|
|
|
0.46 |
7/1/2023 |
12/31/2299 |
N |
J0893 |
INJ; DECITABINE (SUN PHARMA) |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0893 |
INJ; DECITABINE (SUN PHARMA) |
MAXFEE |
DEF |
|
|
|
|
2.24 |
7/1/2023 |
12/31/2299 |
N |
J0894 |
DECITABINE INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0894 |
DECITABINE INJECTION |
MAXFEE |
DEF |
|
|
|
|
2 |
7/1/2023 |
12/31/2299 |
N |
J0895 |
DEFEROXAMINE MESYLATE INJ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0895 |
DEFEROXAMINE MESYLATE INJ |
MAXFEE |
DEF |
|
|
|
|
8.59 |
7/1/2023 |
12/31/2299 |
N |
J0896 |
INJ LUSPATERCEPT-AAMT 0.25MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0896 |
INJ LUSPATERCEPT-AAMT 0.25MG |
MAXFEE |
DEF |
|
|
|
|
39.18 |
7/1/2023 |
12/31/2299 |
N |
J0897 |
DENOSUMAB INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0897 |
DENOSUMAB INJECTION |
MAXFEE |
DEF |
|
|
|
|
24.19 |
7/1/2023 |
12/31/2299 |
N |
J0898 |
ARGATROBAN NONESRD (AUROMED) |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0898 |
ARGATROBAN NONESRD (AUROMED) |
MAXFEE |
DEF |
|
|
|
|
1.64 |
7/1/2023 |
12/31/2299 |
N |
J0899 |
ARGATROBAN DIALYSIS; AUROMED |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J0899 |
ARGATROBAN DIALYSIS; AUROMED |
MAXFEE |
DEF |
|
|
|
|
1.64 |
7/1/2023 |
12/31/2299 |
N |
J1000 |
DEPO-ESTRADIOL CYPIONATE INJ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1000 |
DEPO-ESTRADIOL CYPIONATE INJ |
MAXFEE |
DEF |
|
|
|
|
30.68 |
7/1/2023 |
12/31/2299 |
N |
J1020 |
METHYLPREDNISOLONE 20 MG INJ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1020 |
METHYLPREDNISOLONE 20 MG INJ |
MAXFEE |
DEF |
|
|
|
|
7.17 |
7/1/2023 |
12/31/2299 |
N |
J1030 |
METHYLPREDNISOLONE 40 MG INJ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1030 |
METHYLPREDNISOLONE 40 MG INJ |
MAXFEE |
DEF |
|
|
|
|
7.61 |
7/1/2023 |
12/31/2299 |
N |
J1040 |
METHYLPREDNISOLONE 80 MG INJ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1040 |
METHYLPREDNISOLONE 80 MG INJ |
MAXFEE |
DEF |
|
|
|
|
11.91 |
7/1/2023 |
12/31/2299 |
N |
J1050 |
MEDROXYPROGESTERONE ACETATE |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1050 |
MEDROXYPROGESTERONE ACETATE |
MAXFEE |
DEF |
|
|
|
|
0.63 |
11/1/2017 |
12/31/2299 |
N |
J1071 |
INJ TESTOSTERONE CYPIONATE |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1071 |
INJ TESTOSTERONE CYPIONATE |
MAXFEE |
DEF |
|
|
|
|
0.03 |
1/1/2020 |
12/31/2299 |
N |
J1095 |
INJECTION; DEXAMETHASONE 9% |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1095 |
INJECTION; DEXAMETHASONE 9% |
MAXFEE |
DEF |
|
|
|
|
2.24 |
1/1/2019 |
12/31/2299 |
N |
J1096 |
DEXAMETHA OPTH INSERT 0.1 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1096 |
DEXAMETHA OPTH INSERT 0.1 MG |
MANUAL |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1097 |
PHENYLEP KETOROLAC OPTH SOLN |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1097 |
PHENYLEP KETOROLAC OPTH SOLN |
MANUAL |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1100 |
DEXAMETHASONE SODIUM PHOS |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1100 |
DEXAMETHASONE SODIUM PHOS |
MAXFEE |
DEF |
|
|
|
|
0.12 |
7/1/2023 |
12/31/2299 |
N |
J1110 |
INJ DIHYDROERGOTAMINE MESYLT |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1110 |
INJ DIHYDROERGOTAMINE MESYLT |
MAXFEE |
DEF |
|
|
|
|
50.59 |
7/1/2023 |
12/31/2299 |
N |
J1120 |
ACETAZOLAMID SODIUM INJECTIO |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1120 |
ACETAZOLAMID SODIUM INJECTIO |
MAXFEE |
DEF |
|
|
|
|
29.70 |
7/1/2023 |
12/31/2299 |
N |
J1130 |
INJ DICLOFENAC SODIUM 0.5MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1130 |
INJ DICLOFENAC SODIUM 0.5MG |
MAXFEE |
DEF |
|
|
|
|
0.21 |
1/1/2017 |
12/31/2299 |
N |
J1160 |
DIGOXIN INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1160 |
DIGOXIN INJECTION |
MAXFEE |
DEF |
|
|
|
|
10.81 |
7/1/2023 |
12/31/2299 |
N |
J1162 |
DIGOXIN IMMUNE FAB (OVINE) |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1162 |
DIGOXIN IMMUNE FAB (OVINE) |
MAXFEE |
DEF |
|
|
|
|
4593.57 |
4/1/2023 |
12/31/2299 |
N |
J1165 |
PHENYTOIN SODIUM INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1165 |
PHENYTOIN SODIUM INJECTION |
MAXFEE |
DEF |
|
|
|
|
0.63 |
7/1/2023 |
12/31/2299 |
N |
J1170 |
HYDROMORPHONE INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1170 |
HYDROMORPHONE INJECTION |
MAXFEE |
DEF |
|
|
|
|
4.35 |
7/1/2023 |
12/31/2299 |
N |
J1190 |
DEXRAZOXANE HCL INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1190 |
DEXRAZOXANE HCL INJECTION |
MAXFEE |
DEF |
|
|
|
|
113.90 |
7/1/2023 |
12/31/2299 |
N |
J1200 |
DIPHENHYDRAMINE HCL INJECTIO |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1200 |
DIPHENHYDRAMINE HCL INJECTIO |
MAXFEE |
DEF |
|
|
|
|
1.06 |
7/1/2023 |
12/31/2299 |
N |
J1201 |
INJ. CETIRIZINE HCL 0.5MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1201 |
INJ. CETIRIZINE HCL 0.5MG |
MAXFEE |
DEF |
|
|
|
|
15.07 |
7/1/2023 |
12/31/2299 |
N |
J1205 |
CHLOROTHIAZIDE SODIUM INJ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1205 |
CHLOROTHIAZIDE SODIUM INJ |
MAXFEE |
DEF |
|
|
|
|
61.57 |
7/1/2023 |
12/31/2299 |
N |
J1212 |
DIMETHYL SULFOXIDE 50% 50 ML |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1212 |
DIMETHYL SULFOXIDE 50% 50 ML |
MAXFEE |
DEF |
|
|
|
|
682.52 |
7/1/2023 |
12/31/2299 |
N |
J1230 |
METHADONE INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1230 |
METHADONE INJECTION |
MAXFEE |
DEF |
|
|
|
|
17.14 |
7/1/2023 |
12/31/2299 |
N |
J1240 |
DIMENHYDRINATE INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1240 |
DIMENHYDRINATE INJECTION |
MAXFEE |
DEF |
|
|
|
|
8.98 |
7/1/2023 |
12/31/2299 |
N |
J1245 |
DIPYRIDAMOLE INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1245 |
DIPYRIDAMOLE INJECTION |
MAXFEE |
DEF |
|
|
|
|
3.78 |
7/1/2023 |
12/31/2299 |
N |
J1250 |
INJ DOBUTAMINE HCL/250 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1250 |
INJ DOBUTAMINE HCL/250 MG |
MAXFEE |
DEF |
|
|
|
|
8.83 |
7/1/2023 |
12/31/2299 |
N |
J1260 |
DOLASETRON MESYLATE |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1260 |
DOLASETRON MESYLATE |
MAXFEE |
DEF |
|
|
|
|
6.17 |
10/1/2016 |
12/31/2299 |
N |
J1265 |
DOPAMINE INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1265 |
DOPAMINE INJECTION |
MAXFEE |
DEF |
|
|
|
|
0.70 |
7/1/2023 |
12/31/2299 |
N |
J1267 |
DORIPENEM INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1267 |
DORIPENEM INJECTION |
MAXFEE |
DEF |
|
|
|
|
0.88 |
8/1/2018 |
12/31/2299 |
N |
J1270 |
INJECTION; DOXERCALCIFEROL |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1270 |
INJECTION; DOXERCALCIFEROL |
MAXFEE |
DEF |
|
|
|
|
0.44 |
7/1/2023 |
12/31/2299 |
N |
J1290 |
ECALLANTIDE INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1290 |
ECALLANTIDE INJECTION |
MAXFEE |
DEF |
|
|
|
|
530.72 |
7/1/2023 |
12/31/2299 |
N |
J1300 |
ECULIZUMAB INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1300 |
ECULIZUMAB INJECTION |
MAXFEE |
DEF |
|
|
|
|
225.79 |
7/1/2023 |
12/31/2299 |
N |
J1301 |
INJECTION; EDARAVONE; 1 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1301 |
INJECTION; EDARAVONE; 1 MG |
MAXFEE |
DEF |
|
|
|
|
21.40 |
7/1/2023 |
12/31/2299 |
N |
J1302 |
INJ; SUTIMLIMAB-JOME; 10 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
Y |
J1302 |
INJ; SUTIMLIMAB-JOME; 10 MG |
MAXFEE |
DEF |
|
|
|
|
17.75 |
7/1/2023 |
12/31/2299 |
Y |
J1303 |
INJ.; RAVULIZUMAB-CWVZ 10 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1303 |
INJ.; RAVULIZUMAB-CWVZ 10 MG |
MAXFEE |
DEF |
|
|
|
|
221.88 |
7/1/2023 |
12/31/2299 |
N |
J1305 |
INJ; EVINACUMAB-DGNB; 5MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1305 |
INJ; EVINACUMAB-DGNB; 5MG |
MAXFEE |
DEF |
|
|
|
|
175.78 |
7/1/2023 |
12/31/2299 |
N |
J1306 |
INJECTION; INCLISIRAN; 1 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1306 |
INJECTION; INCLISIRAN; 1 MG |
MANUAL |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1322 |
ELOSULFASE ALFA; INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1322 |
ELOSULFASE ALFA; INJECTION |
MAXFEE |
DEF |
|
|
|
|
280.13 |
7/1/2023 |
12/31/2299 |
N |
J1324 |
ENFUVIRTIDE INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1324 |
ENFUVIRTIDE INJECTION |
MAXFEE |
DEF |
|
|
|
|
0.55 |
9/1/2013 |
12/31/2299 |
N |
J1325 |
EPOPROSTENOL INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1325 |
EPOPROSTENOL INJECTION |
MAXFEE |
DEF |
|
|
|
|
16 |
7/1/2023 |
12/31/2299 |
N |
J1327 |
EPTIFIBATIDE INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1327 |
EPTIFIBATIDE INJECTION |
MAXFEE |
DEF |
|
|
|
|
27.58 |
4/1/2014 |
12/31/2299 |
N |
J1335 |
ERTAPENEM INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1335 |
ERTAPENEM INJECTION |
MAXFEE |
DEF |
|
|
|
|
13.32 |
7/1/2023 |
12/31/2299 |
N |
J1364 |
ERYTHRO LACTOBIONATE /500 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1364 |
ERYTHRO LACTOBIONATE /500 MG |
MAXFEE |
DEF |
|
|
|
|
87.33 |
7/1/2023 |
12/31/2299 |
N |
J1380 |
ESTRADIOL VALERATE 10 MG INJ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1380 |
ESTRADIOL VALERATE 10 MG INJ |
MAXFEE |
DEF |
|
|
|
|
10.78 |
7/1/2023 |
12/31/2299 |
N |
J1410 |
INJ ESTROGEN CONJUGATE 25 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1410 |
INJ ESTROGEN CONJUGATE 25 MG |
MAXFEE |
DEF |
|
|
|
|
371.89 |
7/1/2023 |
12/31/2299 |
N |
J1411 |
INJ; HEMGENIX; PER TX DOSE |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1411 |
INJ; HEMGENIX; PER TX DOSE |
MANUAL |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1426 |
INJECTION; CASIMERSEN; 10 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1426 |
INJECTION; CASIMERSEN; 10 MG |
MAXFEE |
DEF |
|
|
|
|
171.20 |
10/1/2021 |
12/31/2299 |
N |
J1427 |
INJ. VILTOLARSEN |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1427 |
INJ. VILTOLARSEN |
MAXFEE |
DEF |
|
|
|
|
60.31 |
4/1/2022 |
12/31/2299 |
N |
J1428 |
INJ; ETEPLIRSEN; 10 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1428 |
INJ; ETEPLIRSEN; 10 MG |
MAXFEE |
DEF |
|
|
|
|
172.60 |
11/1/2018 |
12/31/2299 |
N |
J1429 |
INJ GOLODIRSEN 10 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1429 |
INJ GOLODIRSEN 10 MG |
MAXFEE |
DEF |
|
|
|
|
171.20 |
4/1/2022 |
12/31/2299 |
N |
J1430 |
ETHANOLAMINE OLEATE 100 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1430 |
ETHANOLAMINE OLEATE 100 MG |
MAXFEE |
DEF |
|
|
|
|
481.06 |
7/1/2023 |
12/31/2299 |
N |
J1437 |
INJ. FE DERISOMALTOSE 10 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1437 |
INJ. FE DERISOMALTOSE 10 MG |
MAXFEE |
DEF |
|
|
|
|
20.61 |
7/1/2023 |
12/31/2299 |
N |
J1438 |
ETANERCEPT INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1438 |
ETANERCEPT INJECTION |
MAXFEE |
DEF |
|
|
|
|
411.71 |
7/1/2016 |
12/31/2299 |
N |
J1439 |
INJ FERRIC CARBOXYMALTOS 1MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1439 |
INJ FERRIC CARBOXYMALTOS 1MG |
MAXFEE |
DEF |
|
|
|
|
1.13 |
4/1/2023 |
12/31/2299 |
N |
J1440 |
FILGRASTIM 300 MCG INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1440 |
FILGRASTIM 300 MCG INJECTION |
MAXFEE |
DEF |
|
|
|
|
64.20 |
7/1/2023 |
12/31/2299 |
N |
J1441 |
FILGRASTIM 480 MCG INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1441 |
FILGRASTIM 480 MCG INJECTION |
MAXFEE |
DEF |
|
|
|
|
NA |
|
|
N |
J1442 |
INJ FILGRASTIM EXCL BIOSIMIL |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1442 |
INJ FILGRASTIM EXCL BIOSIMIL |
MAXFEE |
DEF |
|
|
|
|
0.99 |
7/1/2023 |
12/31/2299 |
N |
J1444 |
FE PYRO CIT POW 0.1 MG IRON |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1444 |
FE PYRO CIT POW 0.1 MG IRON |
MANUAL |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1445 |
INJ TRIFERIC AVNU 0.1MG IRON |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1445 |
INJ TRIFERIC AVNU 0.1MG IRON |
MANUAL |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1447 |
INJ TBO FILGRASTIM 1 MICROG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1447 |
INJ TBO FILGRASTIM 1 MICROG |
MAXFEE |
DEF |
|
|
|
|
0.43 |
7/1/2023 |
12/31/2299 |
N |
J1448 |
INJECTION; TRILACICLIB; 1MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1448 |
INJECTION; TRILACICLIB; 1MG |
MAXFEE |
DEF |
|
|
|
|
5.10 |
7/1/2023 |
12/31/2299 |
N |
J1449 |
INJ EFLAPEGRASTIM-XNST 0.1MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1449 |
INJ EFLAPEGRASTIM-XNST 0.1MG |
MAXFEE |
DEF |
|
|
|
|
31.77 |
7/1/2023 |
12/31/2299 |
N |
J1450 |
FLUCONAZOLE |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1450 |
FLUCONAZOLE |
MAXFEE |
DEF |
|
|
|
|
2.68 |
7/1/2023 |
12/31/2299 |
N |
J1451 |
FOMEPIZOLE; 15 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1451 |
FOMEPIZOLE; 15 MG |
MAXFEE |
DEF |
|
|
|
|
6.70 |
4/1/2014 |
12/31/2299 |
N |
J1453 |
FOSAPREPITANT INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1453 |
FOSAPREPITANT INJECTION |
MAXFEE |
DEF |
|
|
|
|
0.14 |
7/1/2023 |
12/31/2299 |
N |
J1454 |
INJ FOSNETUPITANT; PALONOSET |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1454 |
INJ FOSNETUPITANT; PALONOSET |
MAXFEE |
DEF |
|
|
|
|
372 |
7/1/2023 |
12/31/2299 |
N |
J1455 |
FOSCARNET SODIUM INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1455 |
FOSCARNET SODIUM INJECTION |
MAXFEE |
DEF |
|
|
|
|
13.55 |
9/1/2013 |
12/31/2299 |
N |
J1456 |
INJ; FOSAPREPITANT (TEVA) |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1456 |
INJ; FOSAPREPITANT (TEVA) |
MAXFEE |
DEF |
|
|
|
|
0.10 |
7/1/2023 |
12/31/2299 |
N |
J1457 |
GALLIUM NITRATE INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1457 |
GALLIUM NITRATE INJECTION |
MAXFEE |
DEF |
|
|
|
|
2.14 |
9/1/2013 |
12/31/2299 |
N |
J1458 |
GALSULFASE INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1458 |
GALSULFASE INJECTION |
MAXFEE |
DEF |
|
|
|
|
461.92 |
7/1/2023 |
12/31/2299 |
N |
J1459 |
INJ IVIG PRIVIGEN 500 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1459 |
INJ IVIG PRIVIGEN 500 MG |
MAXFEE |
DEF |
|
|
|
|
47.99 |
7/1/2023 |
12/31/2299 |
N |
J1460 |
GAMMA GLOBULIN 1 CC INJ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1460 |
GAMMA GLOBULIN 1 CC INJ |
MAXFEE |
DEF |
|
|
|
|
48.47 |
7/1/2023 |
12/31/2299 |
N |
J1551 |
INJ CUTAQUIG 100 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1551 |
INJ CUTAQUIG 100 MG |
MAXFEE |
DEF |
|
|
|
|
14.39 |
7/1/2023 |
12/31/2299 |
N |
J1554 |
INJ. ASCENIV |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1554 |
INJ. ASCENIV |
MAXFEE |
DEF |
|
|
|
|
491.41 |
7/1/2023 |
12/31/2299 |
N |
J1555 |
INJ CUVITRU; 100 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1555 |
INJ CUVITRU; 100 MG |
MAXFEE |
DEF |
|
|
|
|
16.28 |
7/1/2023 |
12/31/2299 |
N |
J1556 |
INJ; IMM GLOB BIVIGAM; 500MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1556 |
INJ; IMM GLOB BIVIGAM; 500MG |
MAXFEE |
DEF |
|
|
|
|
72.96 |
7/1/2023 |
12/31/2299 |
N |
J1557 |
GAMMAPLEX INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1557 |
GAMMAPLEX INJECTION |
MAXFEE |
DEF |
|
|
|
|
59.48 |
7/1/2023 |
12/31/2299 |
N |
J1558 |
INJ. XEMBIFY; 100 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1558 |
INJ. XEMBIFY; 100 MG |
MAXFEE |
DEF |
|
|
|
|
14 |
7/1/2023 |
12/31/2299 |
N |
J1559 |
HIZENTRA INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1559 |
HIZENTRA INJECTION |
MAXFEE |
DEF |
|
|
|
|
12.80 |
7/1/2023 |
12/31/2299 |
N |
J1560 |
GAMMA GLOBULIN > 10 CC INJ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1560 |
GAMMA GLOBULIN > 10 CC INJ |
MAXFEE |
DEF |
|
|
|
|
484.65 |
7/1/2023 |
12/31/2299 |
N |
J1561 |
GAMUNEX-C/GAMMAKED |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1561 |
GAMUNEX-C/GAMMAKED |
MAXFEE |
DEF |
|
|
|
|
50.64 |
7/1/2023 |
12/31/2299 |
N |
J1566 |
IMMUNE GLOBULIN; POWDER |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1566 |
IMMUNE GLOBULIN; POWDER |
MAXFEE |
DEF |
|
|
|
|
77.77 |
7/1/2023 |
12/31/2299 |
N |
J1568 |
OCTAGAM INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1568 |
OCTAGAM INJECTION |
MAXFEE |
DEF |
|
|
|
|
44.12 |
7/1/2023 |
12/31/2299 |
N |
J1569 |
GAMMAGARD LIQUID INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1569 |
GAMMAGARD LIQUID INJECTION |
MAXFEE |
DEF |
|
|
|
|
46.03 |
7/1/2023 |
12/31/2299 |
N |
J1570 |
GANCICLOVIR SODIUM INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1570 |
GANCICLOVIR SODIUM INJECTION |
MAXFEE |
DEF |
|
|
|
|
39.49 |
7/1/2023 |
12/31/2299 |
N |
J1571 |
HEPAGAM B IM INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1571 |
HEPAGAM B IM INJECTION |
MAXFEE |
DEF |
|
|
|
|
66.26 |
7/1/2023 |
12/31/2299 |
N |
J1572 |
FLEBOGAMMA INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1572 |
FLEBOGAMMA INJECTION |
MAXFEE |
DEF |
|
|
|
|
56.12 |
7/1/2023 |
12/31/2299 |
N |
J1573 |
HEPAGAM B INTRAVENOUS; INJ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1573 |
HEPAGAM B INTRAVENOUS; INJ |
MAXFEE |
DEF |
|
|
|
|
51.29 |
1/1/2014 |
12/31/2299 |
N |
J1574 |
INJ; GANCICLOVIR (EXELA) |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1574 |
INJ; GANCICLOVIR (EXELA) |
MANUAL |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1575 |
HYQVIA 100MG IMMUNEGLOBULIN |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1575 |
HYQVIA 100MG IMMUNEGLOBULIN |
MAXFEE |
DEF |
|
|
|
|
16.66 |
7/1/2023 |
12/31/2299 |
N |
J1576 |
Inj; panzyga; 500 mg |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1576 |
Inj; panzyga; 500 mg |
MAXFEE |
DEF |
|
|
|
|
65.74 |
7/1/2023 |
12/31/2299 |
N |
J1580 |
GARAMYCIN GENTAMICIN INJ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1580 |
GARAMYCIN GENTAMICIN INJ |
MAXFEE |
DEF |
|
|
|
|
2.99 |
7/1/2023 |
12/31/2299 |
N |
J1595 |
INJECTION GLATIRAMER ACETATE |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1595 |
INJECTION GLATIRAMER ACETATE |
MAXFEE |
DEF |
|
|
|
|
164.22 |
9/1/2013 |
12/31/2299 |
N |
J1599 |
IVIG NON-LYOPHILIZED; NOS |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1599 |
IVIG NON-LYOPHILIZED; NOS |
MAXFEE |
DEF |
|
|
|
|
57.09 |
9/1/2013 |
12/31/2299 |
N |
J1600 |
GOLD SODIUM THIOMALEATE INJ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1600 |
GOLD SODIUM THIOMALEATE INJ |
MAXFEE |
DEF |
|
|
|
|
30.15 |
9/1/2013 |
12/31/2299 |
N |
J1602 |
GOLIMUMAB FOR IV USE 1MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1602 |
GOLIMUMAB FOR IV USE 1MG |
MAXFEE |
DEF |
|
|
|
|
13.29 |
7/1/2023 |
12/31/2299 |
N |
J1610 |
GLUCAGON HYDROCHLORIDE/1 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1610 |
GLUCAGON HYDROCHLORIDE/1 MG |
MAXFEE |
DEF |
|
|
|
|
195.18 |
7/1/2023 |
12/31/2299 |
N |
J1611 |
INJ GLUCAGON HCL; FRESENIUS |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1611 |
INJ GLUCAGON HCL; FRESENIUS |
MAXFEE |
DEF |
|
|
|
|
101.41 |
7/1/2023 |
12/31/2299 |
N |
J1626 |
GRANISETRON HCL INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1626 |
GRANISETRON HCL INJECTION |
MAXFEE |
DEF |
|
|
|
|
0.39 |
7/1/2023 |
12/31/2299 |
N |
J1627 |
INJ; GRANISETRON; XR; 0.1 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1627 |
INJ; GRANISETRON; XR; 0.1 MG |
MAXFEE |
DEF |
|
|
|
|
5.88 |
7/1/2023 |
12/31/2299 |
N |
J1628 |
INJ.; GUSELKUMAB; 1 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1628 |
INJ.; GUSELKUMAB; 1 MG |
MAXFEE |
DEF |
|
|
|
|
108.70 |
1/1/2019 |
12/31/2299 |
N |
J1630 |
HALOPERIDOL INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1630 |
HALOPERIDOL INJECTION |
MAXFEE |
DEF |
|
|
|
|
1.38 |
7/1/2023 |
12/31/2299 |
N |
J1631 |
HALOPERIDOL DECANOATE INJ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1631 |
HALOPERIDOL DECANOATE INJ |
MAXFEE |
DEF |
|
|
|
|
8.33 |
7/1/2023 |
12/31/2299 |
N |
J1632 |
INJ.; BREXANOLONE; 1 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1632 |
INJ.; BREXANOLONE; 1 MG |
MANUAL |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1640 |
HEMIN; 1 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1640 |
HEMIN; 1 MG |
MAXFEE |
DEF |
|
|
|
|
31.08 |
7/1/2023 |
12/31/2299 |
N |
J1642 |
INJ HEPARIN SODIUM PER 10 U |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1642 |
INJ HEPARIN SODIUM PER 10 U |
MAXFEE |
DEF |
|
|
|
|
0.07 |
7/1/2023 |
12/31/2299 |
N |
J1643 |
INJ HEPARIN; PFIZER; 1000U |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1643 |
INJ HEPARIN; PFIZER; 1000U |
MANUAL |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1645 |
DALTEPARIN SODIUM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1645 |
DALTEPARIN SODIUM |
MAXFEE |
DEF |
|
|
|
|
16.60 |
7/1/2023 |
12/31/2299 |
N |
J1650 |
INJ ENOXAPARIN SODIUM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1650 |
INJ ENOXAPARIN SODIUM |
MAXFEE |
DEF |
|
|
|
|
0.68 |
7/1/2023 |
12/31/2299 |
N |
J1652 |
FONDAPARINUX SODIUM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1652 |
FONDAPARINUX SODIUM |
MAXFEE |
DEF |
|
|
|
|
1.07 |
4/1/2023 |
12/31/2299 |
N |
J1670 |
TETANUS IMMUNE GLOBULIN INJ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1670 |
TETANUS IMMUNE GLOBULIN INJ |
MAXFEE |
DEF |
|
|
|
|
540.99 |
7/1/2023 |
12/31/2299 |
N |
J1720 |
HYDROCORTISONE SODIUM SUCC I |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1720 |
HYDROCORTISONE SODIUM SUCC I |
MAXFEE |
DEF |
|
|
|
|
17.51 |
7/1/2023 |
12/31/2299 |
N |
J1726 |
MAKENA; 10 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1726 |
MAKENA; 10 MG |
MAXFEE |
DEF |
|
|
|
|
31.16 |
1/1/2018 |
12/31/2299 |
N |
J1729 |
INJ HYDROXYPROGST CAPOAT NOS |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1729 |
INJ HYDROXYPROGST CAPOAT NOS |
MAXFEE |
DEF |
|
|
|
|
3.12 |
1/1/2018 |
12/31/2299 |
N |
J1738 |
INJ. MELOXICAM 1 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1738 |
INJ. MELOXICAM 1 MG |
MAXFEE |
DEF |
|
|
|
|
3.32 |
7/1/2023 |
12/31/2299 |
N |
J1740 |
IBANDRONATE SODIUM INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1740 |
IBANDRONATE SODIUM INJECTION |
MAXFEE |
DEF |
|
|
|
|
29.31 |
7/1/2023 |
12/31/2299 |
N |
J1741 |
IBUPROFEN INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1741 |
IBUPROFEN INJECTION |
MAXFEE |
DEF |
|
|
|
|
1.69 |
9/1/2013 |
12/31/2299 |
N |
J1742 |
IBUTILIDE FUMARATE INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1742 |
IBUTILIDE FUMARATE INJECTION |
MAXFEE |
DEF |
|
|
|
|
205.06 |
10/1/2021 |
12/31/2299 |
N |
J1743 |
IDURSULFASE INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1743 |
IDURSULFASE INJECTION |
MAXFEE |
DEF |
|
|
|
|
542.92 |
7/1/2023 |
12/31/2299 |
N |
J1744 |
ICATIBANT INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1744 |
ICATIBANT INJECTION |
MAXFEE |
DEF |
|
|
|
|
263.15 |
9/1/2013 |
12/31/2299 |
N |
J1745 |
INFLIXIMAB NOT BIOSIMIL 10MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1745 |
INFLIXIMAB NOT BIOSIMIL 10MG |
MAXFEE |
DEF |
|
|
|
|
32.91 |
7/1/2023 |
12/31/2299 |
N |
J1746 |
INJ.; IBALIZUMAB-UIYK; 10 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1746 |
INJ.; IBALIZUMAB-UIYK; 10 MG |
MAXFEE |
DEF |
|
|
|
|
74.29 |
7/1/2023 |
12/31/2299 |
N |
J1747 |
INJ; SPESOLIMAB-SBZO; 1 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1747 |
INJ; SPESOLIMAB-SBZO; 1 MG |
MAXFEE |
DEF |
|
|
|
|
60.22 |
4/1/2023 |
12/31/2299 |
N |
J1750 |
INJ IRON DEXTRAN |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1750 |
INJ IRON DEXTRAN |
MAXFEE |
DEF |
|
|
|
|
17.18 |
7/1/2023 |
12/31/2299 |
N |
J1756 |
IRON SUCROSE INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1756 |
IRON SUCROSE INJECTION |
MAXFEE |
DEF |
|
|
|
|
0.21 |
4/1/2023 |
12/31/2299 |
N |
J1786 |
IMUGLUCERASE INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1786 |
IMUGLUCERASE INJECTION |
MAXFEE |
DEF |
|
|
|
|
44.25 |
7/1/2023 |
12/31/2299 |
N |
J1790 |
DROPERIDOL INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1790 |
DROPERIDOL INJECTION |
MAXFEE |
DEF |
|
|
|
|
2.14 |
11/1/2013 |
12/31/2299 |
N |
J1800 |
PROPRANOLOL INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1800 |
PROPRANOLOL INJECTION |
MAXFEE |
DEF |
|
|
|
|
3.32 |
7/1/2021 |
12/31/2299 |
N |
J1805 |
Inj; esmolol hcl; 10mg |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1805 |
Inj; esmolol hcl; 10mg |
MAXFEE |
DEF |
|
|
|
|
0.25 |
7/1/2023 |
12/31/2299 |
N |
J1806 |
Inj esmolol hcl wg crit care |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1806 |
Inj esmolol hcl wg crit care |
MAXFEE |
DEF |
|
|
|
|
0.49 |
7/1/2023 |
12/31/2299 |
N |
J1811 |
Fiasp for insulin pump use |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1811 |
Fiasp for insulin pump use |
MAXFEE |
DEF |
|
|
|
|
7.20 |
7/1/2023 |
12/31/2299 |
N |
J1812 |
Inj. insulin (fiasp) |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1812 |
Inj. insulin (fiasp) |
MAXFEE |
DEF |
|
|
|
|
1.55 |
7/1/2023 |
12/31/2299 |
N |
J1813 |
Lyumjev for insulin pump use |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1813 |
Lyumjev for insulin pump use |
MAXFEE |
DEF |
|
|
|
|
15.73 |
7/1/2023 |
12/31/2299 |
N |
J1814 |
Inj. insulin (lyumjev) |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1814 |
Inj. insulin (lyumjev) |
MAXFEE |
DEF |
|
|
|
|
1.47 |
7/1/2023 |
12/31/2299 |
N |
J1815 |
INSULIN INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1815 |
INSULIN INJECTION |
MAXFEE |
DEF |
|
|
|
|
0.90 |
1/1/2022 |
12/31/2299 |
N |
J1817 |
INSULIN FOR INSULIN PUMP USE |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1817 |
INSULIN FOR INSULIN PUMP USE |
MAXFEE |
DEF |
|
|
|
|
8.40 |
7/1/2023 |
12/31/2299 |
N |
J1823 |
INJ. INEBILIZUMAB-CDON; 1 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1823 |
INJ. INEBILIZUMAB-CDON; 1 MG |
MAXFEE |
DEF |
|
|
|
|
472.30 |
7/1/2023 |
12/31/2299 |
N |
J1826 |
INTERFERON BETA-1A INJ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1826 |
INTERFERON BETA-1A INJ |
MAXFEE |
DEF |
|
|
|
|
1125.64 |
9/1/2013 |
12/31/2299 |
N |
J1830 |
INTERFERON BETA-1B / .25 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1830 |
INTERFERON BETA-1B / .25 MG |
MAXFEE |
DEF |
|
|
|
|
301.02 |
9/1/2013 |
12/31/2299 |
N |
J1836 |
Inj; metronidazole; 10 mg |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1836 |
Inj; metronidazole; 10 mg |
MAXFEE |
DEF |
|
|
|
|
0.02 |
7/1/2023 |
12/31/2299 |
N |
J1840 |
KANAMYCIN SULFATE 500 MG INJ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1840 |
KANAMYCIN SULFATE 500 MG INJ |
MAXFEE |
DEF |
|
|
|
|
7.69 |
11/1/2015 |
12/31/2299 |
N |
J1850 |
KANAMYCIN SULFATE 75 MG INJ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1850 |
KANAMYCIN SULFATE 75 MG INJ |
MAXFEE |
DEF |
|
|
|
|
1.15 |
9/1/2011 |
12/31/2299 |
N |
J1885 |
KETOROLAC TROMETHAMINE INJ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1885 |
KETOROLAC TROMETHAMINE INJ |
MAXFEE |
DEF |
|
|
|
|
0.55 |
7/1/2023 |
12/31/2299 |
N |
J1920 |
Inj; labetalol hcl; 5mg |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1920 |
Inj; labetalol hcl; 5mg |
MAXFEE |
DEF |
|
|
|
|
0.24 |
7/1/2023 |
12/31/2299 |
N |
J1921 |
Inj labetalol hcl hikma; 5mg |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1921 |
Inj labetalol hcl hikma; 5mg |
MAXFEE |
DEF |
|
|
|
|
1.24 |
7/1/2023 |
12/31/2299 |
N |
J1930 |
LANREOTIDE INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1930 |
LANREOTIDE INJECTION |
MAXFEE |
DEF |
|
|
|
|
54.18 |
7/1/2023 |
12/31/2299 |
N |
J1931 |
LARONIDASE INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1931 |
LARONIDASE INJECTION |
MAXFEE |
DEF |
|
|
|
|
37.04 |
7/1/2023 |
12/31/2299 |
N |
J1932 |
INJ; LANREOTIDE; (CIPLA) 1MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
Y |
J1932 |
INJ; LANREOTIDE; (CIPLA) 1MG |
MAXFEE |
DEF |
|
|
|
|
51.38 |
7/1/2023 |
12/31/2299 |
Y |
J1940 |
FUROSEMIDE INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1940 |
FUROSEMIDE INJECTION |
MAXFEE |
DEF |
|
|
|
|
0.50 |
7/1/2023 |
12/31/2299 |
N |
J1941 |
Inj; furoscix; 20 mg |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1941 |
Inj; furoscix; 20 mg |
MAXFEE |
DEF |
|
|
|
|
0 |
7/1/2023 |
12/31/2299 |
N |
J1943 |
INJ.; ARISTADA INITIO; 1 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1943 |
INJ.; ARISTADA INITIO; 1 MG |
MAXFEE |
DEF |
|
|
|
|
3.06 |
7/1/2023 |
12/31/2299 |
N |
J1944 |
ARIPIPRAZOLE LAUROXIL 1 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1944 |
ARIPIPRAZOLE LAUROXIL 1 MG |
MAXFEE |
DEF |
|
|
|
|
3.07 |
7/1/2023 |
12/31/2299 |
N |
J1945 |
LEPIRUDIN |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1945 |
LEPIRUDIN |
MAXFEE |
DEF |
|
|
|
|
570.54 |
9/1/2013 |
12/31/2299 |
N |
J1950 |
LEUPROLIDE ACETATE /3.75 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1950 |
LEUPROLIDE ACETATE /3.75 MG |
MAXFEE |
DEF |
|
|
|
|
1543.52 |
7/1/2023 |
12/31/2299 |
N |
J1951 |
INJ FENSOLVI 0.25 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1951 |
INJ FENSOLVI 0.25 MG |
MAXFEE |
DEF |
|
|
|
|
138.81 |
7/1/2023 |
12/31/2299 |
N |
J1952 |
LEUPROLIDE INJ; CAMCEVI; 1MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1952 |
LEUPROLIDE INJ; CAMCEVI; 1MG |
MAXFEE |
DEF |
|
|
|
|
78.31 |
7/1/2023 |
12/31/2299 |
N |
J1953 |
LEVETIRACETAM INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1953 |
LEVETIRACETAM INJECTION |
MAXFEE |
DEF |
|
|
|
|
0.07 |
7/1/2023 |
12/31/2299 |
N |
J1954 |
LEUPROLIDE DEPOT CIPLA 7.5MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1954 |
LEUPROLIDE DEPOT CIPLA 7.5MG |
MAXFEE |
DEF |
|
|
|
|
425.48 |
7/1/2023 |
12/31/2299 |
N |
J1955 |
INJ LEVOCARNITINE PER 1 GM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1955 |
INJ LEVOCARNITINE PER 1 GM |
MAXFEE |
DEF |
|
|
|
|
35.42 |
7/1/2023 |
12/31/2299 |
N |
J1956 |
LEVOFLOXACIN INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1956 |
LEVOFLOXACIN INJECTION |
MAXFEE |
DEF |
|
|
|
|
0.92 |
7/1/2023 |
12/31/2299 |
N |
J1961 |
Inj; lenacapavir; 1 mg |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1961 |
Inj; lenacapavir; 1 mg |
MAXFEE |
DEF |
|
|
|
|
15.01 |
7/1/2023 |
12/31/2299 |
N |
J1980 |
HYOSCYAMINE SULFATE INJ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J1980 |
HYOSCYAMINE SULFATE INJ |
MAXFEE |
DEF |
|
|
|
|
33.23 |
7/1/2023 |
12/31/2299 |
N |
J2001 |
LIDOCAINE INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2001 |
LIDOCAINE INJECTION |
MAXFEE |
DEF |
|
|
|
|
0.03 |
10/1/2022 |
12/31/2299 |
N |
J2010 |
LINCOMYCIN INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2010 |
LINCOMYCIN INJECTION |
MAXFEE |
DEF |
|
|
|
|
9.99 |
7/1/2023 |
12/31/2299 |
N |
J2020 |
LINEZOLID INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2020 |
LINEZOLID INJECTION |
MAXFEE |
DEF |
|
|
|
|
3.47 |
7/1/2023 |
12/31/2299 |
N |
J2021 |
INJ; LINEZOLID (HOSPIRA) |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2021 |
INJ; LINEZOLID (HOSPIRA) |
MAXFEE |
DEF |
|
|
|
|
9.48 |
7/1/2023 |
12/31/2299 |
N |
J2060 |
LORAZEPAM INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2060 |
LORAZEPAM INJECTION |
MAXFEE |
DEF |
|
|
|
|
0.85 |
7/1/2023 |
12/31/2299 |
N |
J2062 |
LOXAPINE FOR INHALATION 1 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2062 |
LOXAPINE FOR INHALATION 1 MG |
MAXFEE |
DEF |
|
|
|
|
16.05 |
1/1/2019 |
12/31/2299 |
N |
J2150 |
MANNITOL INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2150 |
MANNITOL INJECTION |
MAXFEE |
DEF |
|
|
|
|
4.93 |
7/1/2023 |
12/31/2299 |
N |
J2170 |
MECASERMIN INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2170 |
MECASERMIN INJECTION |
MAXFEE |
DEF |
|
|
|
|
35.61 |
9/1/2013 |
12/31/2299 |
N |
J2175 |
MEPERIDINE HYDROCHL /100 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2175 |
MEPERIDINE HYDROCHL /100 MG |
MAXFEE |
DEF |
|
|
|
|
7.31 |
7/1/2023 |
12/31/2299 |
N |
J2182 |
INJECTION; MEPOLIZUMAB; 1MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2182 |
INJECTION; MEPOLIZUMAB; 1MG |
MAXFEE |
DEF |
|
|
|
|
29.75 |
7/1/2023 |
12/31/2299 |
N |
J2184 |
INJ; MEROPENEM (B. BRAUN) |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2184 |
INJ; MEROPENEM (B. BRAUN) |
MAXFEE |
DEF |
|
|
|
|
2.10 |
7/1/2023 |
12/31/2299 |
N |
J2185 |
MEROPENEM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2185 |
MEROPENEM |
MAXFEE |
DEF |
|
|
|
|
0.52 |
7/1/2023 |
12/31/2299 |
N |
J2186 |
INJ.; MEROPENEM; VABORBACTAM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2186 |
INJ.; MEROPENEM; VABORBACTAM |
MAXFEE |
DEF |
|
|
|
|
1.77 |
1/1/2019 |
12/31/2299 |
N |
J2210 |
METHYLERGONOVIN MALEATE INJ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2210 |
METHYLERGONOVIN MALEATE INJ |
MAXFEE |
DEF |
|
|
|
|
20.89 |
7/1/2023 |
12/31/2299 |
N |
J2212 |
METHYLNALTREXONE INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2212 |
METHYLNALTREXONE INJECTION |
MAXFEE |
DEF |
|
|
|
|
0.53 |
9/1/2013 |
12/31/2299 |
N |
J2247 |
INJ; MICAFUNGIN (PAR PHARM) |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2247 |
INJ; MICAFUNGIN (PAR PHARM) |
MAXFEE |
DEF |
|
|
|
|
0.29 |
7/1/2023 |
12/31/2299 |
N |
J2248 |
MICAFUNGIN SODIUM INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2248 |
MICAFUNGIN SODIUM INJECTION |
MAXFEE |
DEF |
|
|
|
|
0.83 |
4/1/2023 |
12/31/2299 |
N |
J2249 |
Inj; remimazolam; 1 mg |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2249 |
Inj; remimazolam; 1 mg |
MAXFEE |
DEF |
|
|
|
|
2.21 |
7/1/2023 |
12/31/2299 |
N |
J2250 |
INJ MIDAZOLAM HYDROCHLORIDE |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2250 |
INJ MIDAZOLAM HYDROCHLORIDE |
MAXFEE |
DEF |
|
|
|
|
0.14 |
7/1/2023 |
12/31/2299 |
N |
J2251 |
INJ MIDAZOLAM (WG CRIT CARE) |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2251 |
INJ MIDAZOLAM (WG CRIT CARE) |
MAXFEE |
DEF |
|
|
|
|
0.29 |
7/1/2023 |
12/31/2299 |
N |
J2260 |
INJ MILRINONE LACTATE / 5 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2260 |
INJ MILRINONE LACTATE / 5 MG |
MAXFEE |
DEF |
|
|
|
|
1.87 |
7/1/2023 |
12/31/2299 |
N |
J2270 |
MORPHINE SULFATE INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2270 |
MORPHINE SULFATE INJECTION |
MAXFEE |
DEF |
|
|
|
|
4.60 |
7/1/2023 |
12/31/2299 |
N |
J2272 |
INJ; MORPHINE (FRESENIUS) |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2272 |
INJ; MORPHINE (FRESENIUS) |
MAXFEE |
DEF |
|
|
|
|
6.93 |
7/1/2023 |
12/31/2299 |
N |
J2274 |
INJ MORPHINE PF EPID ITHC |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2274 |
INJ MORPHINE PF EPID ITHC |
MAXFEE |
DEF |
|
|
|
|
15.70 |
7/1/2023 |
12/31/2299 |
N |
J2278 |
ZICONOTIDE INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2278 |
ZICONOTIDE INJECTION |
MAXFEE |
DEF |
|
|
|
|
9.08 |
7/1/2023 |
12/31/2299 |
N |
J2280 |
INJ; MOXIFLOXACIN 100 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2280 |
INJ; MOXIFLOXACIN 100 MG |
MAXFEE |
DEF |
|
|
|
|
9.85 |
7/1/2023 |
12/31/2299 |
N |
J2281 |
INJ MOXIFLOXACIN (FRES KABI) |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2281 |
INJ MOXIFLOXACIN (FRES KABI) |
MAXFEE |
DEF |
|
|
|
|
4.50 |
7/1/2023 |
12/31/2299 |
N |
J2300 |
INJ NALBUPHINE HYDROCHLORIDE |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2300 |
INJ NALBUPHINE HYDROCHLORIDE |
MAXFEE |
DEF |
|
|
|
|
2.72 |
7/1/2023 |
12/31/2299 |
N |
J2305 |
Inj; nitroglycerin; 5 mg |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2305 |
Inj; nitroglycerin; 5 mg |
MAXFEE |
DEF |
|
|
|
|
1.30 |
7/1/2023 |
12/31/2299 |
N |
J2310 |
INJ NALOXONE HYDROCHLORIDE |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2310 |
INJ NALOXONE HYDROCHLORIDE |
MAXFEE |
DEF |
|
|
|
|
9.45 |
7/1/2023 |
12/31/2299 |
N |
J2311 |
INJ; NALOXONE HCL (ZIMHI) |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2311 |
INJ; NALOXONE HCL (ZIMHI) |
MAXFEE |
DEF |
|
|
|
|
8.51 |
7/1/2023 |
12/31/2299 |
N |
J2315 |
NALTREXONE; DEPOT FORM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2315 |
NALTREXONE; DEPOT FORM |
MAXFEE |
DEF |
|
|
|
|
3.94 |
7/1/2023 |
12/31/2299 |
N |
J2323 |
NATALIZUMAB INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2323 |
NATALIZUMAB INJECTION |
MAXFEE |
DEF |
|
|
|
|
24.86 |
7/1/2023 |
12/31/2299 |
N |
J2325 |
NESIRITIDE INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2325 |
NESIRITIDE INJECTION |
MAXFEE |
DEF |
|
|
|
|
60.25 |
4/1/2014 |
12/31/2299 |
N |
J2326 |
INJ; NUSINERSEN; 0.1MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2326 |
INJ; NUSINERSEN; 0.1MG |
MAXFEE |
DEF |
|
|
|
|
1114.58 |
5/1/2018 |
12/31/2299 |
N |
J2327 |
INJ RISANKIZUMAB-RZAA 1 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2327 |
INJ RISANKIZUMAB-RZAA 1 MG |
MAXFEE |
DEF |
|
|
|
|
15.52 |
7/1/2023 |
12/31/2299 |
N |
J2329 |
Inj ublituximab-xiiy; 1 mg |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2329 |
Inj ublituximab-xiiy; 1 mg |
MAXFEE |
DEF |
|
|
|
|
70.14 |
7/1/2023 |
12/31/2299 |
N |
J2350 |
INJECTION; OCRELIZUMAB; 1 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2350 |
INJECTION; OCRELIZUMAB; 1 MG |
MAXFEE |
DEF |
|
|
|
|
61.42 |
7/1/2023 |
12/31/2299 |
N |
J2353 |
OCTREOTIDE INJECTION; DEPOT |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2353 |
OCTREOTIDE INJECTION; DEPOT |
MAXFEE |
DEF |
|
|
|
|
208.12 |
7/1/2023 |
12/31/2299 |
N |
J2354 |
OCTREOTIDE INJ; NON-DEPOT |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2354 |
OCTREOTIDE INJ; NON-DEPOT |
MAXFEE |
DEF |
|
|
|
|
1.31 |
7/1/2023 |
12/31/2299 |
N |
J2355 |
OPRELVEKIN INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2355 |
OPRELVEKIN INJECTION |
MAXFEE |
DEF |
|
|
|
|
426.92 |
8/1/2018 |
12/31/2299 |
N |
J2356 |
INJ TEZEPELUMAB-EKKO; 1MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2356 |
INJ TEZEPELUMAB-EKKO; 1MG |
MAXFEE |
DEF |
|
|
|
|
18.73 |
7/1/2023 |
12/31/2299 |
N |
J2357 |
OMALIZUMAB INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2357 |
OMALIZUMAB INJECTION |
MAXFEE |
DEF |
|
|
|
|
39.38 |
7/1/2023 |
12/31/2299 |
N |
J2358 |
OLANZAPINE LONG-ACTING INJ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2358 |
OLANZAPINE LONG-ACTING INJ |
MAXFEE |
DEF |
|
|
|
|
2.92 |
10/1/2022 |
12/31/2299 |
N |
J2360 |
ORPHENADRINE INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2360 |
ORPHENADRINE INJECTION |
MAXFEE |
DEF |
|
|
|
|
16.54 |
7/1/2023 |
12/31/2299 |
N |
J2370 |
PHENYLEPHRINE HCL INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2370 |
PHENYLEPHRINE HCL INJECTION |
MAXFEE |
DEF |
|
|
|
|
3.34 |
2/1/2015 |
12/31/2299 |
N |
J2371 |
Inj phenylephrine hcl 20 mcg |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2371 |
Inj phenylephrine hcl 20 mcg |
MAXFEE |
DEF |
|
|
|
|
0.09 |
7/1/2023 |
12/31/2299 |
N |
J2372 |
Inj; biorphen; 20 micrograms |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2372 |
Inj; biorphen; 20 micrograms |
MAXFEE |
DEF |
|
|
|
|
0.19 |
7/1/2023 |
12/31/2299 |
N |
J2400 |
CHLOROPROCAINE HCL INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2400 |
CHLOROPROCAINE HCL INJECTION |
MAXFEE |
DEF |
|
|
|
|
NA |
|
|
N |
J2401 |
CHLOROPROCAINE HCL INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2401 |
CHLOROPROCAINE HCL INJECTION |
MAXFEE |
DEF |
|
|
|
|
0.04 |
1/1/2023 |
12/31/2299 |
N |
J2402 |
CHLOROPROCAINE (CLOROTEKAL) |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2402 |
CHLOROPROCAINE (CLOROTEKAL) |
MANUAL |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2403 |
CHLOROPROCAINE OPHT GEL; 1MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2403 |
CHLOROPROCAINE OPHT GEL; 1MG |
MAXFEE |
DEF |
|
|
|
|
0.07 |
4/1/2023 |
12/31/2299 |
N |
J2405 |
ONDANSETRON HCL INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2405 |
ONDANSETRON HCL INJECTION |
MAXFEE |
DEF |
|
|
|
|
0.11 |
7/1/2023 |
12/31/2299 |
N |
J2406 |
INJECTION; ORITAVANCIN 10 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2406 |
INJECTION; ORITAVANCIN 10 MG |
MAXFEE |
DEF |
|
|
|
|
41.73 |
7/1/2023 |
12/31/2299 |
N |
J2407 |
INJECTION; ORITAVANCIN |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2407 |
INJECTION; ORITAVANCIN |
MAXFEE |
DEF |
|
|
|
|
26.89 |
7/1/2023 |
12/31/2299 |
N |
J2410 |
OXYMORPHONE HCL INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2410 |
OXYMORPHONE HCL INJECTION |
MAXFEE |
DEF |
|
|
|
|
2.85 |
11/1/2017 |
12/31/2299 |
N |
J2425 |
PALIFERMIN INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2425 |
PALIFERMIN INJECTION |
MAXFEE |
DEF |
|
|
|
|
25.13 |
4/1/2023 |
12/31/2299 |
N |
J2426 |
PALIPERIDONE PALMITATE INJ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2426 |
PALIPERIDONE PALMITATE INJ |
MAXFEE |
DEF |
|
|
|
|
14.22 |
7/1/2023 |
12/31/2299 |
N |
J2427 |
Inj; invega hafyera/trinza |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2427 |
Inj; invega hafyera/trinza |
MAXFEE |
DEF |
|
|
|
|
12.11 |
7/1/2023 |
12/31/2299 |
N |
J2430 |
PAMIDRONATE DISODIUM /30 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2430 |
PAMIDRONATE DISODIUM /30 MG |
MAXFEE |
DEF |
|
|
|
|
10.32 |
7/1/2023 |
12/31/2299 |
N |
J2440 |
PAPAVERIN HCL INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2440 |
PAPAVERIN HCL INJECTION |
MAXFEE |
DEF |
|
|
|
|
4.82 |
9/1/2013 |
12/31/2299 |
N |
J2469 |
PALONOSETRON HCL |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2469 |
PALONOSETRON HCL |
MAXFEE |
DEF |
|
|
|
|
1 |
7/1/2023 |
12/31/2299 |
N |
J2501 |
PARICALCITOL |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2501 |
PARICALCITOL |
MAXFEE |
DEF |
|
|
|
|
0.50 |
7/1/2023 |
12/31/2299 |
N |
J2503 |
PEGAPTANIB SODIUM INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2503 |
PEGAPTANIB SODIUM INJECTION |
MAXFEE |
DEF |
|
|
|
|
785.50 |
1/1/2021 |
12/31/2299 |
N |
J2504 |
PEGADEMASE BOVINE; 25 IU |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2504 |
PEGADEMASE BOVINE; 25 IU |
MAXFEE |
DEF |
|
|
|
|
367.96 |
8/1/2018 |
12/31/2299 |
N |
J2505 |
INJECTION; PEGFILGRASTIM 6MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2505 |
INJECTION; PEGFILGRASTIM 6MG |
MAXFEE |
DEF |
|
|
|
|
NA |
|
|
N |
J2506 |
INJ PEGFILGRAST EX BIO 0.5MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2506 |
INJ PEGFILGRAST EX BIO 0.5MG |
MAXFEE |
DEF |
|
|
|
|
85.71 |
7/1/2023 |
12/31/2299 |
N |
J2507 |
PEGLOTICASE INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2507 |
PEGLOTICASE INJECTION |
MAXFEE |
DEF |
|
|
|
|
3268.45 |
7/1/2023 |
12/31/2299 |
N |
J2510 |
PENICILLIN G PROCAINE INJ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2510 |
PENICILLIN G PROCAINE INJ |
MAXFEE |
DEF |
|
|
|
|
43.38 |
7/1/2023 |
12/31/2299 |
N |
J2515 |
PENTOBARBITAL SODIUM INJ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2515 |
PENTOBARBITAL SODIUM INJ |
MAXFEE |
DEF |
|
|
|
|
22.60 |
1/1/2023 |
12/31/2299 |
N |
J2540 |
PENICILLIN G POTASSIUM INJ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2540 |
PENICILLIN G POTASSIUM INJ |
MAXFEE |
DEF |
|
|
|
|
1.07 |
7/1/2023 |
12/31/2299 |
N |
J2543 |
PIPERACILLIN/TAZOBACTAM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2543 |
PIPERACILLIN/TAZOBACTAM |
MAXFEE |
DEF |
|
|
|
|
1.36 |
7/1/2023 |
12/31/2299 |
N |
J2545 |
PENTAMIDINE NON-COMP UNIT |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2545 |
PENTAMIDINE NON-COMP UNIT |
MAXFEE |
DEF |
|
|
|
|
93.86 |
7/1/2023 |
12/31/2299 |
N |
J2550 |
PROMETHAZINE HCL INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2550 |
PROMETHAZINE HCL INJECTION |
MAXFEE |
DEF |
|
|
|
|
3.15 |
7/1/2023 |
12/31/2299 |
N |
J2560 |
PHENOBARBITAL SODIUM INJ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2560 |
PHENOBARBITAL SODIUM INJ |
MAXFEE |
DEF |
|
|
|
|
39.38 |
7/1/2023 |
12/31/2299 |
N |
J2561 |
Inj; sezaby; 1 mg |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2561 |
Inj; sezaby; 1 mg |
MAXFEE |
DEF |
|
|
|
|
1.43 |
7/1/2023 |
12/31/2299 |
N |
J2562 |
PLERIXAFOR INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2562 |
PLERIXAFOR INJECTION |
MAXFEE |
DEF |
|
|
|
|
429.36 |
7/1/2023 |
12/31/2299 |
N |
J2590 |
OXYTOCIN INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2590 |
OXYTOCIN INJECTION |
MAXFEE |
DEF |
|
|
|
|
0.53 |
4/1/2014 |
12/31/2299 |
N |
J2597 |
INJ DESMOPRESSIN ACETATE |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2597 |
INJ DESMOPRESSIN ACETATE |
MAXFEE |
DEF |
|
|
|
|
7.27 |
7/1/2023 |
12/31/2299 |
N |
J2598 |
Inj; vasopressin; 1 unit |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2598 |
Inj; vasopressin; 1 unit |
MAXFEE |
DEF |
|
|
|
|
2.92 |
7/1/2023 |
12/31/2299 |
N |
J2599 |
Inj vasopressin (am reg) 1 u |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2599 |
Inj vasopressin (am reg) 1 u |
MAXFEE |
DEF |
|
|
|
|
2.10 |
7/1/2023 |
12/31/2299 |
N |
J2675 |
INJ PROGESTERONE PER 50 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2675 |
INJ PROGESTERONE PER 50 MG |
MAXFEE |
DEF |
|
|
|
|
0.97 |
7/1/2023 |
12/31/2299 |
N |
J2680 |
FLUPHENAZINE DECANOATE 25 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2680 |
FLUPHENAZINE DECANOATE 25 MG |
MAXFEE |
DEF |
|
|
|
|
10.95 |
7/1/2023 |
12/31/2299 |
N |
J2690 |
PROCAINAMIDE HCL INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2690 |
PROCAINAMIDE HCL INJECTION |
MAXFEE |
DEF |
|
|
|
|
307.99 |
7/1/2023 |
12/31/2299 |
N |
J2700 |
OXACILLIN SODIUM INJECITON |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2700 |
OXACILLIN SODIUM INJECITON |
MAXFEE |
DEF |
|
|
|
|
1.17 |
7/1/2023 |
12/31/2299 |
N |
J2704 |
INJ; PROPOFOL; 10 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2704 |
INJ; PROPOFOL; 10 MG |
MAXFEE |
DEF |
|
|
|
|
0.10 |
7/1/2023 |
12/31/2299 |
N |
J2710 |
NEOSTIGMINE METHYLSLFTE INJ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2710 |
NEOSTIGMINE METHYLSLFTE INJ |
MAXFEE |
DEF |
|
|
|
|
0.40 |
9/1/2013 |
12/31/2299 |
N |
J2720 |
INJ PROTAMINE SULFATE/10 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2720 |
INJ PROTAMINE SULFATE/10 MG |
MAXFEE |
DEF |
|
|
|
|
0.95 |
7/1/2023 |
12/31/2299 |
N |
J2724 |
PROTEIN C CONCENTRATE |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2724 |
PROTEIN C CONCENTRATE |
MAXFEE |
DEF |
|
|
|
|
15.11 |
7/1/2023 |
12/31/2299 |
N |
J2730 |
PRALIDOXIME CHLORIDE INJ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2730 |
PRALIDOXIME CHLORIDE INJ |
MAXFEE |
DEF |
|
|
|
|
91.90 |
8/1/2015 |
12/31/2299 |
N |
J2760 |
PHENTOLAINE MESYLATE INJ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2760 |
PHENTOLAINE MESYLATE INJ |
MAXFEE |
DEF |
|
|
|
|
458.18 |
7/1/2023 |
12/31/2299 |
N |
J2765 |
METOCLOPRAMIDE HCL INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2765 |
METOCLOPRAMIDE HCL INJECTION |
MAXFEE |
DEF |
|
|
|
|
1.24 |
7/1/2023 |
12/31/2299 |
N |
J2770 |
QUINUPRISTIN/DALFOPRISTIN |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2770 |
QUINUPRISTIN/DALFOPRISTIN |
MAXFEE |
DEF |
|
|
|
|
493.97 |
10/1/2022 |
12/31/2299 |
N |
J2777 |
INJ; FARICIMAB-SVOA; 0.1MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2777 |
INJ; FARICIMAB-SVOA; 0.1MG |
MAXFEE |
DEF |
|
|
|
|
37.09 |
7/1/2023 |
12/31/2299 |
N |
J2778 |
RANIBIZUMAB INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2778 |
RANIBIZUMAB INJECTION |
MAXFEE |
DEF |
|
|
|
|
236.58 |
7/1/2023 |
12/31/2299 |
N |
J2779 |
INJ; SUSVIMO 0.1 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2779 |
INJ; SUSVIMO 0.1 MG |
MAXFEE |
DEF |
|
|
|
|
81.02 |
7/1/2023 |
12/31/2299 |
N |
J2780 |
RANITIDINE HYDROCHLORIDE INJ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2780 |
RANITIDINE HYDROCHLORIDE INJ |
MAXFEE |
DEF |
|
|
|
|
6.12 |
1/1/2021 |
12/31/2299 |
N |
J2783 |
RASBURICASE |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2783 |
RASBURICASE |
MAXFEE |
DEF |
|
|
|
|
357.36 |
7/1/2023 |
12/31/2299 |
N |
J2786 |
INJECTION; RESLIZUMAB; 1MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2786 |
INJECTION; RESLIZUMAB; 1MG |
MAXFEE |
DEF |
|
|
|
|
10.20 |
7/1/2023 |
12/31/2299 |
N |
J2787 |
RIBOFLAVIN 5'PHOS OPTH<=3ML |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2787 |
RIBOFLAVIN 5'PHOS OPTH<=3ML |
MAXFEE |
DEF |
|
|
|
|
2016.95 |
1/1/2023 |
12/31/2299 |
N |
J2788 |
RHO D IMMUNE GLOBULIN 50 MCG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2788 |
RHO D IMMUNE GLOBULIN 50 MCG |
MAXFEE |
DEF |
|
|
|
|
26.92 |
7/1/2023 |
12/31/2299 |
N |
J2790 |
RHO D IMMUNE GLOBULIN INJ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2790 |
RHO D IMMUNE GLOBULIN INJ |
MAXFEE |
DEF |
|
|
|
|
81.83 |
7/1/2023 |
12/31/2299 |
N |
J2791 |
RHOPHYLAC INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2791 |
RHOPHYLAC INJECTION |
MAXFEE |
DEF |
|
|
|
|
4.90 |
7/1/2023 |
12/31/2299 |
N |
J2792 |
RHO(D) IMMUNE GLOBULIN H; SD |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2792 |
RHO(D) IMMUNE GLOBULIN H; SD |
MAXFEE |
DEF |
|
|
|
|
33.71 |
7/1/2023 |
12/31/2299 |
N |
J2793 |
RILONACEPT INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2793 |
RILONACEPT INJECTION |
MAXFEE |
DEF |
|
|
|
|
24.32 |
9/1/2013 |
12/31/2299 |
N |
J2794 |
INJ RISPERDAL CONSTA; 0.5 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2794 |
INJ RISPERDAL CONSTA; 0.5 MG |
MAXFEE |
DEF |
|
|
|
|
12.02 |
7/1/2023 |
12/31/2299 |
N |
J2795 |
ROPIVACAINE HCL INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2795 |
ROPIVACAINE HCL INJECTION |
MAXFEE |
DEF |
|
|
|
|
0.07 |
7/1/2023 |
12/31/2299 |
N |
J2796 |
ROMIPLOSTIM INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2796 |
ROMIPLOSTIM INJECTION |
MAXFEE |
DEF |
|
|
|
|
95.47 |
7/1/2023 |
12/31/2299 |
N |
J2797 |
INJ.; ROLAPITANT; 0.5 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2797 |
INJ.; ROLAPITANT; 0.5 MG |
MAXFEE |
DEF |
|
|
|
|
0.95 |
1/1/2019 |
12/31/2299 |
N |
J2798 |
INJ.; PERSERIS; 0.5 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2798 |
INJ.; PERSERIS; 0.5 MG |
MAXFEE |
DEF |
|
|
|
|
11.67 |
7/1/2023 |
12/31/2299 |
N |
J2800 |
METHOCARBAMOL INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2800 |
METHOCARBAMOL INJECTION |
MAXFEE |
DEF |
|
|
|
|
6.65 |
7/1/2023 |
12/31/2299 |
N |
J2805 |
SINCALIDE INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2805 |
SINCALIDE INJECTION |
MAXFEE |
DEF |
|
|
|
|
133.54 |
7/1/2023 |
12/31/2299 |
N |
J2806 |
Inj sincalide; maia; 5 mcg |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2806 |
Inj sincalide; maia; 5 mcg |
MAXFEE |
DEF |
|
|
|
|
0 |
7/1/2023 |
12/31/2299 |
N |
J2810 |
INJ THEOPHYLLINE PER 40 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2810 |
INJ THEOPHYLLINE PER 40 MG |
MAXFEE |
DEF |
|
|
|
|
0.42 |
8/1/2019 |
12/31/2299 |
N |
J2820 |
SARGRAMOSTIM INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2820 |
SARGRAMOSTIM INJECTION |
MAXFEE |
DEF |
|
|
|
|
58.31 |
7/1/2023 |
12/31/2299 |
N |
J2840 |
INJ SEBELIPASE ALFA 1 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2840 |
INJ SEBELIPASE ALFA 1 MG |
MAXFEE |
DEF |
|
|
|
|
53.50 |
1/1/2017 |
12/31/2299 |
N |
J2850 |
INJ SECRETIN SYNTHETIC HUMAN |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2850 |
INJ SECRETIN SYNTHETIC HUMAN |
MAXFEE |
DEF |
|
|
|
|
34.78 |
11/1/2014 |
12/31/2299 |
N |
J2860 |
INJECTION; SILTUXIMAB |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2860 |
INJECTION; SILTUXIMAB |
MAXFEE |
DEF |
|
|
|
|
139.22 |
7/1/2023 |
12/31/2299 |
N |
J2916 |
NA FERRIC GLUCONATE COMPLEX |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2916 |
NA FERRIC GLUCONATE COMPLEX |
MAXFEE |
DEF |
|
|
|
|
2.12 |
7/1/2023 |
12/31/2299 |
N |
J2920 |
METHYLPREDNISOLONE INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2920 |
METHYLPREDNISOLONE INJECTION |
MAXFEE |
DEF |
|
|
|
|
4.24 |
7/1/2023 |
12/31/2299 |
N |
J2930 |
METHYLPREDNISOLONE INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2930 |
METHYLPREDNISOLONE INJECTION |
MAXFEE |
DEF |
|
|
|
|
5.73 |
7/1/2023 |
12/31/2299 |
N |
J2941 |
SOMATROPIN INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2941 |
SOMATROPIN INJECTION |
MAXFEE |
DEF |
|
|
|
|
82.53 |
9/1/2013 |
12/31/2299 |
N |
J2993 |
RETEPLASE INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2993 |
RETEPLASE INJECTION |
MAXFEE |
DEF |
|
|
|
|
2301.91 |
11/1/2013 |
12/31/2299 |
N |
J2997 |
ALTEPLASE RECOMBINANT |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2997 |
ALTEPLASE RECOMBINANT |
MAXFEE |
DEF |
|
|
|
|
89.15 |
7/1/2023 |
12/31/2299 |
N |
J2998 |
INJ PLASMINOGEN TVMH 1MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J2998 |
INJ PLASMINOGEN TVMH 1MG |
MANUAL |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J3000 |
STREPTOMYCIN INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J3000 |
STREPTOMYCIN INJECTION |
MAXFEE |
DEF |
|
|
|
|
31.57 |
7/1/2023 |
12/31/2299 |
N |
J3010 |
FENTANYL CITRATE INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J3010 |
FENTANYL CITRATE INJECTION |
MAXFEE |
DEF |
|
|
|
|
0.84 |
7/1/2023 |
12/31/2299 |
N |
J3030 |
SUMATRIPTAN SUCCINATE / 6 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J3030 |
SUMATRIPTAN SUCCINATE / 6 MG |
MAXFEE |
DEF |
|
|
|
|
24.25 |
9/1/2013 |
12/31/2299 |
N |
J3031 |
INJ.; FREMANEZUMAB-VFRM 1 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J3031 |
INJ.; FREMANEZUMAB-VFRM 1 MG |
MANUAL |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J3032 |
INJ. EPTINEZUMAB-JJMR 1 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J3032 |
INJ. EPTINEZUMAB-JJMR 1 MG |
MAXFEE |
DEF |
|
|
|
|
17.44 |
7/1/2023 |
12/31/2299 |
N |
J3060 |
INJ; TALIGLUCERASE ALFA 10 U |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J3060 |
INJ; TALIGLUCERASE ALFA 10 U |
MAXFEE |
DEF |
|
|
|
|
44.56 |
7/1/2023 |
12/31/2299 |
N |
J3070 |
PENTAZOCINE INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J3070 |
PENTAZOCINE INJECTION |
MAXFEE |
DEF |
|
|
|
|
108.39 |
5/1/2018 |
12/31/2299 |
N |
J3090 |
INJ TEDIZOLID PHOSPHATE |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J3090 |
INJ TEDIZOLID PHOSPHATE |
MAXFEE |
DEF |
|
|
|
|
1.71 |
7/1/2023 |
12/31/2299 |
N |
J3095 |
TELAVANCIN INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J3095 |
TELAVANCIN INJECTION |
MAXFEE |
DEF |
|
|
|
|
6.83 |
7/1/2023 |
12/31/2299 |
N |
J3101 |
TENECTEPLASE INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J3101 |
TENECTEPLASE INJECTION |
MAXFEE |
DEF |
|
|
|
|
152.70 |
7/1/2023 |
12/31/2299 |
N |
J3105 |
TERBUTALINE SULFATE INJ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J3105 |
TERBUTALINE SULFATE INJ |
MAXFEE |
DEF |
|
|
|
|
2.29 |
7/1/2023 |
12/31/2299 |
N |
J3111 |
INJ. ROMOSOZUMAB-AQQG 1 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J3111 |
INJ. ROMOSOZUMAB-AQQG 1 MG |
MAXFEE |
DEF |
|
|
|
|
10.37 |
7/1/2023 |
12/31/2299 |
N |
J3121 |
INJ TESTOSTERO ENANTHATE 1MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J3121 |
INJ TESTOSTERO ENANTHATE 1MG |
MAXFEE |
DEF |
|
|
|
|
0.05 |
2/1/2019 |
12/31/2299 |
N |
J3145 |
TESTOSTERONE UNDECANOATE 1MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J3145 |
TESTOSTERONE UNDECANOATE 1MG |
MAXFEE |
DEF |
|
|
|
|
1.90 |
7/1/2023 |
12/31/2299 |
N |
J3230 |
CHLORPROMAZINE HCL INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J3230 |
CHLORPROMAZINE HCL INJECTION |
MAXFEE |
DEF |
|
|
|
|
35.95 |
7/1/2023 |
12/31/2299 |
N |
J3240 |
THYROTROPIN INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J3240 |
THYROTROPIN INJECTION |
MAXFEE |
DEF |
|
|
|
|
2001.49 |
7/1/2023 |
12/31/2299 |
N |
J3241 |
INJ. TEPROTUMUMAB-TRBW 10 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J3241 |
INJ. TEPROTUMUMAB-TRBW 10 MG |
MAXFEE |
DEF |
|
|
|
|
328 |
4/1/2023 |
12/31/2299 |
N |
J3243 |
TIGECYCLINE INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J3243 |
TIGECYCLINE INJECTION |
MAXFEE |
DEF |
|
|
|
|
0.74 |
7/1/2023 |
12/31/2299 |
N |
J3244 |
INJ. TIGECYCLINE (ACCORD) |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J3244 |
INJ. TIGECYCLINE (ACCORD) |
MAXFEE |
DEF |
|
|
|
|
0.60 |
4/1/2023 |
12/31/2299 |
N |
J3245 |
INJ.; TILDRAKIZUMAB; 1 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J3245 |
INJ.; TILDRAKIZUMAB; 1 MG |
MAXFEE |
DEF |
|
|
|
|
143.27 |
7/1/2023 |
12/31/2299 |
N |
J3246 |
TIROFIBAN HCL |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J3246 |
TIROFIBAN HCL |
MAXFEE |
DEF |
|
|
|
|
9.31 |
4/1/2014 |
12/31/2299 |
N |
J3250 |
TRIMETHOBENZAMIDE HCL INJ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J3250 |
TRIMETHOBENZAMIDE HCL INJ |
MAXFEE |
DEF |
|
|
|
|
45.04 |
7/1/2023 |
12/31/2299 |
N |
J3260 |
TOBRAMYCIN SULFATE INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J3260 |
TOBRAMYCIN SULFATE INJECTION |
MAXFEE |
DEF |
|
|
|
|
2.65 |
7/1/2023 |
12/31/2299 |
N |
J3262 |
TOCILIZUMAB INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J3262 |
TOCILIZUMAB INJECTION |
MAXFEE |
DEF |
|
|
|
|
5.91 |
7/1/2023 |
12/31/2299 |
N |
J3265 |
INJECTION TORSEMIDE 10 MG/ML |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J3265 |
INJECTION TORSEMIDE 10 MG/ML |
MAXFEE |
DEF |
|
|
|
|
2.20 |
9/1/2013 |
12/31/2299 |
N |
J3285 |
TREPROSTINIL INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J3285 |
TREPROSTINIL INJECTION |
MAXFEE |
DEF |
|
|
|
|
55.20 |
7/1/2023 |
12/31/2299 |
N |
J3299 |
INJ XIPERE 1 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J3299 |
INJ XIPERE 1 MG |
MAXFEE |
DEF |
|
|
|
|
48.49 |
7/1/2023 |
12/31/2299 |
N |
J3300 |
TRIAMCINOLONE A INJ PRS-FREE |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J3300 |
TRIAMCINOLONE A INJ PRS-FREE |
MAXFEE |
DEF |
|
|
|
|
4.27 |
7/1/2023 |
12/31/2299 |
N |
J3301 |
TRIAMCINOLONE ACET INJ NOS |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J3301 |
TRIAMCINOLONE ACET INJ NOS |
MAXFEE |
DEF |
|
|
|
|
1.01 |
7/1/2023 |
12/31/2299 |
N |
J3303 |
TRIAMCINOLONE HEXACETONL INJ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J3303 |
TRIAMCINOLONE HEXACETONL INJ |
MAXFEE |
DEF |
|
|
|
|
3.61 |
10/1/2016 |
12/31/2299 |
N |
J3304 |
INJ TRIAMCINOLONE ACE XR 1MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J3304 |
INJ TRIAMCINOLONE ACE XR 1MG |
MAXFEE |
DEF |
|
|
|
|
17.11 |
7/1/2023 |
12/31/2299 |
N |
J3315 |
TRIPTORELIN PAMOATE |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J3315 |
TRIPTORELIN PAMOATE |
MAXFEE |
DEF |
|
|
|
|
382.39 |
7/1/2023 |
12/31/2299 |
N |
J3316 |
INJ.; TRIPTORELIN XR 3.75 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J3316 |
INJ.; TRIPTORELIN XR 3.75 MG |
MAXFEE |
DEF |
|
|
|
|
870.17 |
1/1/2019 |
12/31/2299 |
N |
J3357 |
USTEKINUMAB SUB CU INJ; 1 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J3357 |
USTEKINUMAB SUB CU INJ; 1 MG |
MAXFEE |
DEF |
|
|
|
|
147.65 |
7/1/2023 |
12/31/2299 |
N |
J3358 |
USTEKINUMAB; IV INJECT; 1 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J3358 |
USTEKINUMAB; IV INJECT; 1 MG |
MAXFEE |
DEF |
|
|
|
|
12.59 |
7/1/2023 |
12/31/2299 |
N |
J3360 |
DIAZEPAM INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J3360 |
DIAZEPAM INJECTION |
MAXFEE |
DEF |
|
|
|
|
5.25 |
7/1/2023 |
12/31/2299 |
N |
J3365 |
UROKINASE 250;000 IU INJ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J3365 |
UROKINASE 250;000 IU INJ |
MAXFEE |
DEF |
|
|
|
|
457.73 |
9/1/2013 |
12/31/2299 |
N |
J3370 |
VANCOMYCIN HCL INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J3370 |
VANCOMYCIN HCL INJECTION |
MAXFEE |
DEF |
|
|
|
|
2.41 |
7/1/2023 |
12/31/2299 |
N |
J3371 |
INJ; VANCOMYCIN HCL (MYLAN) |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J3371 |
INJ; VANCOMYCIN HCL (MYLAN) |
MAXFEE |
DEF |
|
|
|
|
6.30 |
7/1/2023 |
12/31/2299 |
N |
J3372 |
INJ; VANCOMYCIN HCL (XELLIA) |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J3372 |
INJ; VANCOMYCIN HCL (XELLIA) |
MAXFEE |
DEF |
|
|
|
|
6.58 |
7/1/2023 |
12/31/2299 |
N |
J3380 |
INJECTION; VEDOLIZUMAB |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J3380 |
INJECTION; VEDOLIZUMAB |
MAXFEE |
DEF |
|
|
|
|
22.68 |
7/1/2023 |
12/31/2299 |
N |
J3385 |
VELAGLUCERASE ALFA |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J3385 |
VELAGLUCERASE ALFA |
MAXFEE |
DEF |
|
|
|
|
367.18 |
7/1/2023 |
12/31/2299 |
N |
J3396 |
VERTEPORFIN INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J3396 |
VERTEPORFIN INJECTION |
MAXFEE |
DEF |
|
|
|
|
11.42 |
7/1/2023 |
12/31/2299 |
N |
J3397 |
INJ.; VESTRONIDASE ALFA-VJBK |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J3397 |
INJ.; VESTRONIDASE ALFA-VJBK |
MAXFEE |
DEF |
|
|
|
|
226.31 |
1/1/2019 |
12/31/2299 |
N |
J3410 |
HYDROXYZINE HCL INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J3410 |
HYDROXYZINE HCL INJECTION |
MAXFEE |
DEF |
|
|
|
|
13.62 |
7/1/2023 |
12/31/2299 |
N |
J3411 |
THIAMINE HCL 100 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J3411 |
THIAMINE HCL 100 MG |
MAXFEE |
DEF |
|
|
|
|
2.50 |
7/1/2023 |
12/31/2299 |
N |
J3415 |
PYRIDOXINE HCL 100 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J3415 |
PYRIDOXINE HCL 100 MG |
MAXFEE |
DEF |
|
|
|
|
15.90 |
7/1/2023 |
12/31/2299 |
N |
J3420 |
VITAMIN B12 INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J3420 |
VITAMIN B12 INJECTION |
MAXFEE |
DEF |
|
|
|
|
1.31 |
7/1/2023 |
12/31/2299 |
N |
J3430 |
VITAMIN K PHYTONADIONE INJ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J3430 |
VITAMIN K PHYTONADIONE INJ |
MAXFEE |
DEF |
|
|
|
|
2.87 |
7/1/2023 |
12/31/2299 |
N |
J3465 |
INJECTION; VORICONAZOLE |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J3465 |
INJECTION; VORICONAZOLE |
MAXFEE |
DEF |
|
|
|
|
1.22 |
7/1/2023 |
12/31/2299 |
N |
J3470 |
HYALURONIDASE INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J3470 |
HYALURONIDASE INJECTION |
MAXFEE |
DEF |
|
|
|
|
21.20 |
9/1/2011 |
12/31/2299 |
N |
J3471 |
OVINE; UP TO 999 USP UNITS |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J3471 |
OVINE; UP TO 999 USP UNITS |
MAXFEE |
DEF |
|
|
|
|
0.49 |
7/1/2023 |
12/31/2299 |
N |
J3472 |
OVINE; 1000 USP UNITS |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J3472 |
OVINE; 1000 USP UNITS |
MAXFEE |
DEF |
|
|
|
|
296.89 |
9/1/2013 |
12/31/2299 |
N |
J3473 |
HYALURONIDASE RECOMBINANT |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J3473 |
HYALURONIDASE RECOMBINANT |
MAXFEE |
DEF |
|
|
|
|
0.36 |
8/1/2019 |
12/31/2299 |
N |
J3480 |
INJ POTASSIUM CHLORIDE |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J3480 |
INJ POTASSIUM CHLORIDE |
MAXFEE |
DEF |
|
|
|
|
0.10 |
7/1/2023 |
12/31/2299 |
N |
J3485 |
ZIDOVUDINE |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J3485 |
ZIDOVUDINE |
MAXFEE |
DEF |
|
|
|
|
1.51 |
2/1/2018 |
12/31/2299 |
N |
J3486 |
ZIPRASIDONE MESYLATE |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J3486 |
ZIPRASIDONE MESYLATE |
MAXFEE |
DEF |
|
|
|
|
9.60 |
7/1/2023 |
12/31/2299 |
N |
J3489 |
ZOLEDRONIC ACID 1MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J3489 |
ZOLEDRONIC ACID 1MG |
MAXFEE |
DEF |
|
|
|
|
9.09 |
7/1/2023 |
12/31/2299 |
N |
J3490 |
DRUGS UNCLASSIFIED INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J3490 |
DRUGS UNCLASSIFIED INJECTION |
MANUAL |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J3535 |
METERED DOSE INHALER DRUG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J3535 |
METERED DOSE INHALER DRUG |
MANUAL |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J3590 |
UNCLASSIFIED BIOLOGICS |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J3590 |
UNCLASSIFIED BIOLOGICS |
MANUAL |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J3591 |
ESRD ON DIALYSI DRUG/BIO NOC |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J3591 |
ESRD ON DIALYSI DRUG/BIO NOC |
MANUAL |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7030 |
NORMAL SALINE SOLUTION INFUS |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7030 |
NORMAL SALINE SOLUTION INFUS |
MAXFEE |
DEF |
|
|
|
|
2.54 |
7/1/2023 |
12/31/2299 |
N |
J7040 |
NORMAL SALINE SOLUTION INFUS |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7040 |
NORMAL SALINE SOLUTION INFUS |
MAXFEE |
DEF |
|
|
|
|
1.27 |
7/1/2023 |
12/31/2299 |
N |
J7042 |
5% DEXTROSE/NORMAL SALINE |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7042 |
5% DEXTROSE/NORMAL SALINE |
MAXFEE |
DEF |
|
|
|
|
1.18 |
7/1/2023 |
12/31/2299 |
N |
J7050 |
NORMAL SALINE SOLUTION INFUS |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7050 |
NORMAL SALINE SOLUTION INFUS |
MAXFEE |
DEF |
|
|
|
|
0.64 |
7/1/2023 |
12/31/2299 |
N |
J7060 |
5% DEXTROSE/WATER |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7060 |
5% DEXTROSE/WATER |
MAXFEE |
DEF |
|
|
|
|
1.81 |
7/1/2023 |
12/31/2299 |
N |
J7070 |
D5W INFUSION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7070 |
D5W INFUSION |
MAXFEE |
DEF |
|
|
|
|
3.62 |
7/1/2023 |
12/31/2299 |
N |
J7100 |
DEXTRAN 40 INFUSION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7100 |
DEXTRAN 40 INFUSION |
MAXFEE |
DEF |
|
|
|
|
17.77 |
2/1/2015 |
12/31/2299 |
N |
J7110 |
DEXTRAN 75 INFUSION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7110 |
DEXTRAN 75 INFUSION |
MAXFEE |
DEF |
|
|
|
|
14.52 |
9/1/2013 |
12/31/2299 |
N |
J7168 |
PROTHROMBIN COMPLEX KCENTRA |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7168 |
PROTHROMBIN COMPLEX KCENTRA |
MAXFEE |
DEF |
|
|
|
|
2.80 |
7/1/2021 |
12/31/2299 |
N |
J7169 |
INJ ANDEXXA; 10 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7169 |
INJ ANDEXXA; 10 MG |
MAXFEE |
DEF |
|
|
|
|
294.25 |
7/1/2020 |
12/31/2299 |
N |
J7175 |
INJ; FACTOR X; (HUMAN); 1IU |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7175 |
INJ; FACTOR X; (HUMAN); 1IU |
MAXFEE |
DEF |
|
|
|
|
9.09 |
7/1/2023 |
12/31/2299 |
N |
J7177 |
INJ.; FIBRYGA; 1 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7177 |
INJ.; FIBRYGA; 1 MG |
MAXFEE |
DEF |
|
|
|
|
1.10 |
4/1/2023 |
12/31/2299 |
N |
J7178 |
INJ HUMAN FIBRINOGEN CON NOS |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7178 |
INJ HUMAN FIBRINOGEN CON NOS |
MAXFEE |
DEF |
|
|
|
|
1.38 |
4/1/2023 |
12/31/2299 |
N |
J7179 |
VONVENDI INJ 1 IU VWF:RCO |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7179 |
VONVENDI INJ 1 IU VWF:RCO |
MAXFEE |
DEF |
|
|
|
|
1.78 |
7/1/2023 |
12/31/2299 |
N |
J7180 |
FACTOR XIII ANTI-HEM FACTOR |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7180 |
FACTOR XIII ANTI-HEM FACTOR |
MAXFEE |
DEF |
|
|
|
|
9.68 |
7/1/2023 |
12/31/2299 |
N |
J7181 |
FACTOR XIII RECOMB A-SUBUNIT |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7181 |
FACTOR XIII RECOMB A-SUBUNIT |
MAXFEE |
DEF |
|
|
|
|
16.89 |
7/1/2023 |
12/31/2299 |
N |
J7182 |
FACTOR VIII RECOMB NOVOEIGHT |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7182 |
FACTOR VIII RECOMB NOVOEIGHT |
MAXFEE |
DEF |
|
|
|
|
1.28 |
7/1/2023 |
12/31/2299 |
N |
J7183 |
WILATE INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7183 |
WILATE INJECTION |
MAXFEE |
DEF |
|
|
|
|
1.26 |
4/1/2023 |
12/31/2299 |
N |
J7185 |
XYNTHA INJ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7185 |
XYNTHA INJ |
MAXFEE |
DEF |
|
|
|
|
1.38 |
7/1/2023 |
12/31/2299 |
N |
J7186 |
ANTIHEMOPHILIC VIII/VWF COMP |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7186 |
ANTIHEMOPHILIC VIII/VWF COMP |
MAXFEE |
DEF |
|
|
|
|
1.22 |
7/1/2023 |
12/31/2299 |
N |
J7187 |
HUMATE-P; INJ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7187 |
HUMATE-P; INJ |
MAXFEE |
DEF |
|
|
|
|
1.35 |
4/1/2023 |
12/31/2299 |
N |
J7188 |
FACTOR VIII RECOMB OBIZUR |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7188 |
FACTOR VIII RECOMB OBIZUR |
MAXFEE |
DEF |
|
|
|
|
3.22 |
4/1/2023 |
12/31/2299 |
N |
J7189 |
FACTOR VIIA RECOMB NOVOSEVEN |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7189 |
FACTOR VIIA RECOMB NOVOSEVEN |
MAXFEE |
DEF |
|
|
|
|
2.41 |
7/1/2023 |
12/31/2299 |
N |
J7190 |
FACTOR VIII |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7190 |
FACTOR VIII |
MAXFEE |
DEF |
|
|
|
|
1.03 |
7/1/2023 |
12/31/2299 |
N |
J7192 |
FACTOR VIII RECOMBINANT NOS |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7192 |
FACTOR VIII RECOMBINANT NOS |
MAXFEE |
DEF |
|
|
|
|
1.51 |
7/1/2023 |
12/31/2299 |
N |
J7193 |
FACTOR IX NON-RECOMBINANT |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7193 |
FACTOR IX NON-RECOMBINANT |
MAXFEE |
DEF |
|
|
|
|
1.30 |
7/1/2023 |
12/31/2299 |
N |
J7194 |
FACTOR IX COMPLEX |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7194 |
FACTOR IX COMPLEX |
MAXFEE |
DEF |
|
|
|
|
1.62 |
7/1/2023 |
12/31/2299 |
N |
J7195 |
FACTOR IX RECOMBINANT NOS |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7195 |
FACTOR IX RECOMBINANT NOS |
MAXFEE |
DEF |
|
|
|
|
1.76 |
7/1/2023 |
12/31/2299 |
N |
J7196 |
ANTITHROMBIN RECOMBINANT |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7196 |
ANTITHROMBIN RECOMBINANT |
MAXFEE |
DEF |
|
|
|
|
0.09 |
9/1/2013 |
12/31/2299 |
N |
J7197 |
ANTITHROMBIN III INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7197 |
ANTITHROMBIN III INJECTION |
MAXFEE |
DEF |
|
|
|
|
3.35 |
7/1/2023 |
12/31/2299 |
N |
J7198 |
ANTI-INHIBITOR |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7198 |
ANTI-INHIBITOR |
MAXFEE |
DEF |
|
|
|
|
2.23 |
7/1/2023 |
12/31/2299 |
N |
J7199 |
HEMOPHILIA CLOT FACTOR NOC |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7199 |
HEMOPHILIA CLOT FACTOR NOC |
MANUAL |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7200 |
FACTOR IX RECOMBINAN RIXUBIS |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7200 |
FACTOR IX RECOMBINAN RIXUBIS |
MAXFEE |
DEF |
|
|
|
|
1.61 |
7/1/2023 |
12/31/2299 |
N |
J7201 |
FACTOR IX ALPROLIX RECOMB |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7201 |
FACTOR IX ALPROLIX RECOMB |
MAXFEE |
DEF |
|
|
|
|
3.46 |
7/1/2023 |
12/31/2299 |
N |
J7202 |
FACTOR IX IDELVION INJ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7202 |
FACTOR IX IDELVION INJ |
MAXFEE |
DEF |
|
|
|
|
4.93 |
7/1/2023 |
12/31/2299 |
N |
J7203 |
FACTOR IX RECOMB GLY REBINYN |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7203 |
FACTOR IX RECOMB GLY REBINYN |
MAXFEE |
DEF |
|
|
|
|
4.41 |
7/1/2023 |
12/31/2299 |
N |
J7204 |
INJ RECOMBIN ESPEROCT PER IU |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7204 |
INJ RECOMBIN ESPEROCT PER IU |
MAXFEE |
DEF |
|
|
|
|
2.11 |
7/1/2023 |
12/31/2299 |
N |
J7205 |
FACTOR VIII FC FUSION RECOMB |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7205 |
FACTOR VIII FC FUSION RECOMB |
MAXFEE |
DEF |
|
|
|
|
2.17 |
7/1/2023 |
12/31/2299 |
N |
J7207 |
FACTOR VIII PEGYLATED RECOMB |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7207 |
FACTOR VIII PEGYLATED RECOMB |
MAXFEE |
DEF |
|
|
|
|
2.11 |
7/1/2023 |
12/31/2299 |
N |
J7208 |
INJ. JIVI 1 IU |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7208 |
INJ. JIVI 1 IU |
MAXFEE |
DEF |
|
|
|
|
2.35 |
7/1/2023 |
12/31/2299 |
N |
J7209 |
FACTOR VIII NUWIQ RECOMB 1IU |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7209 |
FACTOR VIII NUWIQ RECOMB 1IU |
MAXFEE |
DEF |
|
|
|
|
1.36 |
7/1/2023 |
12/31/2299 |
N |
J7210 |
INJ; AFSTYLA; 1 I.U. |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7210 |
INJ; AFSTYLA; 1 I.U. |
MAXFEE |
DEF |
|
|
|
|
1.44 |
4/1/2023 |
12/31/2299 |
N |
J7211 |
INJ; KOVALTRY; 1 I.U. |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7211 |
INJ; KOVALTRY; 1 I.U. |
MAXFEE |
DEF |
|
|
|
|
1.44 |
7/1/2023 |
12/31/2299 |
N |
J7212 |
FACTOR VIIA RECOMB SEVENFACT |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7212 |
FACTOR VIIA RECOMB SEVENFACT |
MAXFEE |
DEF |
|
|
|
|
2.01 |
7/1/2023 |
12/31/2299 |
N |
J7213 |
Inj; ixinity; 1 i.u. |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7213 |
Inj; ixinity; 1 i.u. |
MAXFEE |
DEF |
|
|
|
|
1.75 |
7/1/2023 |
12/31/2299 |
N |
J7294 |
SEG ACET AND ETH ESTR YEARLY |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7294 |
SEG ACET AND ETH ESTR YEARLY |
MAXFEE |
DEF |
|
|
|
|
2236.30 |
10/1/2021 |
12/31/2299 |
N |
J7295 |
ETH ESTR AND ETON MONTHLY |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7295 |
ETH ESTR AND ETON MONTHLY |
MAXFEE |
DEF |
|
|
|
|
174.01 |
10/1/2021 |
12/31/2299 |
N |
J7296 |
KYLEENA; 19.5 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7296 |
KYLEENA; 19.5 MG |
MAXFEE |
DEF |
|
|
|
|
1178.82 |
4/1/2023 |
12/31/2299 |
N |
J7297 |
LILETTA; 52 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7297 |
LILETTA; 52 MG |
MAXFEE |
DEF |
|
|
|
|
732.29 |
4/1/2017 |
12/31/2299 |
N |
J7298 |
MIRENA; 52 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7298 |
MIRENA; 52 MG |
MAXFEE |
DEF |
|
|
|
|
1178.82 |
4/1/2023 |
12/31/2299 |
N |
J7300 |
INTRAUT COPPER CONTRACEPTIVE |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7300 |
INTRAUT COPPER CONTRACEPTIVE |
MAXFEE |
DEF |
|
|
|
|
1096.75 |
1/1/2023 |
12/31/2299 |
N |
J7301 |
SKYLA; 13.5 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7301 |
SKYLA; 13.5 MG |
MAXFEE |
DEF |
|
|
|
|
981.56 |
4/1/2023 |
12/31/2299 |
N |
J7307 |
ETONOGESTREL IMPLANT SYSTEM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7307 |
ETONOGESTREL IMPLANT SYSTEM |
MAXFEE |
DEF |
|
|
|
|
1168.95 |
10/1/2022 |
12/31/2299 |
N |
J7308 |
AMINOLEVULINIC ACID HCL TOP |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7308 |
AMINOLEVULINIC ACID HCL TOP |
MAXFEE |
DEF |
|
|
|
|
391.23 |
7/1/2023 |
12/31/2299 |
N |
J7309 |
METHYL AMINOLEVULINATE; TOP |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7309 |
METHYL AMINOLEVULINATE; TOP |
MAXFEE |
DEF |
|
|
|
|
83.69 |
1/1/2014 |
12/31/2299 |
N |
J7310 |
GANCICLOVIR LONG ACT IMPLANT |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7310 |
GANCICLOVIR LONG ACT IMPLANT |
MAXFEE |
DEF |
|
|
|
|
16960 |
4/1/2009 |
12/31/2299 |
N |
J7311 |
INJ.; RETISERT; 0.01 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7311 |
INJ.; RETISERT; 0.01 MG |
MAXFEE |
DEF |
|
|
|
|
322.38 |
7/1/2023 |
12/31/2299 |
N |
J7312 |
DEXAMETHASONE INTRA IMPLANT |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7312 |
DEXAMETHASONE INTRA IMPLANT |
MAXFEE |
DEF |
|
|
|
|
204.68 |
7/1/2023 |
12/31/2299 |
N |
J7313 |
INJ.; ILUVIEN; 0.01 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7313 |
INJ.; ILUVIEN; 0.01 MG |
MAXFEE |
DEF |
|
|
|
|
490.95 |
4/1/2021 |
12/31/2299 |
N |
J7314 |
INJ.; YUTIQ; 0.01 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7314 |
INJ.; YUTIQ; 0.01 MG |
MAXFEE |
DEF |
|
|
|
|
529.27 |
7/1/2023 |
12/31/2299 |
N |
J7315 |
OPHTHALMIC MITOMYCIN |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7315 |
OPHTHALMIC MITOMYCIN |
MAXFEE |
DEF |
|
|
|
|
384.13 |
9/1/2013 |
12/31/2299 |
N |
J7316 |
INJ; OCRIPLASMIN; 0.125 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7316 |
INJ; OCRIPLASMIN; 0.125 MG |
MAXFEE |
DEF |
|
|
|
|
1046.93 |
8/1/2019 |
12/31/2299 |
N |
J7318 |
INJ; DUROLANE 1 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7318 |
INJ; DUROLANE 1 MG |
MAXFEE |
DEF |
|
|
|
|
6.06 |
7/1/2023 |
12/31/2299 |
N |
J7320 |
GENVISC 850; INJ; 1MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7320 |
GENVISC 850; INJ; 1MG |
MAXFEE |
DEF |
|
|
|
|
6.11 |
7/1/2023 |
12/31/2299 |
N |
J7321 |
HYALGAN SUPARTZ VISCO-3 DOSE |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7321 |
HYALGAN SUPARTZ VISCO-3 DOSE |
MAXFEE |
DEF |
|
|
|
|
73.48 |
7/1/2023 |
12/31/2299 |
N |
J7322 |
HYMOVIS INJECTION 1 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7322 |
HYMOVIS INJECTION 1 MG |
MAXFEE |
DEF |
|
|
|
|
17.02 |
7/1/2023 |
12/31/2299 |
N |
J7323 |
EUFLEXXA INJ PER DOSE |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7323 |
EUFLEXXA INJ PER DOSE |
MAXFEE |
DEF |
|
|
|
|
131.42 |
7/1/2023 |
12/31/2299 |
N |
J7324 |
ORTHOVISC INJ PER DOSE |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7324 |
ORTHOVISC INJ PER DOSE |
MAXFEE |
DEF |
|
|
|
|
117.38 |
7/1/2023 |
12/31/2299 |
N |
J7325 |
SYNVISC OR SYNVISC-ONE |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7325 |
SYNVISC OR SYNVISC-ONE |
MAXFEE |
DEF |
|
|
|
|
9.62 |
7/1/2023 |
12/31/2299 |
N |
J7326 |
GEL-ONE |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7326 |
GEL-ONE |
MAXFEE |
DEF |
|
|
|
|
516.73 |
7/1/2023 |
12/31/2299 |
N |
J7327 |
MONOVISC INJ PER DOSE |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7327 |
MONOVISC INJ PER DOSE |
MAXFEE |
DEF |
|
|
|
|
692.75 |
7/1/2023 |
12/31/2299 |
N |
J7328 |
GELSYN-3 INJECTION 0.1 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7328 |
GELSYN-3 INJECTION 0.1 MG |
MAXFEE |
DEF |
|
|
|
|
0.62 |
7/1/2023 |
12/31/2299 |
N |
J7329 |
INJ; TRIVISC 1 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7329 |
INJ; TRIVISC 1 MG |
MAXFEE |
DEF |
|
|
|
|
8.80 |
7/1/2023 |
12/31/2299 |
N |
J7330 |
CULTURED CHONDROCYTES IMPLNT |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7330 |
CULTURED CHONDROCYTES IMPLNT |
MAXFEE |
DEF |
|
|
|
|
55909.64 |
4/1/2023 |
12/31/2299 |
N |
J7331 |
SYNOJOYNT; INJ.; 1 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7331 |
SYNOJOYNT; INJ.; 1 MG |
MAXFEE |
DEF |
|
|
|
|
13.25 |
4/1/2023 |
12/31/2299 |
N |
J7332 |
INJ.; TRILURON; 1 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7332 |
INJ.; TRILURON; 1 MG |
MAXFEE |
DEF |
|
|
|
|
10.06 |
7/1/2023 |
12/31/2299 |
N |
J7333 |
VISCO-3 INJ DOSE |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7333 |
VISCO-3 INJ DOSE |
MAXFEE |
DEF |
|
|
|
|
NA |
|
|
N |
J7336 |
CAPSAICIN 8% PATCH |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7336 |
CAPSAICIN 8% PATCH |
MAXFEE |
DEF |
|
|
|
|
3.27 |
7/1/2023 |
12/31/2299 |
N |
J7340 |
CARBIDOPA LEVODOPA ENT 100ML |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7340 |
CARBIDOPA LEVODOPA ENT 100ML |
MAXFEE |
DEF |
|
|
|
|
226.83 |
7/1/2023 |
12/31/2299 |
N |
J7342 |
CIPROFLOXACIN OTIC SUSP 6 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7342 |
CIPROFLOXACIN OTIC SUSP 6 MG |
MAXFEE |
DEF |
|
|
|
|
30.02 |
7/1/2023 |
12/31/2299 |
N |
J7345 |
AMINOLEVULINIC ACID; 10% GEL |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7345 |
AMINOLEVULINIC ACID; 10% GEL |
MAXFEE |
DEF |
|
|
|
|
1.65 |
4/1/2023 |
12/31/2299 |
N |
J7351 |
INJ BIMATOPROST ITC IMP1MCG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7351 |
INJ BIMATOPROST ITC IMP1MCG |
MAXFEE |
DEF |
|
|
|
|
206.41 |
7/1/2023 |
12/31/2299 |
N |
J7352 |
AFAMELANOTIDE IMPLANT; 1 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7352 |
AFAMELANOTIDE IMPLANT; 1 MG |
MANUAL |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7401 |
MOMETASONE FUROATE SINUS IMP |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7401 |
MOMETASONE FUROATE SINUS IMP |
MANUAL |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7402 |
MOMETASONE SINUS SINUVA |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7402 |
MOMETASONE SINUS SINUVA |
MAXFEE |
DEF |
|
|
|
|
11.35 |
1/1/2023 |
12/31/2299 |
N |
J7500 |
AZATHIOPRINE ORAL 50MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7500 |
AZATHIOPRINE ORAL 50MG |
MAXFEE |
DEF |
|
|
|
|
13.70 |
7/1/2023 |
12/31/2299 |
N |
J7501 |
AZATHIOPRINE PARENTERAL |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7501 |
AZATHIOPRINE PARENTERAL |
MAXFEE |
DEF |
|
|
|
|
217.30 |
1/1/2014 |
12/31/2299 |
N |
J7502 |
CYCLOSPORINE ORAL 100 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7502 |
CYCLOSPORINE ORAL 100 MG |
MAXFEE |
DEF |
|
|
|
|
1.76 |
7/1/2023 |
12/31/2299 |
N |
J7503 |
TACROL ENVARSUS EX REL ORAL |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7503 |
TACROL ENVARSUS EX REL ORAL |
MAXFEE |
DEF |
|
|
|
|
1.67 |
7/1/2023 |
12/31/2299 |
N |
J7504 |
LYMPHOCYTE IMMUNE GLOBULIN |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7504 |
LYMPHOCYTE IMMUNE GLOBULIN |
MAXFEE |
DEF |
|
|
|
|
2989.44 |
7/1/2023 |
12/31/2299 |
N |
J7505 |
MONOCLONAL ANTIBODIES |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7505 |
MONOCLONAL ANTIBODIES |
MAXFEE |
DEF |
|
|
|
|
1156.08 |
9/1/2013 |
12/31/2299 |
N |
J7507 |
TACROLIMUS IMME REL ORAL 1MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7507 |
TACROLIMUS IMME REL ORAL 1MG |
MAXFEE |
DEF |
|
|
|
|
0.29 |
7/1/2023 |
12/31/2299 |
N |
J7508 |
TACROL ASTAGRAF EX REL ORAL |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7508 |
TACROL ASTAGRAF EX REL ORAL |
MAXFEE |
DEF |
|
|
|
|
0.55 |
7/1/2023 |
12/31/2299 |
N |
J7509 |
METHYLPREDNISOLONE ORAL |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7509 |
METHYLPREDNISOLONE ORAL |
MAXFEE |
DEF |
|
|
|
|
0.26 |
7/1/2023 |
12/31/2299 |
N |
J7510 |
PREDNISOLONE ORAL PER 5 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7510 |
PREDNISOLONE ORAL PER 5 MG |
MAXFEE |
DEF |
|
|
|
|
0.25 |
7/1/2023 |
12/31/2299 |
N |
J7511 |
ANTITHYMOCYTE GLOBULN RABBIT |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7511 |
ANTITHYMOCYTE GLOBULN RABBIT |
MAXFEE |
DEF |
|
|
|
|
920.53 |
7/1/2023 |
12/31/2299 |
N |
J7512 |
PREDNISONE IR OR DR ORAL 1MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7512 |
PREDNISONE IR OR DR ORAL 1MG |
MAXFEE |
DEF |
|
|
|
|
0.01 |
4/1/2023 |
12/31/2299 |
N |
J7513 |
DACLIZUMAB; PARENTERAL |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7513 |
DACLIZUMAB; PARENTERAL |
MAXFEE |
DEF |
|
|
|
|
526.34 |
9/1/2013 |
12/31/2299 |
N |
J7515 |
CYCLOSPORINE ORAL 25 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7515 |
CYCLOSPORINE ORAL 25 MG |
MAXFEE |
DEF |
|
|
|
|
0.75 |
4/1/2023 |
12/31/2299 |
N |
J7516 |
CYCLOSPORIN PARENTERAL 250MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7516 |
CYCLOSPORIN PARENTERAL 250MG |
MAXFEE |
DEF |
|
|
|
|
50.12 |
1/1/2023 |
12/31/2299 |
N |
J7517 |
MYCOPHENOLATE MOFETIL ORAL |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7517 |
MYCOPHENOLATE MOFETIL ORAL |
MAXFEE |
DEF |
|
|
|
|
0.21 |
7/1/2023 |
12/31/2299 |
N |
J7518 |
MYCOPHENOLIC ACID |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7518 |
MYCOPHENOLIC ACID |
MAXFEE |
DEF |
|
|
|
|
0.67 |
7/1/2023 |
12/31/2299 |
N |
J7520 |
SIROLIMUS; ORAL |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7520 |
SIROLIMUS; ORAL |
MAXFEE |
DEF |
|
|
|
|
3.11 |
7/1/2023 |
12/31/2299 |
N |
J7525 |
TACROLIMUS INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7525 |
TACROLIMUS INJECTION |
MAXFEE |
DEF |
|
|
|
|
246.09 |
7/1/2023 |
12/31/2299 |
N |
J7527 |
ORAL EVEROLIMUS |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7527 |
ORAL EVEROLIMUS |
MAXFEE |
DEF |
|
|
|
|
3.20 |
7/1/2023 |
12/31/2299 |
N |
J7599 |
IMMUNOSUPPRESSIVE DRUG NOC |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7599 |
IMMUNOSUPPRESSIVE DRUG NOC |
MANUAL |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7604 |
ACETYLCYSTEINE COMP UNIT |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7604 |
ACETYLCYSTEINE COMP UNIT |
MANUAL |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7605 |
ARFORMOTEROL NON-COMP UNIT |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7605 |
ARFORMOTEROL NON-COMP UNIT |
MAXFEE |
DEF |
|
|
|
|
3.29 |
7/1/2023 |
12/31/2299 |
N |
J7606 |
FORMOTEROL FUMARATE; INH |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7606 |
FORMOTEROL FUMARATE; INH |
MAXFEE |
DEF |
|
|
|
|
5.19 |
7/1/2023 |
12/31/2299 |
N |
J7607 |
LEVALBUTEROL COMP CON |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7607 |
LEVALBUTEROL COMP CON |
MAXFEE |
DEF |
|
|
|
|
0.28 |
9/1/2013 |
12/31/2299 |
N |
J7608 |
ACETYLCYSTEINE NON-COMP UNIT |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7608 |
ACETYLCYSTEINE NON-COMP UNIT |
MAXFEE |
DEF |
|
|
|
|
6.84 |
7/1/2023 |
12/31/2299 |
N |
J7609 |
ALBUTEROL COMP UNIT |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7609 |
ALBUTEROL COMP UNIT |
MAXFEE |
DEF |
|
|
|
|
0.05 |
9/1/2013 |
12/31/2299 |
N |
J7610 |
ALBUTEROL COMP CON |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7610 |
ALBUTEROL COMP CON |
MAXFEE |
DEF |
|
|
|
|
0.11 |
9/1/2013 |
12/31/2299 |
N |
J7611 |
ALBUTEROL NON-COMP CON |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7611 |
ALBUTEROL NON-COMP CON |
MAXFEE |
DEF |
|
|
|
|
0.13 |
7/1/2023 |
12/31/2299 |
N |
J7612 |
LEVALBUTEROL NON-COMP CON |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7612 |
LEVALBUTEROL NON-COMP CON |
MAXFEE |
DEF |
|
|
|
|
0.25 |
7/1/2023 |
12/31/2299 |
N |
J7613 |
ALBUTEROL NON-COMP UNIT |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7613 |
ALBUTEROL NON-COMP UNIT |
MAXFEE |
DEF |
|
|
|
|
0.03 |
4/1/2023 |
12/31/2299 |
N |
J7614 |
LEVALBUTEROL NON-COMP UNIT |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7614 |
LEVALBUTEROL NON-COMP UNIT |
MAXFEE |
DEF |
|
|
|
|
0.04 |
4/1/2023 |
12/31/2299 |
N |
J7615 |
LEVALBUTEROL COMP UNIT |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7615 |
LEVALBUTEROL COMP UNIT |
MAXFEE |
DEF |
|
|
|
|
0.12 |
9/1/2013 |
12/31/2299 |
N |
J7620 |
ALBUTEROL IPRATROP NON-COMP |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7620 |
ALBUTEROL IPRATROP NON-COMP |
MAXFEE |
DEF |
|
|
|
|
0.13 |
4/1/2022 |
12/31/2299 |
N |
J7622 |
BECLOMETHASONE COMP UNIT |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7622 |
BECLOMETHASONE COMP UNIT |
MAXFEE |
DEF |
|
|
|
|
0.03 |
9/1/2013 |
12/31/2299 |
N |
J7624 |
BETAMETHASONE COMP UNIT |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7624 |
BETAMETHASONE COMP UNIT |
MAXFEE |
DEF |
|
|
|
|
1.21 |
9/1/2013 |
12/31/2299 |
N |
J7626 |
BUDESONIDE NON-COMP UNIT |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7626 |
BUDESONIDE NON-COMP UNIT |
MAXFEE |
DEF |
|
|
|
|
0.88 |
7/1/2023 |
12/31/2299 |
N |
J7627 |
BUDESONIDE COMP UNIT |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7627 |
BUDESONIDE COMP UNIT |
MAXFEE |
DEF |
|
|
|
|
5.10 |
9/1/2013 |
12/31/2299 |
N |
J7629 |
BITOLTEROL MESYLATE COMP UNT |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7629 |
BITOLTEROL MESYLATE COMP UNT |
MAXFEE |
DEF |
|
|
|
|
0.17 |
9/1/2013 |
12/31/2299 |
N |
J7631 |
CROMOLYN SODIUM NONCOMP UNIT |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7631 |
CROMOLYN SODIUM NONCOMP UNIT |
MAXFEE |
DEF |
|
|
|
|
1.66 |
7/1/2023 |
12/31/2299 |
N |
J7632 |
CROMOLYN SODIUM COMP UNIT |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7632 |
CROMOLYN SODIUM COMP UNIT |
MAXFEE |
DEF |
|
|
|
|
0.55 |
9/1/2013 |
12/31/2299 |
N |
J7633 |
BUDESONIDE NON-COMP CON |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7633 |
BUDESONIDE NON-COMP CON |
MAXFEE |
DEF |
|
|
|
|
8.06 |
9/1/2013 |
12/31/2299 |
N |
J7634 |
BUDESONIDE COMP CON |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7634 |
BUDESONIDE COMP CON |
MAXFEE |
DEF |
|
|
|
|
8.06 |
9/1/2013 |
12/31/2299 |
N |
J7635 |
ATROPINE COMP CON |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7635 |
ATROPINE COMP CON |
MAXFEE |
DEF |
|
|
|
|
0.11 |
9/1/2013 |
12/31/2299 |
N |
J7636 |
ATROPINE COMP UNIT |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7636 |
ATROPINE COMP UNIT |
MAXFEE |
DEF |
|
|
|
|
0.11 |
9/1/2013 |
12/31/2299 |
N |
J7637 |
DEXAMETHASONE COMP CON |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7637 |
DEXAMETHASONE COMP CON |
MAXFEE |
DEF |
|
|
|
|
0.06 |
9/1/2013 |
12/31/2299 |
N |
J7638 |
DEXAMETHASONE COMP UNIT |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7638 |
DEXAMETHASONE COMP UNIT |
MAXFEE |
DEF |
|
|
|
|
0.12 |
9/1/2013 |
12/31/2299 |
N |
J7639 |
DORNASE ALFA NON-COMP UNIT |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7639 |
DORNASE ALFA NON-COMP UNIT |
MAXFEE |
DEF |
|
|
|
|
52.23 |
7/1/2023 |
12/31/2299 |
N |
J7640 |
FORMOTEROL COMP UNIT |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7640 |
FORMOTEROL COMP UNIT |
MAXFEE |
DEF |
|
|
|
|
5.91 |
9/1/2013 |
12/31/2299 |
N |
J7641 |
FLUNISOLIDE COMP UNIT |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7641 |
FLUNISOLIDE COMP UNIT |
MAXFEE |
DEF |
|
|
|
|
0.14 |
9/1/2013 |
12/31/2299 |
N |
J7642 |
GLYCOPYRROLATE COMP CON |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7642 |
GLYCOPYRROLATE COMP CON |
MAXFEE |
DEF |
|
|
|
|
1.04 |
9/1/2013 |
12/31/2299 |
N |
J7643 |
GLYCOPYRROLATE COMP UNIT |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7643 |
GLYCOPYRROLATE COMP UNIT |
MAXFEE |
DEF |
|
|
|
|
1.04 |
9/1/2013 |
12/31/2299 |
N |
J7644 |
IPRATROPIUM BROMIDE NON-COMP |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7644 |
IPRATROPIUM BROMIDE NON-COMP |
MAXFEE |
DEF |
|
|
|
|
0.26 |
7/1/2023 |
12/31/2299 |
N |
J7645 |
IPRATROPIUM BROMIDE COMP |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7645 |
IPRATROPIUM BROMIDE COMP |
MAXFEE |
DEF |
|
|
|
|
0.23 |
9/1/2013 |
12/31/2299 |
N |
J7669 |
METAPROTERENOL NON-COMP UNIT |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7669 |
METAPROTERENOL NON-COMP UNIT |
MAXFEE |
DEF |
|
|
|
|
0.44 |
11/1/2013 |
12/31/2299 |
N |
J7674 |
METHACHOLINE CHLORIDE; NEB |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7674 |
METHACHOLINE CHLORIDE; NEB |
MAXFEE |
DEF |
|
|
|
|
0.86 |
7/1/2023 |
12/31/2299 |
N |
J7676 |
PENTAMIDINE COMP UNIT DOSE |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7676 |
PENTAMIDINE COMP UNIT DOSE |
MAXFEE |
DEF |
|
|
|
|
80.73 |
9/1/2013 |
12/31/2299 |
N |
J7677 |
REVEFENACIN INH NON-COM 1MCG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7677 |
REVEFENACIN INH NON-COM 1MCG |
MAXFEE |
DEF |
|
|
|
|
0.20 |
7/1/2023 |
12/31/2299 |
N |
J7680 |
TERBUTALINE SULF COMP CON |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7680 |
TERBUTALINE SULF COMP CON |
MAXFEE |
DEF |
|
|
|
|
4.44 |
9/1/2013 |
12/31/2299 |
N |
J7681 |
TERBUTALINE SULF COMP UNIT |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7681 |
TERBUTALINE SULF COMP UNIT |
MAXFEE |
DEF |
|
|
|
|
4.62 |
9/1/2013 |
12/31/2299 |
N |
J7682 |
TOBRAMYCIN NON-COMP UNIT |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7682 |
TOBRAMYCIN NON-COMP UNIT |
MAXFEE |
DEF |
|
|
|
|
29.62 |
7/1/2023 |
12/31/2299 |
N |
J7683 |
TRIAMCINOLONE COMP CON |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7683 |
TRIAMCINOLONE COMP CON |
MAXFEE |
DEF |
|
|
|
|
0.10 |
9/1/2013 |
12/31/2299 |
N |
J7684 |
TRIAMCINOLONE COMP UNIT |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7684 |
TRIAMCINOLONE COMP UNIT |
MAXFEE |
DEF |
|
|
|
|
0.17 |
9/1/2013 |
12/31/2299 |
N |
J7685 |
TOBRAMYCIN COMP UNIT |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7685 |
TOBRAMYCIN COMP UNIT |
MAXFEE |
DEF |
|
|
|
|
118.58 |
9/1/2013 |
12/31/2299 |
N |
J7686 |
TREPROSTINIL; NON-COMP UNIT |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7686 |
TREPROSTINIL; NON-COMP UNIT |
MAXFEE |
DEF |
|
|
|
|
737.38 |
7/1/2023 |
12/31/2299 |
N |
J7699 |
INHALATION SOLUTION FOR DME |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7699 |
INHALATION SOLUTION FOR DME |
MANUAL |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7799 |
NON-INHALATION DRUG FOR DME |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J7799 |
NON-INHALATION DRUG FOR DME |
MANUAL |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J8498 |
ANTIEMETIC RECTAL/SUPP NOS |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J8498 |
ANTIEMETIC RECTAL/SUPP NOS |
MANUAL |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J8499 |
ORAL PRESCRIP DRUG NON CHEMO |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J8499 |
ORAL PRESCRIP DRUG NON CHEMO |
MANUAL |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J8501 |
ORAL APREPITANT |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J8501 |
ORAL APREPITANT |
MAXFEE |
DEF |
|
|
|
|
3.12 |
7/1/2023 |
12/31/2299 |
N |
J8510 |
ORAL BUSULFAN |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J8510 |
ORAL BUSULFAN |
MAXFEE |
DEF |
|
|
|
|
24.18 |
11/1/2019 |
12/31/2299 |
N |
J8515 |
CABERGOLINE; ORAL 0.25MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J8515 |
CABERGOLINE; ORAL 0.25MG |
MAXFEE |
DEF |
|
|
|
|
24.38 |
9/1/2013 |
12/31/2299 |
N |
J8520 |
CAPECITABINE; ORAL; 150 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J8520 |
CAPECITABINE; ORAL; 150 MG |
MAXFEE |
DEF |
|
|
|
|
0.80 |
7/1/2023 |
12/31/2299 |
N |
J8521 |
CAPECITABINE; ORAL; 500 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J8521 |
CAPECITABINE; ORAL; 500 MG |
MAXFEE |
DEF |
|
|
|
|
22.88 |
7/1/2023 |
12/31/2299 |
N |
J8530 |
CYCLOPHOSPHAMIDE ORAL 25 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J8530 |
CYCLOPHOSPHAMIDE ORAL 25 MG |
MAXFEE |
DEF |
|
|
|
|
0.95 |
7/1/2023 |
12/31/2299 |
N |
J8540 |
ORAL DEXAMETHASONE |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J8540 |
ORAL DEXAMETHASONE |
MAXFEE |
DEF |
|
|
|
|
0.10 |
7/1/2023 |
12/31/2299 |
N |
J8560 |
ETOPOSIDE ORAL 50 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J8560 |
ETOPOSIDE ORAL 50 MG |
MAXFEE |
DEF |
|
|
|
|
77.39 |
7/1/2023 |
12/31/2299 |
N |
J8562 |
ORAL FLUDARABINE PHOSPHATE |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J8562 |
ORAL FLUDARABINE PHOSPHATE |
MAXFEE |
DEF |
|
|
|
|
81.77 |
9/1/2013 |
12/31/2299 |
N |
J8597 |
ANTIEMETIC DRUG ORAL NOS |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J8597 |
ANTIEMETIC DRUG ORAL NOS |
MANUAL |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J8600 |
MELPHALAN ORAL 2 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J8600 |
MELPHALAN ORAL 2 MG |
MAXFEE |
DEF |
|
|
|
|
12 |
11/1/2018 |
12/31/2299 |
N |
J8610 |
METHOTREXATE ORAL 2.5 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J8610 |
METHOTREXATE ORAL 2.5 MG |
MAXFEE |
DEF |
|
|
|
|
0.23 |
7/1/2023 |
12/31/2299 |
N |
J8650 |
NABILONE ORAL |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J8650 |
NABILONE ORAL |
MAXFEE |
DEF |
|
|
|
|
87.32 |
9/1/2013 |
12/31/2299 |
N |
J8655 |
ORAL NETUPITANT; PALONOSETRO |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J8655 |
ORAL NETUPITANT; PALONOSETRO |
MAXFEE |
DEF |
|
|
|
|
461.26 |
7/1/2023 |
12/31/2299 |
N |
J8670 |
ROLAPITANT; ORAL; 1MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J8670 |
ROLAPITANT; ORAL; 1MG |
MAXFEE |
DEF |
|
|
|
|
1.63 |
7/1/2023 |
12/31/2299 |
N |
J8700 |
TEMOZOLOMIDE |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J8700 |
TEMOZOLOMIDE |
MAXFEE |
DEF |
|
|
|
|
0.19 |
7/1/2023 |
12/31/2299 |
N |
J8705 |
TOPOTECAN ORAL |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J8705 |
TOPOTECAN ORAL |
MAXFEE |
DEF |
|
|
|
|
112.30 |
7/1/2023 |
12/31/2299 |
N |
J8999 |
ORAL PRESCRIPTION DRUG CHEMO |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J8999 |
ORAL PRESCRIPTION DRUG CHEMO |
MANUAL |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9000 |
DOXORUBICIN HCL INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9000 |
DOXORUBICIN HCL INJECTION |
MAXFEE |
DEF |
|
|
|
|
2.50 |
7/1/2023 |
12/31/2299 |
N |
J9015 |
ALDESLEUKIN INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9015 |
ALDESLEUKIN INJECTION |
MAXFEE |
DEF |
|
|
|
|
2110.63 |
11/1/2014 |
12/31/2299 |
N |
J9017 |
ARSENIC TRIOXIDE INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9017 |
ARSENIC TRIOXIDE INJECTION |
MAXFEE |
DEF |
|
|
|
|
12.97 |
7/1/2023 |
12/31/2299 |
N |
J9019 |
ERWINAZE INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9019 |
ERWINAZE INJECTION |
MAXFEE |
DEF |
|
|
|
|
427.27 |
10/1/2020 |
12/31/2299 |
N |
J9020 |
ASPARAGINASE; NOS |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9020 |
ASPARAGINASE; NOS |
MAXFEE |
DEF |
|
|
|
|
64.56 |
5/1/2015 |
12/31/2299 |
N |
J9021 |
INJ; ASPARA; RYLAZE; 0.1 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9021 |
INJ; ASPARA; RYLAZE; 0.1 MG |
MAXFEE |
DEF |
|
|
|
|
49.53 |
7/1/2023 |
12/31/2299 |
N |
J9022 |
INJ; ATEZOLIZUMAB;10 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9022 |
INJ; ATEZOLIZUMAB;10 MG |
MAXFEE |
DEF |
|
|
|
|
82.68 |
7/1/2023 |
12/31/2299 |
N |
J9023 |
INJECTION; AVELUMAB; 10 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9023 |
INJECTION; AVELUMAB; 10 MG |
MAXFEE |
DEF |
|
|
|
|
90.57 |
7/1/2023 |
12/31/2299 |
N |
J9025 |
AZACITIDINE INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9025 |
AZACITIDINE INJECTION |
MAXFEE |
DEF |
|
|
|
|
0.40 |
7/1/2023 |
12/31/2299 |
N |
J9027 |
CLOFARABINE INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9027 |
CLOFARABINE INJECTION |
MAXFEE |
DEF |
|
|
|
|
29.42 |
7/1/2023 |
12/31/2299 |
N |
J9029 |
Inj; adstiladrin; per tx dos |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9029 |
Inj; adstiladrin; per tx dos |
MAXFEE |
DEF |
|
|
|
|
0 |
7/1/2023 |
12/31/2299 |
N |
J9030 |
BCG LIVE INTRAVESICAL 1MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9030 |
BCG LIVE INTRAVESICAL 1MG |
MAXFEE |
DEF |
|
|
|
|
2.89 |
7/1/2023 |
12/31/2299 |
N |
J9032 |
INJECTION; BELINOSTAT; 10MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9032 |
INJECTION; BELINOSTAT; 10MG |
MAXFEE |
DEF |
|
|
|
|
47.62 |
7/1/2023 |
12/31/2299 |
N |
J9033 |
INJ.; TREANDA 1 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9033 |
INJ.; TREANDA 1 MG |
MAXFEE |
DEF |
|
|
|
|
12.28 |
7/1/2023 |
12/31/2299 |
N |
J9034 |
INJ.; BENDEKA 1 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9034 |
INJ.; BENDEKA 1 MG |
MAXFEE |
DEF |
|
|
|
|
16.51 |
7/1/2023 |
12/31/2299 |
N |
J9035 |
BEVACIZUMAB INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9035 |
BEVACIZUMAB INJECTION |
MAXFEE |
DEF |
|
|
|
|
73.58 |
7/1/2023 |
12/31/2299 |
N |
J9036 |
INJ. BELRAPZO/BENDAMUSTINE |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9036 |
INJ. BELRAPZO/BENDAMUSTINE |
MAXFEE |
DEF |
|
|
|
|
16.72 |
7/1/2023 |
12/31/2299 |
N |
J9037 |
INJ BELANTAMAB MAFODOT BLMF |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9037 |
INJ BELANTAMAB MAFODOT BLMF |
MAXFEE |
DEF |
|
|
|
|
45.28 |
1/1/2023 |
12/31/2299 |
N |
J9039 |
INJECTION; BLINATUMOMAB |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9039 |
INJECTION; BLINATUMOMAB |
MAXFEE |
DEF |
|
|
|
|
144.68 |
7/1/2023 |
12/31/2299 |
N |
J9040 |
BLEOMYCIN SULFATE INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9040 |
BLEOMYCIN SULFATE INJECTION |
MAXFEE |
DEF |
|
|
|
|
24.53 |
7/1/2023 |
12/31/2299 |
N |
J9041 |
INJECTION; BORTEZOMIB; 0.1MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9041 |
INJECTION; BORTEZOMIB; 0.1MG |
MAXFEE |
DEF |
|
|
|
|
3.03 |
7/1/2023 |
12/31/2299 |
N |
J9042 |
BRENTUXIMAB VEDOTIN INJ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9042 |
BRENTUXIMAB VEDOTIN INJ |
MAXFEE |
DEF |
|
|
|
|
221.96 |
7/1/2023 |
12/31/2299 |
N |
J9043 |
CABAZITAXEL INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9043 |
CABAZITAXEL INJECTION |
MAXFEE |
DEF |
|
|
|
|
206.03 |
7/1/2023 |
12/31/2299 |
N |
J9044 |
INJ; BORTEZOMIB; NOS; 0.1 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9044 |
INJ; BORTEZOMIB; NOS; 0.1 MG |
MAXFEE |
DEF |
|
|
|
|
NA |
|
|
N |
J9045 |
CARBOPLATIN INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9045 |
CARBOPLATIN INJECTION |
MAXFEE |
DEF |
|
|
|
|
2.41 |
7/1/2023 |
12/31/2299 |
N |
J9046 |
INJ; BORTEZOMIB; DR. REDDY'S |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9046 |
INJ; BORTEZOMIB; DR. REDDY'S |
MAXFEE |
DEF |
|
|
|
|
48.55 |
7/1/2023 |
12/31/2299 |
N |
J9047 |
INJECTION; CARFILZOMIB; 1 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9047 |
INJECTION; CARFILZOMIB; 1 MG |
MAXFEE |
DEF |
|
|
|
|
47.04 |
7/1/2023 |
12/31/2299 |
N |
J9048 |
INJ; BORTEZOMIB FRESENIUSKAB |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9048 |
INJ; BORTEZOMIB FRESENIUSKAB |
MAXFEE |
DEF |
|
|
|
|
2.68 |
1/1/2023 |
12/31/2299 |
N |
J9049 |
INJ; BORTEZOMIB; HOSPIRA |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9049 |
INJ; BORTEZOMIB; HOSPIRA |
MAXFEE |
DEF |
|
|
|
|
3.89 |
7/1/2023 |
12/31/2299 |
N |
J9050 |
CARMUSTINE INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9050 |
CARMUSTINE INJECTION |
MAXFEE |
DEF |
|
|
|
|
410.96 |
7/1/2023 |
12/31/2299 |
N |
J9055 |
CETUXIMAB INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9055 |
CETUXIMAB INJECTION |
MAXFEE |
DEF |
|
|
|
|
72.08 |
7/1/2023 |
12/31/2299 |
N |
J9056 |
Inj; bendamustine; 1 mg |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9056 |
Inj; bendamustine; 1 mg |
MAXFEE |
DEF |
|
|
|
|
33.33 |
7/1/2023 |
12/31/2299 |
N |
J9057 |
INJ.; COPANLISIB; 1 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9057 |
INJ.; COPANLISIB; 1 MG |
MAXFEE |
DEF |
|
|
|
|
81.57 |
1/1/2019 |
12/31/2299 |
N |
J9058 |
Inj apotex/bendamustine 1 mg |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9058 |
Inj apotex/bendamustine 1 mg |
MAXFEE |
DEF |
|
|
|
|
34.34 |
7/1/2023 |
12/31/2299 |
N |
J9059 |
Inj bendamustine; baxter 1mg |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9059 |
Inj bendamustine; baxter 1mg |
MAXFEE |
DEF |
|
|
|
|
23.96 |
7/1/2023 |
12/31/2299 |
N |
J9060 |
CISPLATIN 10 MG INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9060 |
CISPLATIN 10 MG INJECTION |
MAXFEE |
DEF |
|
|
|
|
3.17 |
7/1/2023 |
12/31/2299 |
N |
J9061 |
INJ; AMIVANTAMAB-VMJW |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9061 |
INJ; AMIVANTAMAB-VMJW |
MAXFEE |
DEF |
|
|
|
|
19.63 |
7/1/2023 |
12/31/2299 |
N |
J9063 |
Inj; elahere; 1 mg |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9063 |
Inj; elahere; 1 mg |
MAXFEE |
DEF |
|
|
|
|
65.80 |
7/1/2023 |
12/31/2299 |
N |
J9065 |
INJ CLADRIBINE PER 1 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9065 |
INJ CLADRIBINE PER 1 MG |
MAXFEE |
DEF |
|
|
|
|
18.30 |
7/1/2023 |
12/31/2299 |
N |
J9070 |
CYCLOPHOSPHAMIDE 100 MG INJ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9070 |
CYCLOPHOSPHAMIDE 100 MG INJ |
MAXFEE |
DEF |
|
|
|
|
17.09 |
7/1/2023 |
12/31/2299 |
N |
J9071 |
INJ CYCLOPHOSPHAMD AUROMEDIC |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9071 |
INJ CYCLOPHOSPHAMD AUROMEDIC |
MAXFEE |
DEF |
|
|
|
|
3.87 |
4/1/2023 |
12/31/2299 |
N |
J9098 |
CYTARABINE LIPOSOME INJ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9098 |
CYTARABINE LIPOSOME INJ |
MAXFEE |
DEF |
|
|
|
|
628.37 |
5/1/2018 |
12/31/2299 |
N |
J9100 |
CYTARABINE HCL 100 MG INJ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9100 |
CYTARABINE HCL 100 MG INJ |
MAXFEE |
DEF |
|
|
|
|
0.92 |
7/1/2023 |
12/31/2299 |
N |
J9118 |
INJ. CALASPARGASE PEGOL-MKNL |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9118 |
INJ. CALASPARGASE PEGOL-MKNL |
MAXFEE |
DEF |
|
|
|
|
72.87 |
7/1/2023 |
12/31/2299 |
N |
J9119 |
INJ.; CEMIPLIMAB-RWLC; 1 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9119 |
INJ.; CEMIPLIMAB-RWLC; 1 MG |
MAXFEE |
DEF |
|
|
|
|
26.92 |
7/1/2023 |
12/31/2299 |
N |
J9120 |
DACTINOMYCIN INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9120 |
DACTINOMYCIN INJECTION |
MAXFEE |
DEF |
|
|
|
|
594.55 |
7/1/2023 |
12/31/2299 |
N |
J9130 |
DACARBAZINE 100 MG INJ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9130 |
DACARBAZINE 100 MG INJ |
MAXFEE |
DEF |
|
|
|
|
4.05 |
7/1/2023 |
12/31/2299 |
N |
J9144 |
DARATUMUMAB; HYALURONIDASE |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9144 |
DARATUMUMAB; HYALURONIDASE |
MAXFEE |
DEF |
|
|
|
|
49.12 |
7/1/2023 |
12/31/2299 |
N |
J9145 |
INJECTION; DARATUMUMAB 10 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9145 |
INJECTION; DARATUMUMAB 10 MG |
MAXFEE |
DEF |
|
|
|
|
61.78 |
7/1/2023 |
12/31/2299 |
N |
J9150 |
DAUNORUBICIN INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9150 |
DAUNORUBICIN INJECTION |
MAXFEE |
DEF |
|
|
|
|
45.62 |
7/1/2023 |
12/31/2299 |
N |
J9151 |
DAUNORUBICIN CITRATE INJ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9151 |
DAUNORUBICIN CITRATE INJ |
MAXFEE |
DEF |
|
|
|
|
246.10 |
9/1/2013 |
12/31/2299 |
N |
J9153 |
INJ DAUNORUBICIN; CYTARABINE |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9153 |
INJ DAUNORUBICIN; CYTARABINE |
MAXFEE |
DEF |
|
|
|
|
227.23 |
7/1/2023 |
12/31/2299 |
N |
J9155 |
DEGARELIX INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9155 |
DEGARELIX INJECTION |
MAXFEE |
DEF |
|
|
|
|
4.19 |
7/1/2023 |
12/31/2299 |
N |
J9160 |
DENILEUKIN DIFTITOX INJ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9160 |
DENILEUKIN DIFTITOX INJ |
MAXFEE |
DEF |
|
|
|
|
1646.18 |
9/1/2013 |
12/31/2299 |
N |
J9171 |
DOCETAXEL INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9171 |
DOCETAXEL INJECTION |
MAXFEE |
DEF |
|
|
|
|
0.94 |
7/1/2023 |
12/31/2299 |
N |
J9173 |
INJ.; DURVALUMAB; 10 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9173 |
INJ.; DURVALUMAB; 10 MG |
MAXFEE |
DEF |
|
|
|
|
79.76 |
7/1/2023 |
12/31/2299 |
N |
J9175 |
ELLIOTTS B SOLUTION PER ML |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9175 |
ELLIOTTS B SOLUTION PER ML |
MAXFEE |
DEF |
|
|
|
|
4.16 |
1/1/2014 |
12/31/2299 |
N |
J9176 |
INJECTION; ELOTUZUMAB; 1MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9176 |
INJECTION; ELOTUZUMAB; 1MG |
MAXFEE |
DEF |
|
|
|
|
7.19 |
7/1/2023 |
12/31/2299 |
N |
J9177 |
INJ ENFORT VEDO-EJFV 0.25MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9177 |
INJ ENFORT VEDO-EJFV 0.25MG |
MAXFEE |
DEF |
|
|
|
|
33.82 |
7/1/2023 |
12/31/2299 |
N |
J9178 |
INJ; EPIRUBICIN HCL; 2 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9178 |
INJ; EPIRUBICIN HCL; 2 MG |
MAXFEE |
DEF |
|
|
|
|
1.34 |
7/1/2023 |
12/31/2299 |
N |
J9179 |
ERIBULIN MESYLATE INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9179 |
ERIBULIN MESYLATE INJECTION |
MAXFEE |
DEF |
|
|
|
|
128.78 |
7/1/2023 |
12/31/2299 |
N |
J9181 |
ETOPOSIDE INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9181 |
ETOPOSIDE INJECTION |
MAXFEE |
DEF |
|
|
|
|
0.70 |
7/1/2023 |
12/31/2299 |
N |
J9185 |
FLUDARABINE PHOSPHATE INJ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9185 |
FLUDARABINE PHOSPHATE INJ |
MAXFEE |
DEF |
|
|
|
|
604.75 |
7/1/2023 |
12/31/2299 |
N |
J9190 |
FLUOROURACIL INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9190 |
FLUOROURACIL INJECTION |
MAXFEE |
DEF |
|
|
|
|
1.83 |
7/1/2023 |
12/31/2299 |
N |
J9196 |
INJ GEMCITABINE HCL (ACCORD) |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9196 |
INJ GEMCITABINE HCL (ACCORD) |
MAXFEE |
DEF |
|
|
|
|
3.72 |
7/1/2023 |
12/31/2299 |
N |
J9198 |
INJ. INFUGEM; 100 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9198 |
INJ. INFUGEM; 100 MG |
MAXFEE |
DEF |
|
|
|
|
40.28 |
7/1/2023 |
12/31/2299 |
N |
J9199 |
INJECTION; INFUGEM; 200 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9199 |
INJECTION; INFUGEM; 200 MG |
MANUAL |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9200 |
FLOXURIDINE INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9200 |
FLOXURIDINE INJECTION |
MAXFEE |
DEF |
|
|
|
|
3551 |
7/1/2023 |
12/31/2299 |
N |
J9201 |
IN GEMCITABINE HCL NOS 200MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9201 |
IN GEMCITABINE HCL NOS 200MG |
MAXFEE |
DEF |
|
|
|
|
3.71 |
7/1/2023 |
12/31/2299 |
N |
J9202 |
GOSERELIN ACETATE IMPLANT |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9202 |
GOSERELIN ACETATE IMPLANT |
MAXFEE |
DEF |
|
|
|
|
613.57 |
7/1/2023 |
12/31/2299 |
N |
J9203 |
GEMTUZUMAB OZOGAMICIN 0.1 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9203 |
GEMTUZUMAB OZOGAMICIN 0.1 MG |
MAXFEE |
DEF |
|
|
|
|
221.84 |
7/1/2023 |
12/31/2299 |
N |
J9204 |
INJ MOGAMULIZUMAB-KPKC; 1 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9204 |
INJ MOGAMULIZUMAB-KPKC; 1 MG |
MAXFEE |
DEF |
|
|
|
|
226.71 |
7/1/2023 |
12/31/2299 |
N |
J9205 |
INJ IRINOTECAN LIPOSOME 1 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9205 |
INJ IRINOTECAN LIPOSOME 1 MG |
MAXFEE |
DEF |
|
|
|
|
61.96 |
7/1/2023 |
12/31/2299 |
N |
J9206 |
IRINOTECAN INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9206 |
IRINOTECAN INJECTION |
MAXFEE |
DEF |
|
|
|
|
3 |
7/1/2023 |
12/31/2299 |
N |
J9207 |
IXABEPILONE INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9207 |
IXABEPILONE INJECTION |
MAXFEE |
DEF |
|
|
|
|
122.55 |
7/1/2023 |
12/31/2299 |
N |
J9208 |
IFOSFAMIDE INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9208 |
IFOSFAMIDE INJECTION |
MAXFEE |
DEF |
|
|
|
|
25.38 |
7/1/2023 |
12/31/2299 |
N |
J9209 |
MESNA INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9209 |
MESNA INJECTION |
MAXFEE |
DEF |
|
|
|
|
1.67 |
7/1/2023 |
12/31/2299 |
N |
J9210 |
INJ.; EMAPALUMAB-LZSG; 1 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9210 |
INJ.; EMAPALUMAB-LZSG; 1 MG |
MAXFEE |
DEF |
|
|
|
|
393.72 |
7/1/2023 |
12/31/2299 |
N |
J9211 |
IDARUBICIN HCL INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9211 |
IDARUBICIN HCL INJECTION |
MAXFEE |
DEF |
|
|
|
|
33.90 |
7/1/2023 |
12/31/2299 |
N |
J9212 |
INTERFERON ALFACON-1 INJ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9212 |
INTERFERON ALFACON-1 INJ |
MAXFEE |
DEF |
|
|
|
|
13.77 |
9/1/2013 |
12/31/2299 |
N |
J9213 |
INTERFERON ALFA-2A INJ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9213 |
INTERFERON ALFA-2A INJ |
MAXFEE |
DEF |
|
|
|
|
40.52 |
4/1/2009 |
12/31/2299 |
N |
J9214 |
INTERFERON ALFA-2B INJ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9214 |
INTERFERON ALFA-2B INJ |
MAXFEE |
DEF |
|
|
|
|
32.57 |
10/1/2022 |
12/31/2299 |
N |
J9215 |
INTERFERON ALFA-N3 INJ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9215 |
INTERFERON ALFA-N3 INJ |
MAXFEE |
DEF |
|
|
|
|
8.60 |
4/1/2006 |
12/31/2299 |
N |
J9216 |
INTERFERON GAMMA 1-B INJ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9216 |
INTERFERON GAMMA 1-B INJ |
MAXFEE |
DEF |
|
|
|
|
2717.27 |
9/1/2013 |
12/31/2299 |
N |
J9217 |
LEUPROLIDE ACETATE SUSPNSION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9217 |
LEUPROLIDE ACETATE SUSPNSION |
MAXFEE |
DEF |
|
|
|
|
165.86 |
7/1/2023 |
12/31/2299 |
N |
J9218 |
LEUPROLIDE ACETATE INJECITON |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9218 |
LEUPROLIDE ACETATE INJECITON |
MAXFEE |
DEF |
|
|
|
|
10.06 |
7/1/2023 |
12/31/2299 |
N |
J9219 |
LEUPROLIDE ACETATE IMPLANT |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9219 |
LEUPROLIDE ACETATE IMPLANT |
MAXFEE |
DEF |
|
|
|
|
4819.82 |
4/1/2009 |
12/31/2299 |
N |
J9223 |
INJ. LURBINECTEDIN; 0.1 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9223 |
INJ. LURBINECTEDIN; 0.1 MG |
MAXFEE |
DEF |
|
|
|
|
197.18 |
7/1/2023 |
12/31/2299 |
N |
J9225 |
VANTAS IMPLANT |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9225 |
VANTAS IMPLANT |
MAXFEE |
DEF |
|
|
|
|
5166.29 |
7/1/2021 |
12/31/2299 |
N |
J9226 |
SUPPRELIN LA IMPLANT |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9226 |
SUPPRELIN LA IMPLANT |
MAXFEE |
DEF |
|
|
|
|
43270.02 |
7/1/2023 |
12/31/2299 |
N |
J9227 |
INJ. ISATUXIMAB-IRFC 10 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9227 |
INJ. ISATUXIMAB-IRFC 10 MG |
MAXFEE |
DEF |
|
|
|
|
74.35 |
7/1/2023 |
12/31/2299 |
N |
J9228 |
IPILIMUMAB INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9228 |
IPILIMUMAB INJECTION |
MAXFEE |
DEF |
|
|
|
|
167.93 |
7/1/2023 |
12/31/2299 |
N |
J9229 |
INJ INOTUZUMAB OZOGAM 0.1 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9229 |
INJ INOTUZUMAB OZOGAM 0.1 MG |
MAXFEE |
DEF |
|
|
|
|
2529.55 |
7/1/2023 |
12/31/2299 |
N |
J9230 |
MECHLORETHAMINE HCL INJ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9230 |
MECHLORETHAMINE HCL INJ |
MAXFEE |
DEF |
|
|
|
|
321.72 |
5/1/2019 |
12/31/2299 |
N |
J9245 |
INJ MELPHA HYDROCH NOS 50 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9245 |
INJ MELPHA HYDROCH NOS 50 MG |
MAXFEE |
DEF |
|
|
|
|
154.19 |
7/1/2023 |
12/31/2299 |
N |
J9246 |
INJ.; EVOMELA; 1 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9246 |
INJ.; EVOMELA; 1 MG |
MAXFEE |
DEF |
|
|
|
|
16.44 |
7/1/2023 |
12/31/2299 |
N |
J9247 |
INJ; MELPHALAN FLUFENAMI 1MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9247 |
INJ; MELPHALAN FLUFENAMI 1MG |
MAXFEE |
DEF |
|
|
|
|
503.50 |
7/1/2022 |
12/31/2299 |
N |
J9250 |
METHOTREXATE SODIUM INJ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9250 |
METHOTREXATE SODIUM INJ |
MAXFEE |
DEF |
|
|
|
|
0.27 |
7/1/2023 |
12/31/2299 |
N |
J9259 |
Paclitaxel (american regent) |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9259 |
Paclitaxel (american regent) |
MAXFEE |
DEF |
|
|
|
|
16.86 |
7/1/2023 |
12/31/2299 |
N |
J9260 |
METHOTREXATE SODIUM INJ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9260 |
METHOTREXATE SODIUM INJ |
MAXFEE |
DEF |
|
|
|
|
2.71 |
7/1/2023 |
12/31/2299 |
N |
J9261 |
NELARABINE INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9261 |
NELARABINE INJECTION |
MAXFEE |
DEF |
|
|
|
|
128.99 |
7/1/2023 |
12/31/2299 |
N |
J9262 |
INJ; OMACETAXINE MEP; 0.01MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9262 |
INJ; OMACETAXINE MEP; 0.01MG |
MAXFEE |
DEF |
|
|
|
|
4.01 |
7/1/2023 |
12/31/2299 |
N |
J9263 |
OXALIPLATIN |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9263 |
OXALIPLATIN |
MAXFEE |
DEF |
|
|
|
|
0.07 |
4/1/2023 |
12/31/2299 |
N |
J9264 |
PACLITAXEL PROTEIN BOUND |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9264 |
PACLITAXEL PROTEIN BOUND |
MAXFEE |
DEF |
|
|
|
|
12.06 |
7/1/2023 |
12/31/2299 |
N |
J9266 |
PEGASPARGASE INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9266 |
PEGASPARGASE INJECTION |
MAXFEE |
DEF |
|
|
|
|
25762.46 |
7/1/2023 |
12/31/2299 |
N |
J9267 |
PACLITAXEL INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9267 |
PACLITAXEL INJECTION |
MAXFEE |
DEF |
|
|
|
|
0.12 |
7/1/2023 |
12/31/2299 |
N |
J9268 |
PENTOSTATIN INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9268 |
PENTOSTATIN INJECTION |
MAXFEE |
DEF |
|
|
|
|
2387.73 |
7/1/2023 |
12/31/2299 |
N |
J9269 |
INJ. TAGRAXOFUSP-ERZS 10 MCG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9269 |
INJ. TAGRAXOFUSP-ERZS 10 MCG |
MAXFEE |
DEF |
|
|
|
|
322.60 |
7/1/2023 |
12/31/2299 |
N |
J9271 |
INJ PEMBROLIZUMAB |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9271 |
INJ PEMBROLIZUMAB |
MAXFEE |
DEF |
|
|
|
|
54.81 |
7/1/2023 |
12/31/2299 |
N |
J9272 |
INJ; DOSTARLIMAB-GXLY; 10 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9272 |
INJ; DOSTARLIMAB-GXLY; 10 MG |
MAXFEE |
DEF |
|
|
|
|
226.93 |
7/1/2023 |
12/31/2299 |
N |
J9273 |
INJ TISOTU VEDOTIN-TFTV; 1MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9273 |
INJ TISOTU VEDOTIN-TFTV; 1MG |
MAXFEE |
DEF |
|
|
|
|
162.05 |
7/1/2023 |
12/31/2299 |
N |
J9274 |
INJ; TEBENTAFUSP-TEBN; 1 MCG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
Y |
J9274 |
INJ; TEBENTAFUSP-TEBN; 1 MCG |
MAXFEE |
DEF |
|
|
|
|
203.83 |
7/1/2023 |
12/31/2299 |
Y |
J9280 |
MITOMYCIN INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9280 |
MITOMYCIN INJECTION |
MAXFEE |
DEF |
|
|
|
|
79.02 |
7/1/2023 |
12/31/2299 |
N |
J9281 |
MITOMYCIN INSTILLATION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9281 |
MITOMYCIN INSTILLATION |
MAXFEE |
DEF |
|
|
|
|
296.17 |
7/1/2023 |
12/31/2299 |
N |
J9285 |
INJ; OLARATUMAB; 10 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9285 |
INJ; OLARATUMAB; 10 MG |
MAXFEE |
DEF |
|
|
|
|
52.07 |
4/1/2020 |
12/31/2299 |
N |
J9293 |
MITOXANTRONE HYDROCHL / 5 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9293 |
MITOXANTRONE HYDROCHL / 5 MG |
MAXFEE |
DEF |
|
|
|
|
29.06 |
7/1/2023 |
12/31/2299 |
N |
J9294 |
INJ PEMETREXED; HOSPIRA 10MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9294 |
INJ PEMETREXED; HOSPIRA 10MG |
MAXFEE |
DEF |
|
|
|
|
10 |
7/1/2023 |
12/31/2299 |
N |
J9295 |
INJECTION; NECITUMUMAB; 1 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9295 |
INJECTION; NECITUMUMAB; 1 MG |
MAXFEE |
DEF |
|
|
|
|
5.74 |
1/1/2021 |
12/31/2299 |
N |
J9296 |
INJ PEMETREXED (ACCORD) 10MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9296 |
INJ PEMETREXED (ACCORD) 10MG |
MAXFEE |
DEF |
|
|
|
|
9.66 |
7/1/2023 |
12/31/2299 |
N |
J9297 |
INJ PEMETREXED (SANDOZ) 10MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9297 |
INJ PEMETREXED (SANDOZ) 10MG |
MAXFEE |
DEF |
|
|
|
|
1.73 |
7/1/2023 |
12/31/2299 |
N |
J9298 |
INJ NIVOL RELATLIMAB 3MG/1MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9298 |
INJ NIVOL RELATLIMAB 3MG/1MG |
MAXFEE |
DEF |
|
|
|
|
183.63 |
7/1/2023 |
12/31/2299 |
N |
J9299 |
INJECTION; NIVOLUMAB |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9299 |
INJECTION; NIVOLUMAB |
MAXFEE |
DEF |
|
|
|
|
30.46 |
7/1/2023 |
12/31/2299 |
N |
J9300 |
GEMTUZUMAB OZOGAMICIN INJ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9300 |
GEMTUZUMAB OZOGAMICIN INJ |
MAXFEE |
DEF |
|
|
|
|
NA |
|
|
N |
J9301 |
OBINUTUZUMAB INJ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9301 |
OBINUTUZUMAB INJ |
MAXFEE |
DEF |
|
|
|
|
70.55 |
7/1/2023 |
12/31/2299 |
N |
J9302 |
OFATUMUMAB INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9302 |
OFATUMUMAB INJECTION |
MAXFEE |
DEF |
|
|
|
|
63.96 |
7/1/2021 |
12/31/2299 |
N |
J9303 |
PANITUMUMAB INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9303 |
PANITUMUMAB INJECTION |
MAXFEE |
DEF |
|
|
|
|
149.71 |
7/1/2023 |
12/31/2299 |
N |
J9304 |
INJ. PEMETREXED; 10 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9304 |
INJ. PEMETREXED; 10 MG |
MAXFEE |
DEF |
|
|
|
|
64.48 |
7/1/2023 |
12/31/2299 |
N |
J9305 |
INJ. PEMETREXED NOS 10MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9305 |
INJ. PEMETREXED NOS 10MG |
MAXFEE |
DEF |
|
|
|
|
7.93 |
7/1/2023 |
12/31/2299 |
N |
J9306 |
INJECTION; PERTUZUMAB; 1 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9306 |
INJECTION; PERTUZUMAB; 1 MG |
MAXFEE |
DEF |
|
|
|
|
15.37 |
7/1/2023 |
12/31/2299 |
N |
J9307 |
PRALATREXATE INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9307 |
PRALATREXATE INJECTION |
MAXFEE |
DEF |
|
|
|
|
356.51 |
7/1/2023 |
12/31/2299 |
N |
J9308 |
INJECTION; RAMUCIRUMAB |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9308 |
INJECTION; RAMUCIRUMAB |
MAXFEE |
DEF |
|
|
|
|
68.87 |
7/1/2023 |
12/31/2299 |
N |
J9309 |
INJ; POLATUZUMAB VEDOTIN 1MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9309 |
INJ; POLATUZUMAB VEDOTIN 1MG |
MAXFEE |
DEF |
|
|
|
|
121.25 |
7/1/2023 |
12/31/2299 |
N |
J9311 |
INJ RITUXIMAB; HYALURONIDASE |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9311 |
INJ RITUXIMAB; HYALURONIDASE |
MAXFEE |
DEF |
|
|
|
|
37.46 |
7/1/2023 |
12/31/2299 |
N |
J9312 |
INJ.; RITUXIMAB; 10 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9312 |
INJ.; RITUXIMAB; 10 MG |
MAXFEE |
DEF |
|
|
|
|
81.04 |
7/1/2023 |
12/31/2299 |
N |
J9313 |
INJ.; LUMOXITI; 0.01 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9313 |
INJ.; LUMOXITI; 0.01 MG |
MAXFEE |
DEF |
|
|
|
|
23.39 |
4/1/2021 |
12/31/2299 |
N |
J9314 |
INJ PEMETREXED (TEVA) 10MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9314 |
INJ PEMETREXED (TEVA) 10MG |
MAXFEE |
DEF |
|
|
|
|
12.30 |
7/1/2023 |
12/31/2299 |
N |
J9315 |
ROMIDEPSIN INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9315 |
ROMIDEPSIN INJECTION |
MAXFEE |
DEF |
|
|
|
|
336.84 |
7/1/2021 |
12/31/2299 |
N |
J9316 |
PERTUZU; TRASTUZU; 10 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9316 |
PERTUZU; TRASTUZU; 10 MG |
MAXFEE |
DEF |
|
|
|
|
68.21 |
7/1/2023 |
12/31/2299 |
N |
J9317 |
SACITUZUMAB GOVITECAN-HZIY |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9317 |
SACITUZUMAB GOVITECAN-HZIY |
MAXFEE |
DEF |
|
|
|
|
33.32 |
7/1/2023 |
12/31/2299 |
N |
J9318 |
INJ ROMIDEPSIN NON-LYO 0.1MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9318 |
INJ ROMIDEPSIN NON-LYO 0.1MG |
MANUAL |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9319 |
INJ ROMIDEPSIN LYOPHIL 0.1MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9319 |
INJ ROMIDEPSIN LYOPHIL 0.1MG |
MAXFEE |
DEF |
|
|
|
|
30.37 |
7/1/2023 |
12/31/2299 |
N |
J9320 |
STREPTOZOCIN INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9320 |
STREPTOZOCIN INJECTION |
MAXFEE |
DEF |
|
|
|
|
370.18 |
1/1/2023 |
12/31/2299 |
N |
J9322 |
Inj pemetrexed (bluepoint) |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9322 |
Inj pemetrexed (bluepoint) |
MAXFEE |
DEF |
|
|
|
|
17.12 |
7/1/2023 |
12/31/2299 |
N |
J9323 |
INJ PEMETREXED DITROMETHAMIN |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9323 |
INJ PEMETREXED DITROMETHAMIN |
MAXFEE |
DEF |
|
|
|
|
11.77 |
7/1/2023 |
12/31/2299 |
N |
J9325 |
INJ TALIMOGENE LAHERPAREPVEC |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9325 |
INJ TALIMOGENE LAHERPAREPVEC |
MAXFEE |
DEF |
|
|
|
|
66.05 |
7/1/2023 |
12/31/2299 |
N |
J9328 |
TEMOZOLOMIDE INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9328 |
TEMOZOLOMIDE INJECTION |
MAXFEE |
DEF |
|
|
|
|
10.41 |
7/1/2023 |
12/31/2299 |
N |
J9330 |
TEMSIROLIMUS INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9330 |
TEMSIROLIMUS INJECTION |
MAXFEE |
DEF |
|
|
|
|
33.64 |
7/1/2023 |
12/31/2299 |
N |
J9331 |
INJ SIROLIMUS PROT PART 1 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9331 |
INJ SIROLIMUS PROT PART 1 MG |
MAXFEE |
DEF |
|
|
|
|
107.61 |
7/1/2023 |
12/31/2299 |
N |
J9332 |
INJ EFGARTIGIMOD 2MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9332 |
INJ EFGARTIGIMOD 2MG |
MAXFEE |
DEF |
|
|
|
|
31.81 |
7/1/2023 |
12/31/2299 |
N |
J9340 |
THIOTEPA INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9340 |
THIOTEPA INJECTION |
MAXFEE |
DEF |
|
|
|
|
259.56 |
7/1/2023 |
12/31/2299 |
N |
J9347 |
Inj; tremelimumab-actl; 1 mg |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9347 |
Inj; tremelimumab-actl; 1 mg |
MAXFEE |
DEF |
|
|
|
|
136.56 |
7/1/2023 |
12/31/2299 |
N |
J9348 |
INJ. NAXITAMAB-GQGK; 1 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9348 |
INJ. NAXITAMAB-GQGK; 1 MG |
MAXFEE |
DEF |
|
|
|
|
579.65 |
7/1/2023 |
12/31/2299 |
N |
J9349 |
INJ.; TAFASITAMAB-CXIX |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9349 |
INJ.; TAFASITAMAB-CXIX |
MAXFEE |
DEF |
|
|
|
|
13.30 |
7/1/2023 |
12/31/2299 |
N |
J9350 |
TOPOTECAN INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9350 |
TOPOTECAN INJECTION |
MAXFEE |
DEF |
|
|
|
|
635.64 |
7/1/2023 |
12/31/2299 |
N |
J9351 |
TOPOTECAN INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9351 |
TOPOTECAN INJECTION |
MAXFEE |
DEF |
|
|
|
|
0.50 |
7/1/2023 |
12/31/2299 |
N |
J9352 |
INJECTION TRABECTEDIN 0.1MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9352 |
INJECTION TRABECTEDIN 0.1MG |
MAXFEE |
DEF |
|
|
|
|
337.28 |
7/1/2023 |
12/31/2299 |
N |
J9353 |
INJ. MARGETUXIMAB-CMKB; 5 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9353 |
INJ. MARGETUXIMAB-CMKB; 5 MG |
MAXFEE |
DEF |
|
|
|
|
45.88 |
7/1/2023 |
12/31/2299 |
N |
J9354 |
INJ; ADO-TRASTUZUMAB EMT 1MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9354 |
INJ; ADO-TRASTUZUMAB EMT 1MG |
MAXFEE |
DEF |
|
|
|
|
38.33 |
7/1/2023 |
12/31/2299 |
N |
J9355 |
INJ TRASTUZUMAB EXCL BIOSIMI |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9355 |
INJ TRASTUZUMAB EXCL BIOSIMI |
MAXFEE |
DEF |
|
|
|
|
81.08 |
7/1/2023 |
12/31/2299 |
N |
J9356 |
INJ. HERCEPTIN HYLECTA; 10MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9356 |
INJ. HERCEPTIN HYLECTA; 10MG |
MAXFEE |
DEF |
|
|
|
|
65.58 |
7/1/2023 |
12/31/2299 |
N |
J9357 |
VALRUBICIN INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9357 |
VALRUBICIN INJECTION |
MAXFEE |
DEF |
|
|
|
|
1391.80 |
7/1/2023 |
12/31/2299 |
N |
J9358 |
INJ FAM-TRASTU DERU-NXKI 1MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9358 |
INJ FAM-TRASTU DERU-NXKI 1MG |
MAXFEE |
DEF |
|
|
|
|
26.24 |
7/1/2023 |
12/31/2299 |
N |
J9359 |
INJ LON TESIRIN-LPYL 0.075MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9359 |
INJ LON TESIRIN-LPYL 0.075MG |
MAXFEE |
DEF |
|
|
|
|
196.45 |
7/1/2023 |
12/31/2299 |
N |
J9360 |
VINBLASTINE SULFATE INJ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9360 |
VINBLASTINE SULFATE INJ |
MAXFEE |
DEF |
|
|
|
|
3.95 |
7/1/2023 |
12/31/2299 |
N |
J9370 |
VINCRISTINE SULFATE 1 MG INJ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9370 |
VINCRISTINE SULFATE 1 MG INJ |
MAXFEE |
DEF |
|
|
|
|
7.49 |
7/1/2023 |
12/31/2299 |
N |
J9371 |
INJ; VINCRISTINE SUL LIP 1MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9371 |
INJ; VINCRISTINE SUL LIP 1MG |
MAXFEE |
DEF |
|
|
|
|
3420.78 |
1/1/2022 |
12/31/2299 |
N |
J9380 |
VINCRISTINE SULFATE 5 MG INJ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9380 |
VINCRISTINE SULFATE 5 MG INJ |
MAXFEE |
DEF |
|
|
|
|
30.94 |
7/1/2023 |
12/31/2299 |
N |
J9381 |
Inj teplizumab mzwv 5 mcg |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9381 |
Inj teplizumab mzwv 5 mcg |
MAXFEE |
DEF |
|
|
|
|
36.27 |
7/1/2023 |
12/31/2299 |
N |
J9390 |
VINORELBINE TARTRATE INJ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9390 |
VINORELBINE TARTRATE INJ |
MAXFEE |
DEF |
|
|
|
|
8.27 |
7/1/2023 |
12/31/2299 |
N |
J9393 |
INJ; FULVESTRANT (TEVA) |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9393 |
INJ; FULVESTRANT (TEVA) |
MAXFEE |
DEF |
|
|
|
|
21.20 |
7/1/2023 |
12/31/2299 |
N |
J9394 |
INJ; FULVESTRANT (FRESENIUS) |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9394 |
INJ; FULVESTRANT (FRESENIUS) |
MAXFEE |
DEF |
|
|
|
|
1.65 |
7/1/2023 |
12/31/2299 |
N |
J9395 |
INJECTION; FULVESTRANT |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9395 |
INJECTION; FULVESTRANT |
MAXFEE |
DEF |
|
|
|
|
9.47 |
7/1/2023 |
12/31/2299 |
N |
J9400 |
INJ; ZIV-AFLIBERCEPT; 1MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9400 |
INJ; ZIV-AFLIBERCEPT; 1MG |
MAXFEE |
DEF |
|
|
|
|
6.81 |
7/1/2023 |
12/31/2299 |
N |
J9600 |
PORFIMER SODIUM INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9600 |
PORFIMER SODIUM INJECTION |
MAXFEE |
DEF |
|
|
|
|
19906.23 |
9/1/2013 |
12/31/2299 |
N |
J9999 |
CHEMOTHERAPY DRUG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
J9999 |
CHEMOTHERAPY DRUG |
MANUAL |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
K1034 |
COVID TEST SELF-ADMN/COLLECT |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
K1034 |
COVID TEST SELF-ADMN/COLLECT |
MAXFEE |
DEF |
|
|
|
|
12 |
4/4/2022 |
12/31/2299 |
N |
M0201 |
COVID-19 VACCINE HOME ADMIN |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
M0201 |
COVID-19 VACCINE HOME ADMIN |
MAXFEE |
OTH |
|
|
|
|
64.55 |
7/1/2023 |
12/31/2299 |
N |
M0201 |
COVID-19 VACCINE HOME ADMIN |
MAXFEE |
DEF |
|
|
|
|
35.45 |
7/1/2023 |
12/31/2299 |
N |
Q0138 |
FERUMOXYTOL; NON-ESRD |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q0138 |
FERUMOXYTOL; NON-ESRD |
MAXFEE |
DEF |
|
|
|
|
0.50 |
7/1/2023 |
12/31/2299 |
N |
Q0139 |
FERUMOXYTOL; ESRD USE |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q0139 |
FERUMOXYTOL; ESRD USE |
MAXFEE |
DEF |
|
|
|
|
0.50 |
7/1/2023 |
12/31/2299 |
N |
Q0161 |
CHLORPROMAZINE HCL 5MG ORAL |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q0161 |
CHLORPROMAZINE HCL 5MG ORAL |
MANUAL |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q0515 |
SERMORELIN ACETATE INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q0515 |
SERMORELIN ACETATE INJECTION |
MAXFEE |
DEF |
|
|
|
|
1.80 |
7/1/2009 |
12/31/2299 |
N |
Q2009 |
FOSPHENYTOIN INJ PE |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q2009 |
FOSPHENYTOIN INJ PE |
MAXFEE |
DEF |
|
|
|
|
1.41 |
4/1/2014 |
12/31/2299 |
N |
Q2017 |
TENIPOSIDE; 50 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q2017 |
TENIPOSIDE; 50 MG |
MAXFEE |
DEF |
|
|
|
|
346.95 |
1/1/2014 |
12/31/2299 |
N |
Q2026 |
RADIESSE INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q2026 |
RADIESSE INJECTION |
MANUAL |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q2027 |
SCULPTRA INJECTION |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q2027 |
SCULPTRA INJECTION |
MANUAL |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q2033 |
INFLUENZA VACCINE; (FLUBLOK) |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q2033 |
INFLUENZA VACCINE; (FLUBLOK) |
MANUAL |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q2034 |
AGRIFLU VACCINE |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q2034 |
AGRIFLU VACCINE |
MANUAL |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q2035 |
AFLURIA VACC; 3 YRS & >; IM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q2035 |
AFLURIA VACC; 3 YRS & >; IM |
MAXFEE |
DEF |
|
|
|
|
20.97 |
1/1/2020 |
12/31/2299 |
N |
Q2039 |
INFLUENZA VIRUS VACCINE; NOS |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q2039 |
INFLUENZA VIRUS VACCINE; NOS |
MAXFEE |
DEF |
|
|
|
|
NA |
|
|
N |
Q2042 |
TISAGENLECLEUCEL CAR-POS T |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q2042 |
TISAGENLECLEUCEL CAR-POS T |
MAXFEE |
DEF |
|
|
|
|
NA |
|
|
N |
Q2043 |
SIPULEUCEL-T AUTO CD54+ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q2043 |
SIPULEUCEL-T AUTO CD54+ |
MAXFEE |
DEF |
|
|
|
|
53062.44 |
7/1/2023 |
12/31/2299 |
N |
Q2049 |
IMPORTED LIPODOX INJ |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q2049 |
IMPORTED LIPODOX INJ |
MAXFEE |
DEF |
|
|
|
|
508.43 |
11/1/2014 |
12/31/2299 |
N |
Q2050 |
DOXORUBICIN INJ 10MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q2050 |
DOXORUBICIN INJ 10MG |
MAXFEE |
DEF |
|
|
|
|
87.98 |
7/1/2023 |
12/31/2299 |
N |
Q2053 |
BREXUCABTAGENE CAR POS T |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q2053 |
BREXUCABTAGENE CAR POS T |
MAXFEE |
DEF |
|
|
|
|
449440 |
7/1/2023 |
12/31/2299 |
N |
Q3027 |
INJ BETA INTERFERON IM 1 MCG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q3027 |
INJ BETA INTERFERON IM 1 MCG |
MAXFEE |
DEF |
|
|
|
|
53.15 |
7/1/2023 |
12/31/2299 |
N |
Q3028 |
INJ BETA INTERFERON SQ 1 MCG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q3028 |
INJ BETA INTERFERON SQ 1 MCG |
MANUAL |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q4074 |
ILOPROST NON-COMP UNIT DOSE |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q4074 |
ILOPROST NON-COMP UNIT DOSE |
MAXFEE |
DEF |
|
|
|
|
144.43 |
7/1/2023 |
12/31/2299 |
N |
Q4081 |
EPOETIN ALFA; 100 UNITS ESRD |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q4081 |
EPOETIN ALFA; 100 UNITS ESRD |
MAXFEE |
DEF |
|
|
|
|
0.69 |
7/1/2023 |
12/31/2299 |
N |
Q4171 |
INTERFYL; 1 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q4171 |
INTERFYL; 1 MG |
MAXFEE |
DEF |
|
|
|
|
12.99 |
7/1/2023 |
12/31/2299 |
N |
Q4272 |
Esano a; per sq cm |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q4272 |
Esano a; per sq cm |
MAXFEE |
DEF |
|
|
|
|
0 |
7/1/2023 |
12/31/2299 |
N |
Q4273 |
Esano aaa; per sq cm |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q4273 |
Esano aaa; per sq cm |
MAXFEE |
DEF |
|
|
|
|
0 |
7/1/2023 |
12/31/2299 |
N |
Q4274 |
Esano ac; per sq cm |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q4274 |
Esano ac; per sq cm |
MAXFEE |
DEF |
|
|
|
|
0 |
7/1/2023 |
12/31/2299 |
N |
Q4275 |
Esano aca; per sq cm |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q4275 |
Esano aca; per sq cm |
MAXFEE |
DEF |
|
|
|
|
0 |
7/1/2023 |
12/31/2299 |
N |
Q4276 |
Orion; per sq cm |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q4276 |
Orion; per sq cm |
MAXFEE |
DEF |
|
|
|
|
0 |
7/1/2023 |
12/31/2299 |
N |
Q4277 |
Woundplus e-grat; per sq cm |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q4277 |
Woundplus e-grat; per sq cm |
MAXFEE |
DEF |
|
|
|
|
0 |
7/1/2023 |
12/31/2299 |
N |
Q4278 |
Epieffect; per sq cm |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q4278 |
Epieffect; per sq cm |
MAXFEE |
DEF |
|
|
|
|
0 |
7/1/2023 |
12/31/2299 |
N |
Q4280 |
Xcell amnio matrix per sq cm |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q4280 |
Xcell amnio matrix per sq cm |
MAXFEE |
DEF |
|
|
|
|
0 |
7/1/2023 |
12/31/2299 |
N |
Q4281 |
Barrera slor dl per sq cm |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q4281 |
Barrera slor dl per sq cm |
MAXFEE |
DEF |
|
|
|
|
0 |
7/1/2023 |
12/31/2299 |
N |
Q4282 |
Cygnus dual per sq cm |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q4282 |
Cygnus dual per sq cm |
MAXFEE |
DEF |
|
|
|
|
0 |
7/1/2023 |
12/31/2299 |
N |
Q4283 |
Biovance tri or 3l; sq cm |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q4283 |
Biovance tri or 3l; sq cm |
MAXFEE |
DEF |
|
|
|
|
0 |
7/1/2023 |
12/31/2299 |
N |
Q4284 |
Dermabind sl; per sq cm |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q4284 |
Dermabind sl; per sq cm |
MAXFEE |
DEF |
|
|
|
|
0 |
7/1/2023 |
12/31/2299 |
N |
Q5101 |
INJECTION; ZARXIO |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q5101 |
INJECTION; ZARXIO |
MAXFEE |
DEF |
|
|
|
|
0.18 |
7/1/2023 |
12/31/2299 |
N |
Q5103 |
INJECTION; INFLECTRA |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q5103 |
INJECTION; INFLECTRA |
MAXFEE |
DEF |
|
|
|
|
18.43 |
7/1/2023 |
12/31/2299 |
N |
Q5104 |
INJECTION; RENFLEXIS |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q5104 |
INJECTION; RENFLEXIS |
MAXFEE |
DEF |
|
|
|
|
35.55 |
7/1/2023 |
12/31/2299 |
N |
Q5105 |
INJ RETACRIT ESRD ON DIALYSI |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q5105 |
INJ RETACRIT ESRD ON DIALYSI |
MAXFEE |
DEF |
|
|
|
|
0.75 |
7/1/2023 |
12/31/2299 |
N |
Q5106 |
INJ RETACRIT NON-ESRD USE |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q5106 |
INJ RETACRIT NON-ESRD USE |
MAXFEE |
DEF |
|
|
|
|
7.50 |
7/1/2023 |
12/31/2299 |
N |
Q5107 |
INJ MVASI 10 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q5107 |
INJ MVASI 10 MG |
MAXFEE |
DEF |
|
|
|
|
28.40 |
7/1/2023 |
12/31/2299 |
N |
Q5108 |
INJECTION; FULPHILA |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q5108 |
INJECTION; FULPHILA |
MAXFEE |
DEF |
|
|
|
|
111.15 |
7/1/2023 |
12/31/2299 |
N |
Q5109 |
INJECTION; IXIFI; 10 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q5109 |
INJECTION; IXIFI; 10 MG |
MAXFEE |
DEF |
|
|
|
|
101.25 |
1/1/2019 |
12/31/2299 |
N |
Q5110 |
NIVESTYM |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q5110 |
NIVESTYM |
MAXFEE |
DEF |
|
|
|
|
0.33 |
4/1/2023 |
12/31/2299 |
N |
Q5111 |
INJECTION; UDENYCA 0.5 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q5111 |
INJECTION; UDENYCA 0.5 MG |
MANUAL |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q5112 |
INJ ONTRUZANT 10 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q5112 |
INJ ONTRUZANT 10 MG |
MAXFEE |
DEF |
|
|
|
|
46.93 |
7/1/2023 |
12/31/2299 |
N |
Q5113 |
INJ HERZUMA 10 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q5113 |
INJ HERZUMA 10 MG |
MAXFEE |
DEF |
|
|
|
|
29.87 |
7/1/2023 |
12/31/2299 |
N |
Q5114 |
INJ OGIVRI 10 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q5114 |
INJ OGIVRI 10 MG |
MAXFEE |
DEF |
|
|
|
|
40.41 |
7/1/2023 |
12/31/2299 |
N |
Q5115 |
INJ TRUXIMA 10 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q5115 |
INJ TRUXIMA 10 MG |
MAXFEE |
DEF |
|
|
|
|
39.79 |
7/1/2023 |
12/31/2299 |
N |
Q5116 |
INJ.; TRAZIMERA; 10 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q5116 |
INJ.; TRAZIMERA; 10 MG |
MAXFEE |
DEF |
|
|
|
|
23.15 |
7/1/2023 |
12/31/2299 |
N |
Q5117 |
INJ.; KANJINTI; 10 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q5117 |
INJ.; KANJINTI; 10 MG |
MAXFEE |
DEF |
|
|
|
|
23.96 |
7/1/2023 |
12/31/2299 |
N |
Q5118 |
INJ.; ZIRABEV; 10 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q5118 |
INJ.; ZIRABEV; 10 MG |
MAXFEE |
DEF |
|
|
|
|
28.19 |
7/1/2023 |
12/31/2299 |
N |
Q5119 |
INJ RUXIENCE; 10 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q5119 |
INJ RUXIENCE; 10 MG |
MAXFEE |
DEF |
|
|
|
|
27.51 |
7/1/2023 |
12/31/2299 |
N |
Q5120 |
INJ PEGFILGRASTIM-BMEZ 0.5MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q5120 |
INJ PEGFILGRASTIM-BMEZ 0.5MG |
MAXFEE |
DEF |
|
|
|
|
30.05 |
7/1/2023 |
12/31/2299 |
N |
Q5121 |
INJ. AVSOLA; 10 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q5121 |
INJ. AVSOLA; 10 MG |
MAXFEE |
DEF |
|
|
|
|
28.33 |
7/1/2023 |
12/31/2299 |
N |
Q5122 |
INJ; NYVEPRIA |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q5122 |
INJ; NYVEPRIA |
MAXFEE |
DEF |
|
|
|
|
101.89 |
7/1/2023 |
12/31/2299 |
N |
Q5123 |
INJ. RIABNI; 10 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q5123 |
INJ. RIABNI; 10 MG |
MAXFEE |
DEF |
|
|
|
|
44.58 |
7/1/2023 |
12/31/2299 |
N |
Q5124 |
INJ. BYOOVIZ; 0.1 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q5124 |
INJ. BYOOVIZ; 0.1 MG |
MAXFEE |
DEF |
|
|
|
|
220.83 |
7/1/2023 |
12/31/2299 |
N |
Q5125 |
INJ; RELEUKO 1 MCG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q5125 |
INJ; RELEUKO 1 MCG |
MAXFEE |
DEF |
|
|
|
|
0.59 |
4/1/2023 |
12/31/2299 |
N |
Q5126 |
INJ ALYMSYS 10 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q5126 |
INJ ALYMSYS 10 MG |
MAXFEE |
DEF |
|
|
|
|
72.52 |
7/1/2023 |
12/31/2299 |
N |
Q5127 |
INJ; STIMUFEND; 0.5 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q5127 |
INJ; STIMUFEND; 0.5 MG |
MAXFEE |
DEF |
|
|
|
|
620.45 |
4/1/2023 |
12/31/2299 |
N |
Q5128 |
INJ; CIMERLI; 0.1 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q5128 |
INJ; CIMERLI; 0.1 MG |
MAXFEE |
DEF |
|
|
|
|
279.50 |
7/1/2023 |
12/31/2299 |
N |
Q5129 |
INJ; VEGZELMA; 10 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q5129 |
INJ; VEGZELMA; 10 MG |
MAXFEE |
DEF |
|
|
|
|
18.12 |
4/1/2023 |
12/31/2299 |
N |
Q5130 |
INJ; FYLNETRA; 0.5 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q5130 |
INJ; FYLNETRA; 0.5 MG |
MAXFEE |
DEF |
|
|
|
|
354.16 |
4/1/2023 |
12/31/2299 |
N |
Q5131 |
Inj; idacio; 20 mg |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q5131 |
Inj; idacio; 20 mg |
MAXFEE |
DEF |
|
|
|
|
0 |
7/1/2023 |
12/31/2299 |
N |
Q9950 |
INJ SULF HEXA LIPID MICROSPH |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q9950 |
INJ SULF HEXA LIPID MICROSPH |
MAXFEE |
DEF |
|
|
|
|
19 |
7/1/2023 |
12/31/2299 |
N |
Q9951 |
LOCM >= 400 MG/ML IODINE;1ML |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q9951 |
LOCM >= 400 MG/ML IODINE;1ML |
MANUAL |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q9954 |
ORAL MR CONTRAST; 100 ML |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q9954 |
ORAL MR CONTRAST; 100 ML |
MAXFEE |
DEF |
|
|
|
|
11.66 |
9/1/2013 |
12/31/2299 |
N |
Q9955 |
INJ PERFLEXANE LIP MICROS;ML |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q9955 |
INJ PERFLEXANE LIP MICROS;ML |
MAXFEE |
DEF |
|
|
|
|
13.25 |
9/1/2005 |
12/31/2299 |
N |
Q9957 |
INJ PERFLUTREN LIP MICROS;ML |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q9957 |
INJ PERFLUTREN LIP MICROS;ML |
MAXFEE |
DEF |
|
|
|
|
49.06 |
4/1/2023 |
12/31/2299 |
N |
Q9957 |
INJ PERFLUTREN LIP MICROS;ML |
MAXFEE |
DEF |
|
|
|
|
42.72 |
7/1/2023 |
12/31/2299 |
N |
Q9965 |
LOCM 100-199MG/ML IODINE;1ML |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q9965 |
LOCM 100-199MG/ML IODINE;1ML |
MAXFEE |
DEF |
|
|
|
|
1.31 |
7/1/2023 |
12/31/2299 |
N |
Q9966 |
LOCM 200-299MG/ML IODINE;1ML |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q9966 |
LOCM 200-299MG/ML IODINE;1ML |
MAXFEE |
DEF |
|
|
|
|
0.37 |
7/1/2023 |
12/31/2299 |
N |
Q9967 |
LOCM 300-399MG/ML IODINE;1ML |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q9967 |
LOCM 300-399MG/ML IODINE;1ML |
MAXFEE |
DEF |
|
|
|
|
0.13 |
7/1/2023 |
12/31/2299 |
N |
Q9978 |
NETUPITANT PALONOSETRON ORAL |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q9978 |
NETUPITANT PALONOSETRON ORAL |
MANUAL |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q9982 |
FLUTEMETAMOL F18 DIAGNOSTIC |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q9982 |
FLUTEMETAMOL F18 DIAGNOSTIC |
MAXFEE |
DEF |
|
|
|
|
28248 |
7/1/2016 |
12/31/2299 |
N |
Q9983 |
FLORBETABEN F18 DIAGNOSTIC |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q9983 |
FLORBETABEN F18 DIAGNOSTIC |
MANUAL |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q9991 |
BUPRENORPH XR 100 MG OR LESS |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q9991 |
BUPRENORPH XR 100 MG OR LESS |
MAXFEE |
DEF |
|
|
|
|
1886.37 |
7/1/2023 |
12/31/2299 |
N |
Q9992 |
BUPRENORPHINE XR OVER 100 MG |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
Q9992 |
BUPRENORPHINE XR OVER 100 MG |
MAXFEE |
DEF |
|
|
|
|
1886.37 |
7/1/2023 |
12/31/2299 |
N |
S1091 |
STENT NON-CORONARY PROPEL |
PRXOVR |
DEF |
|
|
|
|
NA |
NA |
NA |
N |
S1091 |
STENT NON-CORONARY PROPEL |
MAXFEE |
DEF |
|
|
|
|
1444.50 |
4/1/2021 |
12/31/2299 |
N |